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ABSTRACT
Previous studies have suggested that children with Fetal Alcohol Spectrum
Disorder (FASD) display hypersensitivity to light touch. In support of this notion,
we have demonstrated that applying a chronic constriction injury (CCI) to the
sciatic nerve of rats that have prenatal alcohol exposure (PAE) results in
heightened sensitivity to light touch, clinically termed allodynia. These
observations coincided with heightened glial activation and enhanced peripheral
immune reactivity. Considering allodynia is known to be mediated by both
peripheral immune responses and spinal glial activation, it is reasonable to
speculate that allodynia following PAE may be mediated through an alteration of
immune reactivity. Thus, I hypothesized that PAE results in immune sensitization
leading to enhanced susceptibility to developing allodynia.
To address the possibility that PAE creates susceptibility to developing
neuropathy, a minor CCI was applied to rats that have been prenatally exposed
to saccharin (Sac) or alcohol (PAE). Induction of allodynia occurs only in PAE
rats with a minor injury. Interestingly, data acquired by immunohistochemistry
(IHC) and subsequent microscopy analyses show that spinal astrocyte activation
was altered compared to Sac rats. Furthermore, pharmacological blockade of
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spinal cytokines leading to reduced allodynia also demonstrate an alteration in
the proinflammatory cytokine profile at the spinal cord and the sciatic nerve.
Strikingly, PAE resulted in downregulation of normal IL-10 responses within the
spinal cord and dorsal root ganglia (DRG) as shown by IHC. Additionally, satellite
glial cells were activated in the DRG compared to controls which coincided with
heightened expression of the proinflammatory cytokine IL-1. Spinal cord IHC
analysis of glutamate transporters demonstrated that PAE alone is sufficient to
upregulate both glutamate transporter 1 (GLT-1) and the astrocyte specific
transporter glutamate aspartate transporter (GLAST) followed by a
downregulation after minor CCI. These data suggest that an increase in synaptic
and peri-synaptic glutamate develops following minor injury that is regulated
predominantly by glia. Interestingly, no significant change was seen in the
neuronal specific transporter EAAC1 or in NMDA receptor subunits.
Collectively, the work described and presented in this dissertation
demonstrates that PAE primes peripheral and spinal neuroimmune responses
which lead to allodynia following minor CCI. Additionally, my data demonstrate
that PAE may alter glutamate transporters in the spinal cord which may lead to
continued heightened glial activation and increased cytokine actions following
injury. Furthermore, our studies support the possibility that glial cells are
sensitized as a consequence of PAE, which in turn influence neuronal activity.
Taken together, the results from this work demonstrate that PAE leads to lifelong susceptibility to developing allodynia.
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Chapter 1
Introduction
Fetal alcohol spectrum disorder (FASD) is caused by exposure to alcohol during
gestation and results in a continuum of disabilities ranging from mild to severe
that includes cognitive (i.e. intellectual ability, learning, and memory) and
behavioral (e.g. mood, attention, and impulse control) deficits (Mattson et al.,
1998). In 2017, a study showed that globally 10% of women consume alcohol
while pregnant (Popova et al., 2017). Additionally, it has been shown that the
prevalence of FASD is 2% to 5% within the United States (May et al., 2014).
Unfortunately, many of these children with FASD either go undiagnosed or
misdiagnosed (Chasnoff et al., 2015).
Early studies began by describing many issues as a result of alcohol
exposure during gestation such as physical facial characteristics as well as
cognitive disorders. Many of these studies focus on women who consumed large
amounts of alcohol during pregnancy. As research on FASD has grown, we have
quickly learned that even small amounts of alcohol during pregnancy can result
in abnormalities. Many of these abnormalities may not be physical, and more so,
some may not be detected until later in life. Over 40 years of research through
clinical studies and in animal models of FASD have focused on issues that range
from physical alterations to cognitive disorders as well as sensory disorders.
The first studies demonstrating sensory alterations in children with FASD
was done by Morse and Cermak (Morse and Cermak, 1994). These studies
describe many characteristics of sensory processing disorders (SPD) in FASD
children. Interestingly, ensuing studies done by Jirikowic and colleagues support
1

prior findings and demonstrate issues with sensory processing in young schoolaged children with FASD (Jirikowic et al., 2008). In support of this possibility,
studies in rhesus monkey demonstrate that prenatal alcohol exposure (PAE)
leads to light touch hypersensitivity (Schneider et al., 2005). These reports hint at
a potential underlying mechanism of the adverse effects of PAE resulting in
neurological dysfunction.
Clinically, touch hypersensitivity, referred to as allodynia, is a well-known
neuropathic pain condition in patients with peripheral nerve damage. The
neurological mechanisms underlying allodynia are thought to include nonneuronal immune cells that become functionally augmented within the dorsal
horn of the spinal cord. Interestingly, recent reports demonstrate neuroimmune
dysfunction both within the clinic and in animal models of FASD. These studies
uncover that FASD as a result of PAE leads to heightened severity of illness and
dysfunctional immune cell production (McGill et al., 2009).
Interestingly, preclinical studies in the brain show exaggerated release of
proinflammatory cytokine expression following PAE (Topper et al., 2015).
Unfortunately, much of this work has only been demonstrated in brains of
neonates. Little is known about how PAE alters immune function within the spinal
cord which could potentially explain hypersensitivity seen in children with FASD
and in animal models with PAE. Additionally, these reports fail to demonstrate
whether the effects of PAE on neuroimmune function are life-long. Furthermore,
these studies focus primarily on chronic and high PAE to mimic situations such
as binge and heavy drinking. These reports do not characterize the effects of
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moderate exposure to alcohol which would reflect a woman having a drink or two
during pregnancy. Thus, much still needs to be explored on the life-long effects
of moderate PAE. The following sections describe FASD, how moderate PAE
has life-long effects on neuroimmune function, and how these alterations may
result in a heightened susceptibility to developing allodynia.

Fetal Alcohol Spectrum Disorder (FASD)
The effects of prenatal alcohol exposure was first described in 1973 by Jones
and Smith (Jones and Smith, 1973). Here they described Fetal Alcohol
Syndrome (FAS) which shows the most severe symptoms such as growth
abnormalities, facial dysmorphology, as well as fine motor dysfunction (Jones
and Smith, 1973). Although the exact amount of alcohol was not known in this
study, it was known that the mothers were alcoholic women who ingested high
amounts of alcohol throughout pregnancy. As research on FASD has grown we
now know that high amounts of alcohol exposure result in FAS. Along with the
above-mentioned symptoms others include visual, auditory, as well as cardiac
issues (Riley et al., 2011). Interestingly, many symptoms are not correlated with
the amount of alcohol exposure (Bailey et al., 2004). It has been discovered that
the types of symptoms and the severity seem to be a combination of the amount
of alcohol, the pattern of drinking, consistency of drinking, at what developmental
timeframe the mother was drinking, as well as the nutrition of the mother (Sood
et al., 2001; Bailey et al., 2004; Alfonso-Loeches and Guerri, 2011). As a result,
the term “fetal alcohol spectrum disorder” (FASD) was coined to encompass a
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range of severity of symptoms that can be mild to severe. Thus, diagnosed
children fall within an umbrella of FASD, that is, FAS, partial FAS (pFAS), static
encephalopathy/alcohol exposed, and neurobehavioral disorder/alcohol exposed
(Astley et al., 1999).
Since 1973, much has been discovered about FASD children. Outside of
the obvious physical characteristics sometimes observed of FASD in infants,
some symptoms are not known until later in life. Some of these include cognitive
and behavioral problems, learning and memory deficits, as well as issues with
executive and motor function (Burd et al., 2012; Popova et al., 2017). Additionally,
many of these children have issues with social functioning and substance abuse
disorders (Lange et al., 2012; Stevens et al., 2012). Evidently, PAE has
significant functional alterations not readily or overtly detected until later in life.
Unfortunately, the insidious effects of moderate PAE are not well characterized.

Reports on moderate PAE
To date a limited number of reports have been published that show the effects of
a moderate PAE (1 standard drink or 14g of ethanol per day (Valenzuela et al.,
2012)) on children with FASD. Furthermore, of the published studies, none find
any significant issues with moderate drinking and child behavior, IQ scores, or
problems with attention, learning, and cognitive abilities (O'Callaghan et al., 2007;
Robinson et al., 2010; Falgreen Eriksen et al., 2012). Additionally, no issues are
demonstrated in these children up to 5 years of age (Kelly et al., 2010). In
contrast, Murray and colleagues demonstrate that moderate exposure to alcohol
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results in conduct problems such as stealing, lying, and aggressive outburst
(Larkby et al., 2011; Murray et al., 2016). A separate study demonstrates that low
levels of alcohol consumption can influence craniofacial development (Muggli et
al., 2017). Many of these reports have significant limitations which prevents
researchers from making conclusions. For example, in these reports, many of the
women in the study self-reported their alcohol consumption. Additionally, the
blood alcohol content of these women during pregnancy was unknown, thereby
limiting the ability to determine the exact amount of alcohol consumed.
Furthermore, many of these studies could not fully determine whether the cohorts
of children were true representations of the population. Thus, larger cohorts and
extensive details about the children are needed to make definite conclusions
about the effects of moderate PAE. These limitations led Malmuk and colleagues
to conclude that there is no safe limit of alcohol that can be consumed while
pregnant (Mamluk et al., 2017). Interestingly, despite the limited clinical studies
showing significant alterations as a result of moderate PAE, studies using animal
models of PAE have furthered our understanding of the insidious effects of
alcohol exposure.

Shedding light on the effects of PAE using animal models
Many studies using animal models demonstrate the impact that moderate PAE
can have on the central nervous system (CNS). Furthermore, these studies show
that these effects can have life-long implications where some can only be
uncovered following injury or insult. Previous studies utilizing moderate PAE
5

expose rodents to alcohol throughout gestation (human equivalent to first and
second trimester), or postnatally until about Day 8 after birth (third trimester). It
should be noted that a moderate alcohol exposure involves blood alcohol levels
of ≤ 0.17grams/deciliter (g/dl) of alcohol daily where the US legal limit is about
0.08g/dl (Valenzuela et al., 2012). Reports that explore the effects of moderate
PAE focus on both behavioral outcomes and biochemical changes within the
brain.
Interestingly, previous studies demonstrate that moderate exposure to
alcohol results in significant alterations to hippocampal dependent memory
(Savage et al., 2002). Strikingly, this study demonstrates deficits in rodents that
have exposure levels as low as 0.03g/dl. A separate study shows that moderate
PAE also effects learning ability in rodents (Savage et al., 2010). Furthermore,
other studies demonstrate that moderate PAE is able to alter motor coordination,
social behavior, and stress responses (Valenzuela et al., 2012). These studies
provide strong evidence for significant and subtle behavioral alterations as a
result of moderate PAE.
When brains of rodents exposed to moderate amounts of alcohol are
examined, significant cellular phenotype and subcellular alterations are observed.
Many of these rodents that demonstrate issues with learning and memory also
display alterations in glutamate receptors that are crucial for brain function
(Valenzuela et al., 2012). Additionally, changes in neurotransmitters that are
necessary for brain plasticity are observed suggesting a potential mechanism as
to how PAE can alter brain function (Valenzuela et al., 2012). Interestingly,
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studies demonstrate that moderate PAE can alter neurogenesis. One study
demonstrates that although alcohol exposure does not affect the number of
neurons that are able to survive and differentiate within the dentate gyrus;
moderate PAE did affect the neurons ability to increase neurogenesis during
enrichment conditions (Choi et al., 2005). Strikingly, disruption in neurogenesis is
observed in adult rodents suggesting the life-long effects of moderate PAE
(Akers et al., 2014). What many of these studies demonstrate are the significant
consequences of moderate alcohol exposure. The data suggest that despite not
seeing observable consequences of PAE, that underlying consequences can still
be present. It is not until brain function is challenged through various behavioral
tasks that the adverse effects of PAE are observed. The implications for this
could point to the need for more extensive clinical studies where little effects are
observed in children as a result of drinking moderate amount of alcohol during
pregnancy.

Does PAE lead to underlying immune alteration
The first description of immune dysfunction in FASD children was done by
Johnson and colleagues (Johnson et al., 1981). Here they describe that in the
clinic, children with FAS tend to have greater susceptibility to developing
infectious diseases. This report additionally demonstrates alterations in the
formation and migration of the immune cells responsible for fighting against
infection (Johnson et al., 1981). Other studies have shown that children with
FASD do in fact have increased risk for middle ear infections (Church and Gerkin,
7

1988), respiratory infections (Gauthier and Brown, 2017), as well as meningitis
and autoimmune neuromuscular diseases (Chiapelli and Taylor, 1995). Many
observations suggest that alcohol exposure has significant effects on immune
function. Interestingly, previous reports suggest that immune alterations can also
be linked to problems in cognition (Marin and Kipnis, 2013), which may be linked
to impairments seen in FASD children. These reports provide strong evidence for
further exploration of the immune system following PAE.
Interestingly, studies involving PAE animals demonstrate underlying
immune alterations that are not initially apparent. For example one study
demonstrates reduction in neuronal number and alterations in glia specifically
within the dentate gyrus (Uban et al., 2010). This suggests that in addition to
neuronal dysfunction, moderate PAE may also alter neuroimmune function.
Within the CNS, glial cells (astrocytes and microglia) are primarily responsible for
mediating immune reactions and maintaining proper neural function. Microglia
are considered the resident immune cells of the CNS where their primary
function is to protect the CNS from potential infectious agents following insult or
lesion (Kettenmann et al., 2011; Perry and Teeling, 2013). Along with microglia,
astrocytes are also crucial for maintaining the CNS. They have numerous
functions such as being supportive to neurons, regulating blood flow, playing a
role in CNS metabolism, and also maintaining the blood brain barrier (Sofroniew
and Vinters, 2010). In addition to this, astrocytes release various immune factors
responsible for mounting immune reactions similar to microglia (Sofroniew and
Vinters, 2010).
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Upon immune activation, glia are able to secrete proinflammatory
cytokines such as IL-1β, TNF, as well as anti-inflammatory cytokines such as IL10. The release of these immune factors results in neuroinflammatory response
at the site of injury or insult. In addition to this, glia secrete chemokines which
initiate the infiltration of other innate and adaptive immune cells from the
periphery (Gao et al., 2010b; Prinz and Priller, 2017). These factors include the
chemotactic cytokines such as CCL2, CXCL1, CXCL10, and CX3CL1 (Lindia et
al., 2005; Gao et al., 2010b; Liu et al., 2013; Chen et al., 2014). This infiltration of
peripheral leukocytes results in increased expression of proinflammatory
cytokines. Overall, these events result in a heightened immune response that
leads to neuropathology.
Much of the work that has explored the effects of PAE on immune function
utilize third trimester binge alcohol exposure. These studies demonstrate that
alcohol exposure is able to decrease the viability of microglial cells within the
cerebellum (Kane et al., 2011). The blood alcohol levels of 250-325mg/dl may
suggest that viability may be decreased due to the toxic levels of alcohol
exposure (Kane et al., 2011). A separate study utilizing a similar binge alcohol
exposure model demonstrate that within the hippocampus, glial cells have
increased activation compared to controls. Additionally, this study show
increased expression of proinflammatory cytokines IL-1β and the antiinflammatory IL-10. Curiously, this study utilizes a binge alcohol exposure during
the third trimester but only saw their effects during the withdrawal period of
alcohol exposure (Topper et al., 2015). Both of these studies demonstrate the
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alcohol exposure does in fact alter glial function. Unfortunately, these studies do
not examine how a more moderate exposure may affect glia.
A recent study utilizing a moderate PAE during the first and second
trimester explore the effects within the mother and the brains of the offspring.
Interestingly, alcohol exposure increased the expression of IL-1β and the
chemokines macrophage inflammatory protein (MIP) and fractalkine (CX3CL1)
within the maternal sera and amniotic fluid. In addition to this, these immune
factors are increased within the offspring. Furthermore, the offspring demonstrate
activated microglia (Pascual et al., 2017). A separate study utilizing a moderate
PAE during the first and second trimester look at both brain and peripheral
immune responses. This study demonstrates that following alcohol exposure the
expression levels of CCL2, IL-10, and TNFα were all significantly increased
within the cerebral cortex (Terasaki and Schwarz, 2016b). Overall these studies
demonstrate alcohol is able to disrupt basal immune expression in PAE offspring.
Considering these data show that PAE is able to alter the expression of immune
factors, one question that arises is whether alcohol exposure may also affect
immune responses following insult or injury.

The effects of PAE on immune responses following challenge
Many studies that explore the effects of PAE on immune factors have only
demonstrated effects on basal responses. Most of these studies have not
examined whether PAE may alter the function and responses of these immune
cells. Teraski and Schwarz explored the effects of administering the immune
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activator lipopolysaccharide (LPS) to moderate PAE adult offspring (Terasaki and
Schwarz, 2016b). Interestingly, this study found that within the hippocampus,
exaggerated expression of the IL-1β was seen. Additionally, the expression level
of the microglial activation marker CD11b was also increased compared to
control conditions. Peripherally, the levels of IL-1β were also significantly
increased specifically within the spleen following LPS challenge (Terasaki and
Schwarz, 2016b). These studies demonstrate that following immune challenge,
moderate PAE is able to alter both brain and peripheral immune responses.
A separate study examined the effects of moderate PAE on the immune
response following a CNS injury. This report exposed rodents to alcohol
prenatally and inflicted a CNS injury in adult offspring. Interestingly, this study
demonstrates that rodents that are alcohol exposed have a decreased astrocyte
and TNF response following injury compared to control conditions (DeVito and
Stone, 2001). This in combination with the report from Terasaki and Schwarz
would suggest that PAE can have opposite effects on immune responses. These
differences may be explained by the exposure paradigms. Additionally, the type
of damage could also result in the opposite effects observed. Overall, both
studies described above suggest that the effects of PAE may be life-long in that
these effects were demonstrated in adult PAE offspring. Additionally, these
studies suggest that PAE may alter immune responses such that a secondary
challenge such as LPS or a CNS wound is able to reveal dysfunctional immune
responses compared to control conditions.
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The majority of studies that explore the effects of PAE on immune function
focus primarily within the brain and peripherally. These studies neglect the
effects of PAE within the spinal cord. Considering that PAE can significantly alter
immune responses within the brain it would stand to reason that these effects
may also extend to the spinal cord. Considering the spinal cord is responsible for
motor and sensory function (Prochazka and Mushahwar, 2001) and the immune
system within the spinal cord modulates pathological sensory function (Milligan
and Watkins, 2009), it would suggest that PAE may have significant effects on
sensory processing within the spinal cord. Furthermore, because the effects of
PAE are life-long, it would suggest that PAE may render an individual susceptible
to sensory disorders, such as neuropathic pain later in life.

The effects of PAE on spinal neuroimmune function and
neuropathic pain
As mentioned previously, PAE affects immune function within the brain and
peripherally as well. While speculative, it would suggest that PAE alters
neuroimmune function similarly within the spinal cord. Thus, it is possible that
disruptions in sensory processing may occur in children that FASD.
The first reports of sensory alteration as a result of FASD was
demonstrated by Morse and Cermak (Morse and Cermak, 1994). This study
looked at people with FASD that ranged from 2 to 19 years of age. Interestingly,
their data show that individuals with FASD are 2 to 6 times more likely to display
sensory processing disorders (SPDs) which include clumsiness, inattention, and
12

hypersensitivity to stimuli (Morse and Cermak, 1994). A separate study utilizes
more comprehensive methods to diagnose children with FASD and to determine
whether these individuals display sensory impairments (Jirikowic et al., 2008).
Interestingly, this study replicated prior findings showing that FASD children
display deficits in sensory processing and decreased sensory-motor performance
(Jirikowic et al., 2008). Together, these reports claim that children with FASD
display touch hypersensitivity as evidenced by clinical studies. Further support
for this notion, are shown in animals models of FASD. Studies in rhesus
monkeys with PAE demonstrate increased sensitivity to tactile stimuli (Schneider
et al., 2008). Coincidentally, touch hypersensitivity, referred to as allodynia, is a
well-known pathological pain condition in patients with peripheral nerve damage.
Neuropathic pain occurs through trauma and/or inflammation of peripheral
nerves that communicate to pain transmission neurons in the dorsal horn of the
spinal cord. Following sciatic nerve damage, the process of Wallerian
degeneration commences. Wallerian degeneration is the process that occurs
leading to the loss of function in axons and nerve terminals when peripheral
nerves undergo trauma or damage (Gaudet et al., 2011). A subsequent
inflammatory response occurs within the periphery at the site of tissue injury
(Gaudet et al., 2011). More specifically, peripheral leukocytes release
proinflammatory cytokines such as IL-1β and TNFα. In addition, chemokines
such as CXCL10, CCL2, CX3CL1, CXCL1 are released from surrounding glia.
These chemokines work to recruit other leukocytes to the site of injury to further
aid in the induction of allodynia (Zhuang et al., 2007; Gao et al., 2010b; Zhang et
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al., 2013; Jiang et al., 2016). In addition to this, the anti-inflammatory IL-10
downregulates within the spinal cord following sciatic nerve damage (Wilkerson
et al., 2012a). Overall, these changes result in a proinflammatory environment
resulting in inflammation at the sciatic nerve.
During the induction of inflammation at the sciatic nerve, inflammatory
factors communicate with sensory nociceptors (Milligan and Watkins, 2009).
These factors bind their receptors which are located at the post-synaptic terminal
of these sensory neurons. IL-1β binds its receptor IL-1 whereas TNFα binds its
receptor TNF receptor 1 (Milligan and Watkins, 2009). Once bound, intracellular
signals such as ERK and PKC are activated, leading to depolarization which
sends pain signals through primary afferents of sensory nociceptors towards the
DRG (Okuse, 2007; Milligan and Watkins, 2009). The cell bodies of sensory
neurons are located in the DRG. These neurons bifurcate meaning they have two
projections sites: one towards the sciatic nerve and the other projects to the
spinal cord dorsal horn (Milligan and Watkins, 2009). Thus, these cells
communicate with incoming signals from the periphery to the central nervous
system namely the spinal cord.
At the DRG site, these cells communicate with satellite glial cells (SGCs)
which surround the cell bodies of the primary afferent cells (Costa and Moreira
Neto, 2015). SGCs work to maintain the cellular environment similar to
astrocytes within the spinal cord (Verderio and Matteoli, 2011; Franke et al.,
2012). Under neuropathic conditions, sensory neurons release neurotransmitters
in a paracrine fashion into the extracellular space which activate SGCs. In
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response to this, SGCs will release proinflammatory cytokines which bind their
receptors found on sensory neuron cell bodies (Takeda et al., 2009). Additionally,
activation of SGCs results in upregulation of the intermediate filament protein
glial fibrillary acidic protein (GFAP) (Takeda et al., 2009; Nascimento et al., 2014).
Following activation primary afferent neurons release various factors such as
glutamate and substance P which work to communicate with and activate SGCs
(Takeda et al., 2009). This results in SGCs to release their own proinflammatory
factors such as IL-1 which then communicate back to primary afferent neurons
as well as other nearby cell bodies (Takeda et al., 2009). Thus, SGCs and
sensory neurons communicate through various inflammatory factors such as IL1β. This communication has been shown to aid in the induction of allodynia
(Takeda et al., 2009).
Following activation of SGCs at the DRG, pain signals travel into the
dorsal horn spinal cord (Takeda et al., 2009). After sciatic CCI, DRG projections
to the dorsal horn of the spinal cord occur at three distinct levels; the lumbar L4L6 segments (Lindborg et al., 2018). In addition to this, the spinal cord is
organized into laminae starting at the superficial layer of the dorsal horn (Milligan
and Watkins, 2009). The pain relevant laminae extend throughout the dorsal horn
spinal cord, ending at lamina 6 (Milligan and Watkins, 2009).
When the DRG sensory cells project into the spinal cord, communication
about both noxious and non-noxious stimuli occurs through distinct nerve fibers
which differ in their myelination (Milligan and Watkins, 2009). Aβ fibers are
heavily myelinated and respond to stimuli that are non-noxious such as vibration
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and light touch (Milligan and Watkins, 2009). Additionally, Aδ fibers are lightly
myelinated whereas C fibers are unmyelinated and respond to pain signals
(Milligan and Watkins, 2009). More specifically, these two fibers communicate to
pain projection neurons which are located in the spinal cord lamina I, IV and V of
the dorsal horn (Milligan and Watkins, 2009). These pain projection neurons then
cross over from the ipsilateral side of the spinal cord to the contralateral side
where they then ascend into pain relevant regions of the brain such as the
brainstem and thalamus and ultimately into the somatosensory cortex where pain
is perceived (Hucho and Levine, 2007).
Interestingly, many changes occur within the spinal cord resulting in light
touch to be coded as painful. As mentioned previously, pain signals travel into
the spinal cord through Aδ and C nerve fibers. These fibers communicate with
pain projection neurons but also communicate with a specific type of neuron
called wide dynamic range (WDR) neurons (D'mello and Dickenson, 2008).
These neurons are found within lamina 5 of the dorsal horn spinal cord (D'mello
and Dickenson, 2008). Additionally, these neurons are able to receive input from
all nerve fibers that project into the spinal cord meaning they respond to many
incoming stimuli. Thus, these neurons respond to both incoming touch stimuli as
well as painful stimuli. More specifically, during pathological conditions when
persistent stimulation occurs from Aδ and C fibers, WDRs undergo synaptic
plasticity referred to as “wind up” (D'mello and Dickenson, 2008). This plasticity
results in alteration of WDR where information that was previously coded as nonpainful from Aβ fibers is now considered painful. This ultimately results in
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allodynia (D'mello and Dickenson, 2008; Milligan and Watkins, 2009). Although
neurons play an important part in the induction of allodynia, the communication to
non-neuronal glial cells also plays a crucial role.
Within the dorsal horn spinal cord, synapses between sensory neurons
and pain projection neurons are surrounded by glial cells such as astrocytes and
microglia (Milligan and Watkins, 2009). These cells respond to a large number of
factors including other excitatory neurotransmitters such as glutamate (Milligan
and

Watkins,

2009).

Following

nerve

damage,

the

excitatory

pain

neurotransmitter glutamate is released in the synaptic terminal within the dorsal
horn of the spinal cord. Synaptic glutamate concentration is influenced not only
by the degree of presynaptic release, but also by glutamate clearance through
glutamate transporters which are found on neurons and glial cells (Danbolt,
2001). Five glutamate transporters have been identified, with GLAST found on
astrocytes, GLT-1 found on neurons and glia, and EAAC1 found solely on
neurons. Two others, EAAT4 and EAAT5 are found within the brain (Furuta et al.,
1997). In spinal cord laminae I-II where pain projection neurons exist, only GLT-1
and EAAT3 are expressed at the highest levels, while GLAST is expressed
throughout the dorsal horn (Furuta et al., 1997; Sweitzer et al., 2002). Normally,
glutamate transporters (GLT-1, GLAST, and EAAC1) clear glutamate from the
perisynaptic cleft (Danbolt, 2001). However, during peripheral nerve injury, an
initial two-fold upregulation of glutamate transporters occurs followed by a twofold downregulation (Sung et al., 2003). More specifically, previous reports have
demonstrated that the expression of GLAST, GLT-1, and EAAC1 peaks at Day 4

17

post-CCI injury followed by their down regulation by Day 7 (Sung et al., 2003).
This ultimately results in glutamate accumulation which contributes to induction of
allodynia through the process known as central sensitization.
Following sciatic nerve injury, glutamate-responsive glial cells (astrocytes
and microglia) within the dorsal horn release cytokines IL-1β and TNFα (Milligan
and Watkins, 2009) which bind to and activate their receptors on pain projection
neurons as well as on nearby glial cells. Under these pathological conditions,
astrocytes and neurons release the chemotactic cytokines such as CCL2,
CX3CL1, CXCL10, and CXCL1 that binds their receptor and work to recruit
peripheral leukocytes which release proinflammatory cytokines into the synapse
further augmenting glial function and aiding in the induction of allodynia (Zhuang
et al., 2007; Gao et al., 2010b; Zhang et al., 2013; Jiang et al., 2016). An
example of this occurs when CCL2 bind its receptor CCR2 found on endothelial
cells. This binding increases the expression of the ligand ICAM-1 typically found
on the surface of endothelial cells (Marlin and Springer, 1987; Ostermann et al.,
2002). This allows peripheral leukocytes such as T-cells and macrophages to
infiltrate the spinal cord through the binding of ICAM-1 to the β-2 integrin
leukocyte function-associated antigen 1 (LFA-1) expressed on leukocytes (Marlin
and Springer, 1987; Ostermann et al., 2002). Over time, persistent release of
excitatory neurotransmitters from leukocytes as well as surrounding glia results in
constant depolarization of pain projection neurons. Normally, only the glutamate
receptors AMPA and Kainate depolarize following the binding of the excess
glutamate within the synaptic cleft. NMDA receptors do not depolarize because
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magnesium prevents ions from infiltrating the receptor (Grace et al., 2014).
During pathological conditions, constant release of glutamate into the synapse
leads to NMDAR plasticity, where phosphorylation of various NMDA receptor
subunits such as NR2b occurs, leading to release of the magnesium block
allowing NMDA receptors to be depolarized (Latremoliere and Woolf, 2009). This
ultimately, leads to over-excited pain projection neurons which relay amplified
signals to the brain (Schäfers et al., 2003).

Does

PAE

alter

immune

function

leading

to

enhanced

neuropathic pain?
Considering how immune signaling play a large role in the induction of
allodynia, and PAE alters immune function, it would stand to reason that PAE
may have significant effects on neuropathic pain. Thus, to explore this, an animal
model of neuropathic pain using sciatic CCI was applied to adult (4 month) rats
with moderate PAE. Using this study design, we wondered whether CCI results
in exaggerated sensitivity to light touch, whether altered immune responses are
observed as an effect of PAE, and whether the effects of PAE are long-lasting
into adulthood. The initial study determined baseline (BL) responses of both
prenatal saccharin (Sac) and PAE rats using von Frey behavioral test. At this
point either a sham or standard (4-suture) CCI to both prenatal saccharin and
PAE rats was performed. Following surgery, responses to touch stimuli were
determined at Day 3 and 10 post-surgery (Fig. 1). As expected, sham conditions
display normal sensitivity at baseline and at Day 3 and 10 in that responses fall
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at about 10 grams of stimulus intensity. In contrast, Sac rats with CCI develop
robust allodynia in that these animals respond at stimulus intensity of less than
one gram. Strikingly, PAE rats develop potentiated allodynia at both Days 3 and
10 in that significant differences were seen compared to Sac rats (Fig. 1a).
Curiously, contralateral allodynia is also seen following a standard CCI in Sac
Figure 1

Figure 1. Prenatal alcohol exposure (PAE) potentiates allodynia in adult
rats following CCI. Absolute threshold behavioral responses for (a) ipsilateral
and (b) contralateral hindpaws are shown. At baseline (BL), responses to low
threshold mechanical stimuli were similar in all groups (ipsilateral, F1,36 = 1.877,P
= 0.179; contralateral, F1,36 = 1.228, P = 0.275), regardless of PAE or Sac
treatment. Statistics show a main effect of alcohol exposure from data collected
from the ipsilateral hindpaw (F1,36=12.009, P = 0.001) but not in the contralateral
hindpaw (F1,36 = 4.169, P = 0.049). There was a main effect of CCI surgery
(ipsilateral, F1,36 = 311.943, P < 0.001; contralateral, F1,36 = 54.554, P < 0.001). In
addition, an interaction between alcohol exposure and CCI surgery only in the
ipsilateral hindpaw (ipsilateral, F1,36 = 5.246, P = 0.028; contralateral, F1,36 =
1.383, P = 0.247) is observed. Comparison of treatment groups post-surgery
demonstrate a larger increase in sensitivity following CCI in PAE animals
compared to their Sac-CCI counterparts where a main effect of alcohol exposure
in the ipsilateral hindpaw (ipsilateral, F1,36 = 12.938, P = 0.001; contralateral, F1,36
= 4.003, P = 0.053] is observed. In addition, a main effect of CCI surgery
[ipsilateral, F1,36 = 347.595, P < 0.001; contralateral, F1,36 = 58.406, P < 0.001]
and an interaction of alcohol exposure and CCI surgery in the ipsilateral paw
[ipsilateral, F1,36 = 8.312, P = 0.007; contralateral, F1,36 = 1.928, P = 0.174] was
revealed. N = 10 rats in each group.
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rats at Days 3 and 10. Exaggerated allodynia is also observed in PAE allodynia
only at Day 3 but not 10 (Fig. 1b). Interestingly, PAE alone was not sufficient to
elicit an effect on sensitivity in that no differences were seen between Sac and
PAE rats with sham surgery (Fig. 1). Additionally, it is not until CCI is applied that
the effects of PAE are seen in that exaggerated sensitivity to light touch is
demonstrated (Fig. 1). Furthermore, although not demonstrated in young
juveniles (3 to 8 week rats), the effects of PAE are seen in 4 month rats
suggesting that the effects of PAE are long-lasting.
To determine whether PAE has significant effects on glial cell activation,
spinal cord from behaviorally verified rats at Day 10 (Fig. 1) were collected. More
specifically, rats underwent saline/paraformaldehyde perfusion followed by spinal
cord processing and mounting for IHC. At this point, IHC was run on spinal cords
and images were collected using fluorescence microscopy. Immunoreactivity (IR)
was determined for both GFAP expression to determine astrocyte activation and
for Ionized binding calcium adaptor protein 1 (Iba1) to determine microglial
activation. IR was specifically quantified within the entire dorsal horn spinal cord
(Fig. 2a,c). As previously mentioned the dorsal horn spinal cord is the region of
the spinal cord where the majority of pain processing occurs. GFAP data
demonstrate that Sac and PAE rats with sham surgery as well as Sac rats with
CCI display similar levels of astrocyte activation. Interestingly, it is not until CCI is
applied to PAE rats that significant increases in astrocyte activation were seen
(Fig. 2b). Microglial data demonstrated no significant differences between either
sham groups whether they are Sac or PAE rats in the ipsilateral or contralateral
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hindpaw. Additionally, although not significant slight increases in microglial
activation were seen in Sac rats with CCI. Similarly, although not significant, PAE
rats with CCI demonstrated the highest microglial activation. Curiously,
significant differences are seen in PAE rats with CCI despite not showing
Figure 2

Figure 2. PAE results in heightened glial activation following CCI. Image
analysis of acquired IR images for (a) GFAP and (b) Iba1 that include the
representative images in lower panels. White dotted line represents the dorsal
horn spinal cord. Arrows indicate superficial lamina. PAE-CCI treated spinal
cords display heightened GFAP expression compared to sham (ipsilateral: F1,14 =
0.04474, p = 0.0030; contralateral: F1,14 = 0.04399, p = 0.0039). While Iba-1 IR is
significantly increased in PAE rats with CCI compared to PAE sham rats
(ipsilateral: F1,12 = 2.639; p = 0.0011; contralateral, F 1,12 = 2.639, p = 0.0161) and
Sac CCI (ipsilateral: F1,12 = 19.52; p = 0.0173; contralateral, F 1,12 = 11.01, p =
0.2708) in the ipsilateral hindpaw N = 4-5 rats per group.

significant increases in sensitivity at Day 10 when tissues were collected (Fig. 1
and 2d). Astrocyte data show differences only in PAE rats with CCI despite prior
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reports demonstrating upregulation of astrocyte activation in healthy animals with
CCI (Wilkerson et al., 2012a). Additionally, despite potentiated allodynia in PAE
rats with CCI, clear differences are not seen in microglial cells despite data
demonstrating that microglia mediate induction of allodynia (Wilkerson et al.,
2012a). These datademonstrate that the observed potentiated allodynia may be
mediated by the increased expression of glial activation.
To further our studies, we wanted to determine whether the effects of a
standard CCI are enduring past Day 10. It is possible that the effects of PAE on
sensitivity might be temporary and may return to levels comparable to Sac rats.
Thus, separate cohorts of Sac and PAE rats were used and BL responses were
determined prior to applying either sham or CCI surgery. Behavioral sensitivity
was determined up until Day 28 post-surgery. As shown previously (Fig. 1), rats
displayed normal sensitivity at BL and following sham surgery until at least Day
28 (Fig. 3). Sac rats with a standard CCI developed robust allodynia following
surgery as expected. Interestingly, PAE rats with CCI developed potentiated
allodynia which endures until Day 28 (Fig. 3). These data demonstrated the
chronicity of CCI on PAE rats. In addition, results replicated previous findings
(Fig. 1) and show that potentiated allodynia persists long-term (Fig. 3).
At Day 28, behavioral testing commenced, and rats underwent saline
perfusion in order to collect tissue for analysis of various immune factors in pain
relevant regions (Noor et al., 2017). Flow cytometry was used within the lumbar
spinal cord to determine the expression of microglial and macrophage cells. As
shown through IHC, no significant differences were demonstrated in both

23

microglia or peripheral immune macrophages following CCI in Sac rats or in
sham groups. As expected, significant increases were seen in both microglia and
macrophages in PAE rats with standard CCI. Interestingly, splenic cells from
PAE CCI rats that were stimulated demonstrated heightened expression of the
chemokine CCL2 suggesting that peripheral leukocytes may be playing a role in
potentiated allodynia (Fig. 1 and 3).
Figure 3

Figure 3. Potentiated allodynia is enduring in PAE rats. At baseline (BL), (a)
ipsilateral and (b) contralateral threshold responses are similar between all
groups (ipsilateral, F1,16 = 1.209, P = 0.288; contralateral, F1,16 = 0.036, P =
0.852). Following CCI surgery, both PAE and Sac control rats displayed
significantly increased hindpaw sensitivity on Days 3, 10,15, 18, 23, and 28 postsurgery where there was a main effect of alcohol exposure (ipsilateral, F1,16 =
84.616, P < 0.001; contralateral, F1,16 = 138.980, P < 0.001), CCI surgery
(ipsilateral, F1,16 = 787.072, P < 0.001; contralateral, F1,16 = 1180.917, P <
0.0010), and an interaction between alcohol exposure and CCI surgery
(ipsilateral, F1,16 = 82.506, P < 0.001; contralateral, F1,16 = 103.264, P < 0.001).
Compared to Sac animals, PAE rats displayed the greatest degree of hindpaw
sensitivity following CCI surgery where a main effect of alcohol exposure
(ipsilateral, F1,16 = 93.167, P < 0.001; contralateral, F1,16 = 149.318, P < 0.001),
CCI surgery (ipsilateral, F1,16 = 857.901, P < 0.001; contralateral, F1,16 =
1258.469, P < 0.001) is observed, and an interaction between alcohol exposure
and CCI surgery (ipsilateral, F1,16 = 92.780, P < 0.001; contralateral, F1,16 =
110.212, P < 0.001).
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Additionally, the 2 integrin LFA-1 was significantly upregulated in PAE
rats without CCI and was further increased following CCI. These data
demonstrate that in addition to glial cells playing a role in potentiated allodynia,
peripheral leukocytes may also contribute. Analysis of the SCN looked at the
expression of IL-1, TNF, and CXCL1. Interestingly, sham groups did not
demonstrate any significant increases in any of these factors. It is not until CCI is
applied that significant increases in CXCL1 are seen in Sac rats. In contrast, PAE
rats with CCI demonstrated significant increases compared to Sac rats with CCI
in all three immune factors. Furthermore, the expression of IL-10 was analyzed
within both the DRG and SCN. Interestingly within the SCN, IL-10 responses
increased in Sac rats with CCI but were blunted in PAE rats with injury. DRG
data demonstrated that whereas healthy Sac rats with sham surgery display
basal levels of IL-10, PAE sham rats do not demonstrate similar expression.
Furthermore, following CCI, Sac rats have upregulation of IL-10 whereas PAE
rats do not. The data suggest that potentiated allodynia may be induced as a
result of heightened proinflammatory immune responses in combination with
blunted anti-inflammatory responses.
The above data show that the effects of PAE are both peripheral and
central and are not localized to one specific CNS region. Many of the immune
alterations that were demonstrated were seen within the lumbar spinal, the
sciatic nerve and in the DRG. Other prior reports that have been mentioned also
demonstrated alterations within the brain (Drew and Kane, 2014; Topper et al.,
2015).
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Curiously, no effects of PAE are shown at BL or following sham surgery
despite seeing some alterations in LFA-1 expression and in IL-10 responses
within the DRG. Thus, the data suggest that the effects of PAE are not apparent
until after a secondary insult is applied such as CCI. Furthermore, immune
responses within the spinal cord and peripherally seem to be primed, meaning
they become more reactive, where insult results in exaggerated responses which
may explain potentiated allodynia following CCI.
The deleterious effects of PAE were demonstrated to be life-long by
applying a standard CCI. Heightened sensitivity as well as immune responses
were shown. Additionally, results suggest that PAE results in immune priming
where a secondary insult is sufficient to result in these exaggerated responses.
This was seen peripherally with CCL2, IL-1, LFA-1, and in TNF. Interestingly,
glia also demonstrated heightened reactivity following CCI. This data makes it
difficult to determine what specific factors may be mediating potentiated allodynia.
Despite seeing significant differences following CCI, in some situations clear
differences were not observed. This would raise the importance of trying to
unmask the effects of PAE in order to better pinpoint what specific alterations
PAE is having on the immune response. Noor and colleagues (Noor et al., 2017)
demonstrated many factors that could potentially be contributing to exaggerated
sensitivity following CCI. Glial responses within the dorsal horn demonstrated
heightened responses compared to controls. Additionally, LFA-1 expression was
heightened as a result of PAE alone suggesting that peripheral leukocyte
migration may be altered and could contribute to potentiated allodynia within the
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spinal cord. Furthermore, CCL2 and CXCL1 expression was heightened
following CCI further supporting this idea. Overall, this suggests that PAE may
result in heightened susceptibility to developing allodynia through alteration of
immune responses.
One cannot ignore other factors may result in potentiated allodynia.
Previous studies show glial cells within the brain are altered corresponding with
what Noor and colleagues demonstrate (Topper et al., 2015). It is possible that
PAE alters mechanisms within glial cells resulting in potentiated allodynia. Recall,
that during peripheral neuropathy, glutamate transporters are responsible for
clearing

glutamate

from

the

synapse.

These

transporters

eventually

downregulate which ultimately leads to central sensitization (Sung et al., 2003).
These studies also look at the effects of inhibiting these transporters to determine
the effects on touch sensitivity. When the glutamate transporter GLT-1 and
EAAC1 are inhibited, small increases in sensitivity are seen. Strikingly, when
GLAST is inhibited in addition to the other glutamate transporters, potentiated
allodynia is seen similar to what is seen in PAE rats (Sung et al., 2003). Thus, it
is possible that PAE may work through the alteration of glutamate transporters
which would potentiate allodynia. Prior reports demonstrate that PAE does
decrease both the expression of GLAST and the glutamate uptake (Brolese et al.,
2015). This suggests that PAE alters glutamate uptake within the synapse
resulting in heightened susceptibility to developing allodynia.
Neuronal communication may play a specific role in potentiated allodynia
seen in PAE rats with CCI. Previous studies show that following CCI, NMDA
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receptor subunits become phosphorylated (Huang et al., 2018). This leads to
NMDA receptors to become activated leading to strong depolarization following
the binding of glutamate which leads to allodynia. It is possible that PAE may
lead to alterations of the NMDA receptor which could aid in the induction of
allodynia. Interestingly, previous studies utilizing animals with moderate PAE
show alterations of NMDA receptor subunits in the brain (Brady et al., 2012).
More specifically, decreases in NR2B are shown which is a subunit involved in
the induction of allodynia (Brady et al., 2012; Huang et al., 2018). It stands to
reason that PAE may alter NMDA receptor function in order to heighten the
susceptibility of developing allodynia.
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Specific Aims
Based on the above detailed background and initial experiments recently
published (Noor, et al., 2017), my central hypothesis is: PAE potentiates glialneuroimmune responses and leukocyte actions underlying the lifelong risk for
developing neuropathic pain. This work is conducted to achieve the following
specific aims:

Specific Aim 1: Determine whether PAE generates life-long spinal glial and
peripheral immune dysregulation resulting in susceptibility to allodynia.
The sub-hypothesis for this aim is: Applying a minor sciatic nerve injury results in
allodynia and glial activation only in PAE rats.

Approach: To do this, 1-year old PAE and Sac controls are used. Behavioral
responses are assessed prior to and after either Sham or minor CCI. At the Day
10 post-surgery, spinal cords are processed for IHC staining and IR of glial
activation markers is assessed. Additionally, pain relevant tissues as well as
peripheral blood monocytes are collected from a separate group of 1-year old
PAE and Sac rats. These tissues are assessed using flow cytometry and
enzyme-linked immunosorbent assay (ELISA) to characterize the immune profile
of PAE and Sac rats.

*This data has been published
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Specific Aim 2: Determine whether susceptibility to allodynia from PAE is
mediated by spinal and peripheral immune cytokine dysregulation.
The sub-hypothesis for this aim is: PAE alters proinflammatory immune reactivity
leading to increased susceptibility to chronic peripheral neuropathic pain.

Approach: Using adult (4 month) PAE and Sac rats, minor or sham surgery is
applied. The enduring effects of a minor injury are determined by assessing
behavior until Day 28. These rats then receive i.t. injection of an LFA-1
antagonist and spinal cords and DRGs are collected at peak drug efficacy. IHC is
used to determine glial activation and expression of LFA-1 in the spinal cord. In
addition, expression of IL-1β and IL-10 is assessed in spinal cords and DRGs. A
separate group of only PAE rats are assessed following minor CCI until Day 10.
At this point, i.t. injection of IL-1 receptor antagonist (IL-1RA) are given and
behavior is assessed. Finally, another group of both PAE and Sac rats receive
either sham or minor CCI and are assessed until Day 10. At this point, intrathecal
(i.t.) injection of an LFA-1 antagonist is administered and behavioral assessment
is done until peak drug efficacy. Ipsilateral and contralateral sciatic nerve (SCN),
dorsal root ganglia (DRG), and lumbar spinal cord is collected and assessed
using qrt-PCR and electrochemiluminescence.

*This data is in review
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Specific Aim 3: Determine whether PAE-induced susceptibility to allodynia
is due to altered astrocyte glutamate transporter function.
The sub-hypothesis for this aim is: PAE alters basal glutamate transporter
function resulting in heightened susceptibility to developing chronic peripheral
neuropathic pain.

Approach: Adult (5-7 month) PAE and Sac rats received either sham or minor
CCI and are behaviorally assessed up to Day 10 post-sciatic nerve manipulation.
At Day10, all rats receive i.t. UCPH101 (GLAST inhibitor) and assessed up to 3
and at 24 hours post-injection. Spinal cords are examined for the glutamate
transporters

GLT-1,

EAAC1,

and

GLAST

using

IHC

procedures

for

immunoreactive detection under microscopy followed by image acquisition and
analysis. Additionally, qrt-PCR is used to assess gene expression of these
transported from spinal tissues collected from a separate group of PAE and Sac
rats receiving sham and minor CCI. Furthermore, semi-quantitative protein
analysis by western blot is used to determine the expression of the NMDA
receptor subunit NR2B as well as phosphorylated NR2B in an effort to detect
alterations in the sensitization state of spinal neurons under basal or neuropathic
conditions.

*This data is in preparation
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Chapter 2 - Prenatal alcohol exposure is a risk factor for adult
neuropathic pain via aberrant neuroimmune function
Abstract
Background: Clinical studies show that prenatal alcohol exposure (PAE) results
in effects that persist into adulthood. Experimental animal models of moderate
PAE demonstrate that young-adults with PAE display potentiated sensitivity to
light touch, clinically termed allodynia, following sciatic nerve chronic constriction
injury (CCI) that coincides with heightened spinal glial, spinal macrophage, and
peripheral

immune

responses.

However,

basal

touch

sensitivity

and

corresponding glial and leukocyte activation are unaltered. Therefore, the current
study explored whether the enduring pathological consequences of moderate
PAE on sensory processing are unmasked only following secondary neural insult.
Methods: In middle-aged (1 year) Long Evans rats that underwent either
prenatal saccharin exposure (control) or moderate PAE, we modified the wellcharacterized model of sciatic neuropathy, CCI, to study the effects of PAE on
neuro-immune responses in adult offspring. Standard CCI manipulation required
4 chromic gut sutures, while the modified version applied a single suture loosely
ligated around one sciatic nerve. Spinal glial immunoreactivity was examined
using immunohistochemistry. The characterization and functional responses of
leukocyte populations were studied using flow cytometry and cell stimulation
assays followed by quantification of the proinflammatory cytokines interleukin1beta (IL-1) and tumor necrosis factor-alpha (TNF-. Data were statistically
analyzed by ANOVA and unpaired t-tests.
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Results: The current report demonstrates that significant reduction of CCI
generates robust allodynia only in PAE rats, while the pathological effects of PAE
following the application of a standard CCI are revealed by enhanced allodynia
and elevated spinal glial activation. Additionally, minor CCI increases spinal
astrocyte activation but not microglia, suggesting astrocytes play a larger role in
PAE-induced

susceptibility

to

aberrant

sensory

processing.

Leukocyte

populations from PAE are altered under basal conditions (i.e. prior to secondary
insult), as the distribution of leukocyte populations in lymphoid organs and other
regions are different from those of controls. Lastly, following in vitro leukocyte
stimulation, only PAE augments the immune response to antigen stimulation as
assessed by heightened production of TNF-α and IL-1β.
Conclusions: These studies demonstrate PAE may prime spinal astrocytes and
peripheral leukocytes that contribute to enduring susceptibility to adult-onset
neuropathic pain that is not apparent until a secondary insult later in life.
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Background
The adverse effects of alcohol consumption on the developing central nervous
system (CNS) have been recognized for decades and include an overt and
distinct pattern of malformations that occur following the highest exposure levels,
referred to as fetal alcohol syndrome (Jones and Smith, 1973; Hoyme et al.,
2016). However, it is now recognized that a wide range of disabilities are
associated with much lower levels of alcohol exposure during fetal development
resulting in a spectrum of CNS-related disorders. This spectrum of disorders is
referred to as fetal alcohol spectrum disorder (FASD) (Valenzuela et al., 2012;
Reid et al., 2015; Hoyme et al., 2016). Associated disabilities that occur across
the lifespan as a result of moderate exposure to alcohol during CNS
development include not only behavioral and cognitive deficits (Mattson et al.,
1998; Alfonso-Loeches and Guerri, 2011; Reid et al., 2015), but also sensory
touch abnormalities in individuals with FASD (Franklin et al., 2008). In support of
these clinical observations, preclinical experiments in adult rhesus monkeys
reveal touch abnormalities such as tactile hypersensitivity are observed in
monkeys exposed prenatally to low/moderate levels of alcohol (Schneider et al.,
2005).
Tactile hypersensitivity, referred to as light-touch mechanical allodynia
frequently observed in chronic pain patients, is caused by spinal cord neuronal
alterations that pathologically convert non-painful touch into painful signals (Braz
et al., 2014). Anatomically, sensory peripheral nerve terminals project to the
spinal cord and communicate to these pain-responsive neurons in the spinal cord
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(Grace et al., 2014). Notably, allodynia often occurs following damage to
peripheral nerves (Dworkin et al., 2003). Studies using animal models of
neuropathic pain, such as a standard localized sciatic nerve damage referred to
as chronic constriction injury (CCI), have demonstrated that spinal immune and
glial cells (astrocytes and microglia) release proinflammatory cytokines such as
interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), which play critical
roles in mediating chronic allodynia (Costigan et al., 2009a; Milligan and Watkins,
2009; Calvo et al., 2012; Grace et al., 2014). A number of reports accumulating
for several decades show that animal models of chronic peripheral neuropathy
develop pathological pain through aberrant neuroimmune mechanisms (i.e.
activated glia and proinflammatory cytokines) (Milligan and Watkins, 2009; Grace
et al., 2014).
Similarly, animal models of prenatal alcohol exposure (PAE) have
advanced our understanding of the pathophysiology caused by mild to moderate
levels of alcohol exposure and some support possible aberrant neuroimmune
actions underlying CNS-related pathologies that persist into adulthood (Drew and
Kane, 2014). For example, experimental rodent PAE models show increased
reactive brain microglial and astrocyte responses (Drew and Kane, 2014; Topper
et al., 2015), elevated brain proinflammatory cytokine and chemokine production
(Tiwari and Chopra, 2011; Topper et al., 2015; Bodnar et al., 2016; Boschen and
Klintsova, 2017), decreased microglial survival (Drew and Kane, 2014), and
altered brain glial and immune responses following injury (DeVito and Stone,
2001; Arjona et al., 2006; Zhang et al., 2012). Notably, these data support clinical
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observations of patients with FASD that also present with aberrant immune
responses such as augmented lymphocyte formation (Johnson et al., 1981) and
altered cytokine synthesis (Ahluwalia et al., 2000).
More recently, rat offspring with moderate levels of PAE reveal potentiated
tactile hypersensitivity (a.k.a. allodynia) following adult-onset peripheral nerve
damage that occurs in parallel with augmented spinal glial activation and
peripheral immune responses, while no such changes are observed in nonalcohol exposed rodents (Noor et al., 2017). These data suggest PAE-induced
aberrations in neuroimmune function may underlie the clinical sensory
abnormalities observed in individuals with FASD. Moreover, the most intriguing
aspects of the data are that PAE alone is insufficient to alter basal touch
sensitivity. Specifically, the adverse effects of PAE on abnormal sensory
processing and associated spinal glial and immune function only becomes
apparent following a secondary insult, which in these experiments, is the
application of a well characterized CCI nerve injury model (Noor et al., 2017).
These data suggest that moderate PAE may create susceptibility for developing
neuropathic pain that occurs long into adulthood. Therefore, the hypotheses of
the current set of studies are twofold: (1) that the damaging effects of PAE on the
CNS are unmasked only following an insult or challenge to the peripheral/central
nervous system, and (2) the magnitude of the response to the insult is
disproportionately greater to the degree of the insult itself. The goal of these
studies is to determine that PAE renders one susceptible to neuropathic pain
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induced by minor sciatic nerve injury, with PAE-induced neuropathy mediated by
exaggerated alterations in spinal glial and immune responses.
Applying a well-characterized rodent model of sciatic neuropathy in adult
offspring with PAE provides insight into understanding (1) aberrant immune cell
and glial CNS activation as a consequence of PAE, and (2) adverse conditions
during CNS development that create adult susceptibility to developing chronic
neuropathic pain from minor insults. Reducing injury to the sciatic nerve from the
well characterized standard 4-suture to a minor 1-suture CCI addresses two
critical questions. First, while the standard sciatic nerve CCI in the rat is wellcharacterized to involve spinal glial activation and other trafficking leukocytes
(Bennett and Xie, 1988; Wilkerson et al., 2012a; Dengler et al., 2014; Grace et al.,
2014), no reports exist showing 1-suture CCI generates allodynia. Second, the
chronic underlying pathology from PAE on CNS sensory processing is best
unmasked following minor injury. Thus, the goals of the current report sought to
unmask the effects of PAE on augmented spinal glial (astrocyte and microglial)
phenotypes and profiles, and functional responses of peripheral immune cells
characterized to traffic to the spinal cord to identify aberrant allodynia and
neuroimmune reactivity.

Materials and Methods
Animals and Study Group Strategy
All procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) of The University of New Mexico Health Sciences Center,
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and closely adhered to guidelines from the International Association for the Study
of Pain for the use of animals in research. Long-Evans rat breeders purchased
from Harlan Industries (Indianapolis, IN) were maintained in a breeding colony on
a 12:12-hour reverse light/dark schedule (lights on from 2100 to 0900 hours), and
fed standard rat chow and water, available ad libitum. For all experiments, 12-13
month male prenatal alcohol or saccharin exposed (described below) rat
offspring derived from 14 litters were used. Offspring were habituated to a
standard light/dark cycle (lights on from 0600 hours to 1800 hours) for at least 5
days and kept in these conditions for the duration of the study. A total of 14
female Long-Evans rat dams and 50 male offspring were used in all experiments.
Offspring (12-13 months of age) were predominantly pair housed with 5 singled
housed due to incompatibility with a cage mate.

Moderate Prenatal Alcohol Exposure Using the Voluntary Drinking
Paradigm
Pregnant female rat dams were given either ethanol or saccharin throughout
pregnancy until birth according to the voluntary drinking paradigm previously
described (Savage et al., 2010). Briefly, 3 to 4 month female Long-Evans rat
breeders were acclimated for 4 hours per day, from 1000 to 1400 hours, to
drinking water containing 0.066% (w/v) saccharin (Sac) that gradually increased
in ethanol content from 0% (v/v) on Days 1-2, to 2.5% (v/v) on Days 3-4, to 5%
(v/v) on Day 5 and thereafter for two weeks. It should be noted that regular
drinking water is available at all times during housing. Thus, animals could

38

voluntarily choose to drink either saccharin sweetened water containing 5%
ethanol or regular water during the four-hour drinking period. At the end of the
two-week prepregnancy drinking phase, the mean daily ethanol consumption
was determined for each rat and rats that consumed 1 standard deviation above
or below the group mean were excluded from the study. Subsequently, female
rats were assigned to either a 5% ethanol or Sac control drinking group such that
the mean prepregnancy ethanol consumption was similar between groups. The
females were then placed with proven male rat breeders until pregnant. No
alcohol was consumed during the breeding period, which averaged between 1-2
days. Beginning on gestational day 1, rat dams were given either 0% (Sac) or 5%
(PAE) ethanol in Sac water (4 hours/day). Sac control group rats were given a
volume of 0% ethanol in Sac water that was matched to the mean volume
voluntarily consumed by the 5% ethanol group. Total ethanol consumption was
recorded for each dam, which averaged 2.04 g of ethanol/kg body weight/day.
This level of drinking by rat dams produced a mean peak serum blood alcohol
concentration of 0.06 g/dl. No significant differences were observed between
prenatal treatment groups in dam weight gain during pregnancy, pup birth
weights, or litter size, replicating previous reports (Savage et al., 2010).
Offspring were weaned at 24 days of age and male offspring pair-housed with
the exception of five single-housed rats due to incompatibility with a cage mate.
For all experiments, 12-13 month prenatal alcohol or saccharin exposed animals
were used. A total of 50 male offspring were used in these experiments.
Behavioral testing of offspring was performed during the first three hours of the
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light cycle to avoid the influence of elevated hormones under normal circadian
rhythms.

Chronic constriction injury (CCI)
In adult (12-13 months) male Sac or PAE rats, sham or CCI aseptic surgical
procedures were performed as previously described (Bennett and Xie, 1988;
Noor et al., 2017) and modified in some experimental groups, as described here.
Under isoflurane anesthesia (induction 5% vol. followed by 3.5% in oxygen), the
sciatic nerve was carefully isolated with sterile glass prongs and snuggly ligated
with 1 (minor injury) or 4 (standard injury; (Bennett and Xie, 1988)) segments of
sterile 4-0 chromic gut sutures (Ethicon, Somerville, NJ) without pinching into the
nerve. Sterile isotonic saline (0.9%) was applied to the nerve during the
procedure to prevent dehydration. Sham surgery involved isolation of the sciatic
nerve similar to CCI but without nerve ligation. The nerve was then gently placed
back into position and the overlying muscle was sutured closed with two 3–0
sterile silk sutures (Ethicon, Somerville, NJ). Rats fully recovered from
anesthesia within approximately 5 minutes and were monitored daily following
surgery for any post-operative complications.

Behavioral Assessment of Allodynia
Allodynia was assessed using the von Frey fiber test as previously described
(Dengler et al., 2014). Briefly, rats were first habituated to the testing
environment by placing rats atop 2-mm thick parallel bars spaced 8-mm apart
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allowing full access to the plantar hindpaw. Habituation occurred for
approximately 45 min/day for 4 sequential days within the first 3 hours of the light
cycle in a sound- and temperature-controlled dimly lit section of the colony room.
Baseline responses were then assessed using the von Frey behavioral test. For
these experiments, the scale range of the calibrated monofilaments was modified
and included 3 monofilaments calibrated to bend at 0.027 g (2.44 log stimulus),
0.067 g (2.83 log stimulus) and 0.166 g (3.22 log stimulus). Thus, a total of 13
calibrated monofilaments were used in these studies. Additionally, these
calibrated monofilaments (2.44–5.18 log stimulus intensity) were applied
randomly to the plantar surface of the left and right hindpaw for a maximum of 8
seconds per application. A metronome placed in the room provided guidance at 1
tick/sec. Lifting, licking, or shaking of the paw was considered a response. In a
similar manner to baseline (Hoyme et al.) evaluation, animals were re-assessed
following CCI or sham surgery on days 3 and 10. The experimental tester was
blind to the prenatal and surgical treatment groups.

Immunohistochemical (IHC) tissue sample preparation
All tissue was collected from behaviorally verified rats on Day 10 after sham or
CCI surgery. Tissues were processed as described previously (Noor et al., 2017).
Briefly, rats were overdosed with sodium phenobarbital (Sleepaway, Fort Dodge
Animal Health, Fort Dodge, IA) and transcardially perfused with 0.1M phosphate
buffered saline (PBS; pH = 7.4), initially at a rate of 28 mls/min, then increased to
32 mls/min (~10 min), followed by 4% paraformaldehyde (PFA; pH = 7.4; 28-34
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mls/min, 8 min). Immediately following transcardial perfusion, the spinal vertebral
column from C2-L6 with the spinal column intact within the vertebral column were
collected and cut at vertebra T7 into a rostral and caudal half of the spinal
vertebral column. All spinal cord sections underwent 48-hour post-fixation in 4%
PFA at 4 °C. Approximately a third (initial N=12) of the total spinal cords collected
for IHC underwent decalcification. The purpose for maintaining the spinal cord
within the vertebral column was to identify possible immune cell and astrocytic
endfeet changes that occur within the subarachnoid matrix known to house a
sentinel and infiltrating immune cells. Our prior work employing this method
documents our success in younger rats (3-4 month olds rats) (Wilkerson et al.,
2012b; Wilkerson et al., 2012a). Decalcified spinal cords underwent unexpected
prolonged tissue decalcification, possibly due to the age of the rats (1 year olds
in the current study) that resulted in altered integrity of the Iba1 epitope as
virtually no IR signal was detectable. To avoid this problem, spinal cords (N=24)
collected from subsequent experiments did not undergo decalcification and were
isolated as described below. Thus, each experimental condition consisted of
sample sizes of N=6 rats.
For spinal vertebral columns that underwent decalcification, segments
were placed in a 3-liter water bath containing 10% ethylenediaminetetraacetic
acid (EDTA) (Sigma-Aldrich, St. Louis, MO), 0.01% sodium azide and 0.5%
paraformaldehyde with gentle consistent stirring atop a stir plate, with the
solution exchanged every 5 days. A fully decalcified spinal vertebral column was
determined when no resistance occurred upon penetrating the dorsal and lateral
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spinous processes with a 30-gauge hypodermic needle. At four months of
decalcification, spinal cords were isolated from vertebral columns.
For non-decalcified and decalcified vertebral columns, entire spinal cord (T7- L6)
was carefully isolated from the spinal vertebral column making sure to maintain
an intact spinal cord. The isolated spinal cords were segmented and
subsequently paraffin processed. L4-L5 paraffin-embedded blocks were
subsequently sliced on a microtome with adjacent 7μm tissue sections mounted
onto vectabond-treated slides.
To investigate spinal augmented glial activation, we analyzed the
expression of the astrocyte marker, glial fibrillary acidic protein (GFAP), and the
microglial activation marker ionized calcium-binding adapter molecule 1 (Iba1) in
L4-6 spinal segments reported previously (Wilkerson et al., 2012a). In addition,
we analyzed the expression of the microglial specific marker, transmembrane
protein 119 (TMEM119) as described below. Slides containing tissue from
lumbar (L4-L6) spinal cord were chosen for glial staining to capture overall glial
reactivity (Wilkerson et al., 2012a). Paraffin-processed tissues underwent
deparaffinization followed by rehydration and antigen retrieval procedures in a
rice cooker at 94-96°C allowing for a gentle and equal distribution of temperature
warming throughout tissue sections. For antigen retrieval, GFAP required a Trisbased buffer at pH 9.5 (BioCare Medical, Concord, CA), Iba1 required a Trisbased buffer at pH 9.0 (Vector, Burlingame, CA), and TMEM119 required a
citrate-based buffer at pH 6.0 (BioCare Medical, Concord, CA). All tissue
sections were incubated with 5% normal donkey serum (NDS), PBS pH 7.4 for
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2h, followed by overnight primary antibody incubation using rabbit anti-rat GFAP
(Millipore, 1:1000)(Wilkerson et al., 2012a), rabbit anti-rat Iba-1 (Wako, 1:300)
(Wilkerson et al., 2012a), or rabbit anti-rat TMEM119 (Abcam, 1:100) (Satoh et
al., 2016) in a humidity chamber at 4 °C. Tissues were washed 3x with 0.1M PBS
pH 7.4 followed by donkey-anti rabbit FITC- or TRITC- conjugated secondary
antibody incubation for 2h in a humidity chamber at room temperature, and
rinsed in 0.1 M PBS. Tissues were then stained with the nuclear stain 4,6diamidino-2-phenylindole (DAPI) (Vector Labs, Burlingame, CA) separately
before cover slipping. These slides were left at room temperature overnight
before proceeding with image acquisition and microscopy analysis.

Microscope spectral imaging for immunofluorescent quantification
Image acquisition for spectral analysis was preformed using the Nuance spectral
imaging system (http://www.cri-inc.com/products/nuancew.asp; Perkin Elmer,
Waltham, MA) as described previously (Noor et al., 2017). Briefly, images of
dorsal horn spinal cord were obtained using a 20X objective with a Zeiss
Axioplan2 inverted fluorescence microscope. Flat-field correction was applied in
order to produce a uniform illumination during image acquisition. Image cubes
were obtained from multi-labeled tissue containing DAPI, conjugated secondary
antibody, as well as autofluorescence. A spectral library was then created using
single-labeled slides for each fluorophore (e.g. FITC or TRITC) and a label-free
(autofluorescence) slide. A computed spectrum (420 nm – 720 nm) was obtained
by separating the known spectrum (autofluorescence) from mixed spectrum
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(single labeled) to produce pure spectrum of each fluorophore. This allowed the
separation of spectrum from multi-labeled slides (e.g. DAPI + TRITC) to obtain
composite images containing only labels of interest. These composite images
were then used for further analysis using Slidebook 6 software (below). Twelve to
twenty-four images per experimental group (4 sections per animal, 3-6 animals
per condition) per side (ipsilateral and contralateral) of sciatic manipulation were
acquired and analyzed. In addition, the Nuance spectral imaging system was
used for representative acquired images of TMEM119 shown in Figure 3e. 20X
and 60X objectives were used to produce representative images.

Slidebook software image analysis
Composite images were analyzed using Slidebook 6 software (Intelligent Imaging
Innovations, Denver, CO, USA). To eliminate signals originating from artifacts,
the experimenter determined an acceptable threshold of very low-level emission
fluorescent intensity per each experimental condition (e.g. Sac+Sham,
PAE+Sham, etc.) by closely replicating the on-screen composite computer image
with that observed through the microscope eyepiece, as described previously
(Noor et al., 2017). In addition, the dorsal horn of the spinal cord (region of
interest (ROI)) was outlined for analysis eliminating the surrounding white matter
and peri-spinal blank space (intrathecal space). The image was then refined to
include the predetermined threshold within the outlined area. The ‘Sum Intensity’
(the total signal within the outlined area in the dorsal horn) was determined and
divided by the ‘Area’ (total area in micrometers squared (μm2)) to obtain the
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‘Fluorescence Intensity’. The average of four adjacent sections from a single
slide (representing a single animal) was calculated to determine the value for
each animal. Finally, averages for each slide within the same condition were
calculated along with the standard deviation and standard error of the mean.
Data are analyzed as “Sum Intensity of ROI/m2. Fluorescence intensity was
characterized from these thin sections to capture staining density and intensity of
both astrocytes and microglia at the dorsal lamina (I-V) within a single lumbar
segment to assess the overall highly localized profile, as both GFAP and Iba1
are well-documented to upregulate these markers upon increased cellular
activation (Ito et al., 2001; Zamanian et al., 2012).

Preparation of single cell suspensions of peripheral immune cells for flow
cytometry.
Surgically-naive rats (Sac- control and PAE) were deeply anesthetized with
Isoflurane (Piramal Healthcare, Mumbai, India) (8-10 min, 5% vol. in oxygen).
Peritoneal exudate cells (PECs), peripheral blood, thymus, spleens, and medial
iliac lymph nodes were collected and immediately placed on ice. Medial iliac
lymph nodes are draining lymph nodes for sciatic nerves and the immune cells
from these lymph nodes were examined (Van den Broeck et al., 2006; Harrell et
al., 2008). Single cell suspensions from PECs, spleens and peripheral blood
were prepared identically, as described previously (Noor et al., 2017). Briefly,
PECs were collected using ice-cold Iscove’s media (Sigma-Aldrich, St. Louis, MO)
and pelleted by centrifuge at 300xg at 4 °C for 8 min. The resultant cell pellet was

46

incubated with 2 ml hypotonic salt solution (ACK lysis buffer; Sigma-Aldrich, St.
Louis, MO) for 5 minutes on ice to lyse red blood cells (RBCs). One million cells
were resuspended in 2 ml ice-cold 0.1M PBS (pH=7.4) and processed for flow
cytometry as described here. The remaining cells were used for in vitro
stimulation experiments described below.
Spleens were harvested in RPMI 1640 media (medium originally
developed by Roswell Park Memorial Institute, purchased from Sigma-Aldrich, St.
Louis, MO) and homogenized via passage through a 40 μm cell strainer
(CorningTM sterile cell strainers, Fisher Scientific, USA) to prepare a single-cell
suspension. RBCs were lysed similarly to that conducted with PECs.
Splenocytes were used for flow cytometry described below. Single cell
suspensions from lymph nodes and thymus were prepared using 40 μm cell
strainers, conducted similarly to the preparative procedures described for
isolating splenocytes. However, the RBC lysis step was not performed for lymph
node and thymus samples.
Peripheral blood was collected (in BD vacutainerR K2EDTA blood
collection tube) through cardiac puncture immediately after PECs collection.
Peripheral blood (PBMNs) were isolated using Ficol Premium 1.84 (GE
Healthcare Life Sciences, PA, USA) according to the manufacturer’s instructions.
Briefly, 1 ml blood was diluted to 4 ml with PBS (w/o Ca/Mg) and layered on 3 ml
Ficol in a 15 ml conical tube and centrifuged at 400xg for 30 min at 20 °C, without
brakes. PBMNs were collected from the interface and washed twice with PBS at
400xg for 10 min at 20 °C. Cells were resuspended in 2ml of 0.1 M PBS pH 7.4
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on ice until proceeding to identify live cells (described below; viability dye
staining).

Flow cytometry data acquisition and analysis of immune cell profiles in
PAE rats.
Using flow cytometry, major immune cell subtypes in Sac and PAE rats were
identified using the following gating strategy: live cells were identified based on
absence of cell viability dye, B and T cells contained positive CD3 and CD45RA
expression respectively, NK cells contained positive CD161 expression, and
myeloid cells were positive for CD11b/c expression.
Live cells were counted on a hemocytometer using the trypan blue
staining exclusion criteria. Between 0.5x106 - 1x106 cells were transferred in a
FACS tube (BD FalconTM, MA, USA) and pelleted by centrifugation at 300xg for 5
min at 4 °C, with the supernatant discarded. Cells were then resuspended in PBS
(without calcium and magnesium; Sigma-Aldrich, St. Louis, MO) and stained with
Viability Dye eFluor® 450 (eBioscience, San Diego, CA) for 30 min, washed with
FACS buffer (1x PBS containing 1.0% bovine serum albumin, and 1 mM EDTA)
and incubated with a saturating solution of Fc block (BD Biosciences, San Jose,
CA, USA) for 10 min followed by staining with fluorochrome-conjugated
antibodies for 30 min. All of these steps were conducted on ice. Antibodies
against rat CD3 (cluster of differentiation 3, clone IF4) and CD45 RA (clone OX33) were purchased from BD Biosciences (San Jose, CA, USA). CD11b/c (clone
OX-42, recognizes a common epitope shared by Integrin αM and αX chains) and
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CD161 (clone 10/78) were purchased from Affymetrix (Santa Clara, CA, USA).
These antibodies were used for 0.125-0.5 μg/106 cells, as recommended by the
manufacturer. Following antibody staining, cells were washed and resuspended
in 300 µl FACS buffer and then passed through a 40 μm cell strainer immediately
prior to analysis to avoid cell clumping. At least 50,000 live cell events were
collected for each sample. Data were acquired using the BD LSR Fortessa cell
analyzer (BD Biosciences, San Jose, CA) and analyzed using FlowJo software
v.8.7.4 (Treestar Inc., Ashland, USA). Live, intact healthy cells were identified
based on their size (Forward Scatter (FSC-A)) versus granularity (Side Scatter
(SSC-A)). Dead cells were further excluded by the presence of positive viability
dye staining and only cells displaying the absence of viability dye were included
for flow cytometry analysis for different immune markers. T cell and B cell
proportions were determined by positive expression of CD3 (T cell co-receptor)
and CD45 RA (CD45 isoform expressed by only B cells) respectively. Natural
killer cells (NK) were identified by negative expression of T/B cell markers and
positive expression of CD161 (expressed predominantly on NK cells and
involved in activating NK-cell-mediated toxicity (Ryan et al., 1995; Warren and
Smyth, 1999). Myeloid cells (e.g. macrophages, monocytes, dendritic cells and
neutrophils) were identified by positive expression of CD11b/c and negative
expression for lymphoid cell (T cell, B cells and NK cells) markers.
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Intracellular detection of TNFα from splenocytes by flow cytomtery.
To examine the production of the proinflammatory cytokine tumor necrosis factorα (TNFα), splenocytes collected from each rat were stimulated in vitro, as
described previously (Noor et al., 2017). Briefly, splenocytes were collected from
rats and resuspended in RPMI 1640 complete medium supplemented with 10%
(v/v) fetal bovine serum (FBS) (Sigma), 2.0 mM L-glutamine (Thermos Fisher
Scientific, PA, USA), 50 μM 2-mercaptoethanol (Sigma-Aldrich), 100 U/ml
penicillin and 100 μg/ml streptomycin (Thermos Fisher Scientific, PA, USA) to a
cell density of 1x106/ml. Splenocytes were plated in a 24-well culture plate
(Corning Costar, Sigma-Aldrich) 1x106 cells/well, and each well was stimulated
with 50 ng PMA (a phorbol ester, Protein Kinase C activator, 50 ng/ml) and
ionomycin (a calcium ionophore, 1 g/ml), incubated for 5 hours at 37 °C and 5%
CO2. In order to block secretion of cytokines from activated splenic leukocytes, 2
l/ml protein transport inhibitor cocktail (containing brefildin A and monensin,
from eBioscience) was simultaneously added with PMA/ionomycin (PMA/Io)
solution at the beginning of the cultures. Following 5 hr of stimulation, splenic
cells were gently removed from the wells, washed twice with PBS and stained
with viability dye and surface marker CD11b/c, as described above. Cells were
fixed with 4% PFA (Sigma-Aldrich) for 10 min at room temperature. Following
fixation, cells were permeabilized with 0.3% saponin (Sigma-Aldrich) in FACs
buffer followed by incubation with anti-rat TNFα at 1 μg/106 cells (Affymetrix,
Santa Clara, CA, USA) for 40 min on ice in the dark. Cells were then washed
twice in saponin-FACs buffer and processed for flow cytometric data acquisition.
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Viable cells were identified as described above. Cd11b/c cells expressing TNFα
are represented. Proportions of TNFα+ leukocytes were evaluated based on the
isotype control staining.

IL-1β and TNF-α detection by enzyme-linked immunosorbent assay (ELISA)
PECs from each animal were plated in a 24-well tissue culture plate at 2 × 105
cells per well, in duplicate followed by stimulation or control treatment. Cells were
stimulated with 1 μg/ml lipopolysaccharide at 37 °C (LPS, major cell-membrane
component from gram-negative bacteria) purchased from Sigma-Aldrich, St.
Louis, MO, USA. LPS (diluted in RPMI). Following a 24 hr stimulation, plates
were spun at 300xg, 5 min and cell-free supernatants collected and stored at 80 °C until assaying. Cells were washed 2x with ice-cold PBS.

PBS was

aspirated and cell lysates were prepared using a whole cell lysis buffer (Pierce R
IP lysis buffer, Thermo Fisher Scientific, Waltham, MA, USA). Briefly, for each
well, cells were treated with 120 μl of cell lysis buffer, on ice, for 10 mins. To
remove cell debris, cell lysates were transferred to microcentrifuge tubes and
spun at 13,000xg, 10 mins, 4 °C. Cell lysates were collected and stored at 80 °C, avoiding freeze/thaw cycles. TNFα and interleukin 1β (IL-1β) levels were
measured using commercially available ELISA kits (R&D Systems, Minneapolis,
USA). Each experimental well (from the tissue culture plate) was run in duplicate
on the 96-well ELISA plate. All experiments and data analysis were performed
according to the manufacturer’s instructions.
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Statistical analysis
SPSS (IBM, Chicago, IL, USA) was used for all behavioral analysis. At BL, a 2way (2 x 3) analysis of variance (ANOVA) was used for analysis of the betweensubject factors of prenatal exposure (Sac versus PAE) and surgery (Sham
versus minor CCI versus Standard CCI). Additionally, a 2-way (2 x 3) repeated
measures ANOVA was used for analysis of the between-subject factors of
prenatal exposure and surgery for days post-surgery. Data from acquired
microscope images, flow cytometry, and ELISA were analyzed using GraphPad
Prism version 7 software (Graphpad Software Inc., San Diego, CA, USA). IHC
IR was analyzed using a 2-way (2 x 3) ANOVA followed by Fisher’s LSD test for
post-hoc examination. A total of N=6; Sac and N=8; PAE rats were used for
characterizing peripheral immune cell phenotypes and their functional responses.
To ensure healthy “live” single cell suspension and immediate flow cytometry
data acquisition (without fixation), rats were equally divided into two different
tissue collection days (N=3/day; Sac and N=4/day; PAE, per experiment yielding
a total of 5 different tissue samples per animal), which is a standard number of
animals used in flow analysis ((Vorderstrasse et al., 2003; Ghasemlou et al.,
2015; Jatana et al., 2017; Prasad et al., 2017)). Each tissue digestion and flow
cytometry data collection day was considered an independent biological
experiment. Data from each experiment was combined to generate N=6 for Sac
and N=8 for PAE. Data comparing surgically-naïve Sac and PAE groups were
analyzed with unpaired t-tests. ELISA data for pro-inflammatory cytokine
production were analyzed using two-way (2 x 2) ANOVA. To control the type I
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error rate during multiple comparisons, reported with adjusted P values, Tukey’s
test was applied for post hoc examination. The threshold for statistical
significance was set a priori at α = 0.05 for all sets of multiple comparisons. In
order to minimize unnecessary duplication, we used the minimum number of
animals possible to make statistically significant conclusions, which was based
on our previous publications (Wilkerson et al., 2012a; Dengler et al., 2014; Noor
et al., 2017; Whitehead et al., 2017). These studies utilized sample sizes of N=3
(IHC analysis), and N=6 (behavioral analysis) to reliably produce statistically
significant differences between treatment groups. Outliers were removed
following Grubbs’ Z-test (Grubbs, 1950). In all cases, the data are presented as
the mean ± SEM.

Results
PAE induces long-lasting susceptibility to allodynia from even minor
peripheral nerve damage
Under basal conditions, light touch sensory thresholds appear similar in both
PAE and Sac offspring with hindpaw responses occurring at approximately 10
grams of touch stimuli. In uninjured rats (sham treatment), sensory thresholds
remained near their BL values on Day 3 and 10 indicating that repeated
stimulation to the hindpaws during von Frey behavioral testing does not affect
threshold responses. In addition, following minor sciatic nerve 1-suture CCI in
Sac rats, ipsilateral hindpaw responses remained close to their BL values on Day
3, with sensory thresholds measured on Day 10 that completely overlapped
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Sham-treated rats. However, striking allodynia was observed as measured by
increased sensitivity of the ipsilateral hindpaw on Day 3 and 10 after surgery (Fig
1a). While threshold responses of the contralateral hindpaw remained stably near
BL values in Sham-treated and Sac - 1 suture CCI rats, PAE rats with 1 suture
CCI revealed a subtle but significant increase in contralateral hindpaw thresholds
on Days 3 and 10 (Fig 1b). Thus, these initial data support that the enduring
pathological consequences of PAE are revealed only after a minor nerve injury,
where allodynia was clearly observed in 1 year aged rats. These data indicate
that PAE creates long-lasting susceptibility to developing neuropathies, such as
allodynia, following minor challenges to the nervous system.

PAE results in long-term potentiation of allodynia following a standard
chronic constriction injury
Using a standard 4-suture sciatic chronic constriction injury (CCI), we have
previously reported that prenatal alcohol exposure (PAE) potentiates allodynia in
young adult rats (4 months) compared to the levels of allodynia observed in
saccharin (Sac) control offspring (Noor et al., 2017). The current data
demonstrate that the susceptibility to standard injury persists into middle age (1213 month-old rats). BL thresholds in both PAE and Sac-treated rats were similar
prior to surgery replicating data shown in Fig 1a and b and prior work by Noor, et
al (Noor et al., 2017). Following standard CCI, Sac rats develop typical bilateral
allodynia whereas PAE rats develop potentiated bilateral allodynia (Fig. 1 c-d),
also replicating our prior report in younger (4 month) adult rat offspring. Overall,
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these findings suggest that the effects of PAE are long-lasting and result in
enhanced allodynia following a standard CCI in middle-aged offspring.

PAE underlies enhanced spinal expression of astrocytic GFAP in
neuropathic rats
Spinal astrocytes and microglia were evaluated in middle-aged Sac exposed or
PAE offspring that had undergone standard or minor CCI. Behavioral
assessment in these rats (data shown in Fig. 1) was terminated on Day 10 postsurgery

followed

by

spinal

tissue

collection

and

preparation

for

immunohistochemistry (IHC) to determine the immunoreactivity (IR) of the
astrocyte ‘activation’ marker glial fibrillary acidic protein (GFAP). Standard 4suture CCI induced exaggerated astrocyte responses in both the ipsilateral and
contralateral dorsal horn of the spinal cord relative to CCI in PAE rats that
displayed bilateral allodynia compared to Sac rats (Fig. 2a-b). Minor 1-suture CCI
also resulted in significantly elevated bilateral spinal astrocyte responses in PAE
rats compared to sham conditions and Sac rats with minor injury. It is notable
that spinal cord dorsal horn GFAP IR from PAE rats with minor injury was
comparable to Sac rats with standard CCI and allodynia (Fig. 1c and Fig. 2a).
Representative images (Fig. 2c) of Sac-treated sham, Sac standard CCI, and
PAE standard CCI conditions for GFAP used for analysis are shown. The results
suggest that PAE underlies elevated astrocyte activation only following a
secondary injury such as either standard or minor sciatic nerve injury.
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Elevated spinal microglial activation markers are only seen following
standard CCI but not minor CCI
Spinal dorsal horn microglial responses in middle-aged offspring following IHC
processing revealed the transmembrane protein 119 (TMEM119), characterized
as a microglial specific proliferation marker (Bennett et al., 2016; Satoh et al.,
2016), was significantly elevated bilaterally in PAE rats with standard CCI
compared to PAE sham, PAE minor injury, and Sac standard CCI (Fig. 3a-b).
Additionally, significant bilateral increases in spinal cord TMEM119 IR were
observed in Sac rats with standard CCI compared to Sac offspring with sham
treatment or minor CCI injury (Fig. 3a-b).
To provide parallel lines of evidence, we examined the expression of
ionized calcium-binding adaptor molecule 1 (Iba1), a protein that is up-regulated
in both microglia and macrophages upon increased activation. Significant
bilateral increases in Iba1 IR from Sac and PAE offspring were observed in the
spinal cord dorsal horn with standard injury compared to all sham-treated rats,
Sac minor and standard CCI and PAE with minor CCI. (Fig. 3d-e). Images of
TMEM119 (Fig. 3c) and Iba1 (Fig. 3f) represent Sac sham, Sac standard CCI,
and PAE standard CCI conditions. Insets for TMEM119 provide a representation
of microglia surrounding nearby nuclei. Overall, these results suggest microglia
may not be the key cell type responsible for primed spinal cord responses in PAE
that lead to enhanced susceptibility to allodynia (Fig. 1c-d). It should be noted
that our 7 μm tissue sections do not provide the thickness needed to display the
multi-level microglial branching processes that TMEM119 IR has previously
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shown (Bennett et al., 2016). However, thin 7-um sections allows for adjacent
sections within the same anatomical regions of interest to be stained for different
cellular markers. Additionally, decalcified spinal cords described above,
underwent prolonged tissue decalcification that resulted in altered integrity of the
Iba1 epitope. As a result, data for Iba1 IR from decalcified tissue was not
included in the final Iba1 data set (Fig. 3c-d), as virtually no IR signal was
detectable. To avoid artificially losing Iba-1 IR, a separate group of spinal cord
tissue that did not undergo decalcification were isolated as described above.
Subjects were removed if values fell 2 standard deviations +/- mean. N=2
subjects were removed A total of 7 subjects (N=2 Sac 1-Sut, N=2 Sac 4-Sut, N=2
PAE 1-Sut, N=1 PAE 4-Sut) were removed from the ipsilateral data set and 6
subjects (N=2 Sac 1-Sut, N=3 Sac 4-Sut, N=1 PAE 4-Sut) were removed from
the contralateral data set in Fig. 3 (a-b).

PAE alters the peripheral immune cell profile in middle-aged offspring.
In addition to spinal astrocytes and microglia, peripheral leukocytes, known to
traffic to the level at the spinal cord where incoming nociceptive signals from
damaged peripheral nerves communicate to pain projection neurons, may be
important contributors of neuropathic pain. Our prior work revealed that PAE
potentiates peripheral immune responses from the sciatic nerve following nerve
injury in young-adults. Thus, the phenotype of peripheral leukocytes in specific
immune organs prior to trafficking to the spinal cord were examined for
elevations in their specific populations or activation markers as an indication of a
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primed state at basal levels. Thus, general immune cell populations in the
primary lymphoid organ (thymus) and secondary/peripheral lymphoid organs
(spleen, lymph node) in middle-aged PAE offspring were characterized. In
addition, immune cell composition was characterized in the circulating/peripheral
blood and the peritoneal cavity. The major immune cell subsets, T cells, B cells,
NK cells and myeloid cells in these immune compartments were identified using
the gating strategy represented in Fig 4 (a-e). In the thymus, the majority of
viable cells were mature T cells (Fig. 4f) with no differences between cells
collected from Sac or PAE rat offspring. Note that the thymus is primarily
involved in T cell maturation, therefore, it was not unexpected that other immune
cell subsets were not reliably detected in the thymus (data not shown). T cells
(about 30-65%) and B cells (2-40%) were identified in the spleen, lymph node,
PECs and the peripheral blood (Fig. 4f-g) with no differences in their proportions
from Sac or PAE treated rat offspring. Interestingly, compared to Sac-treated rats,
NK cells collected from PAE rats were significantly increased in the lymph node,
whereas the NK cell population was significantly decreased in the PECs (Fig. 4h).
While there was a strong trend toward decreased NK cells in the PBMNs, the
proportion of NK cells in the spleen from PAE and Sac rats were virtually the
same (Fig 4h). Combined, these data suggest that of the immune cell examined,
NK derived from PAE cells are somewhat primed under basal conditions and
may contribute to enhanced trafficking following a secondary challenge, as they
have already migrated to tissue areas where antigen presentation of pathogenor danger-associated molecular patterns takes place.
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Myeloid cell proportions from middle-aged PAE offspring are elevated in
secondary lymphoid organs
The composition of myeloid immune cells was compared from the immune
compartments, the spleen, lymph node, PECs and PBMNs using the gating
strategy described in Fig. 4 (a-e). Compared to Sac offspring, data revealed
significant increases in myeloid cell proportions in the spleen and the lymph node
of PAE rats (Fig. 5a-b for representative plots). More importantly, though
CD11b/c expression is considered a general myeloid cell marker, expression and
up regulation of CD11b/c often corresponds with leukocyte activation. Therefore,
these data suggest a chronic basal increase in the programming of myeloid cell
activation in peripheral lymphoid organs that occurs as a consequence of PAE.
While the proportions of myeloid cells in the PBMNs and PECs were comparable
between Sac and PAE groups (Fig. 5b), these data further support that immune
cell responses in later life may be heightened following minor challenges.

PAE primes peripheral immune cells resulting in augmented proinflammatory cytokine production
The current report demonstrates alterations in peripheral immune cell
populations (Fig. 4-5) of PAE rats that suggest the functional leukocyte
responses to typical immune stimulators may be exacerbated to typical
challenges. Leukocyte responses were evaluated in a mixed population of
immune cells collected from Sac or PAE rats. PMA/Io (for splenocytes) and LPS
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(myeloid cells) stimulation was used to examine the protein production of the
classic pro-inflammatory cytokines, TNFα and IL-1β, which are key in mediating
allodynia following sciatic nerve damage. Data revealed a profound enhanced
cellular response from 1 year-old PAE offspring compared to cellular responses
from Sac offspring. Leukocytes were isolated from the spleen and peritoneal
cavity. Following PMA/Io stimulation, significant increases in the proportions of
TNFα producing splenic leukocytes was observed in cells from PAE compared to
cells collected from the Sac group (Fig. 6 a-b). Compared to leukocytes without
LPS stimulation, LPS stimulation significantly induced TNFα and IL-1β protein
levels in leukocytes from Sac offspring, as expected (Fig. 6c-d). However, LPS
stimulation of leukocytes from PAE offspring resulted in the greatest increase in
TNFα production as detected in the cell culture supernatant (Fig. 6c) and cell
lysate (data not shown). Similarly, compared to stimulated leukocytes from Sac
offspring, IL-β levels from cell lysates were greatest from PAE leukocytes
stimulated with LPS (Fig. 6d). Together, these data demonstrate that adult
immune cells that have previously undergone PAE appear “normal” under basal
conditions, but generate exaggerated cytokine responses to typical stimuli.
Moreover, the primed immune cell programming induced by PAE persists
throughout adulthood. These data indicate the potential contribution of the PAEprimed peripheral immune system underlying the susceptibility to neuropathy in
middle-aged rats.
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Discussion
Data from recent reports support the emerging idea that moderate drinking
during pregnancy, which results in mean maternal peak serum ethanol levels of
60-80 mg/dL, exacerbates later-life central nervous system (CNS) dysfunction
upon subsequent challenge either from immune activation or nervous tissue
damage (Terasaki and Schwarz, 2016a; Noor et al., 2017). These reports
demonstrate that long-term PAE-related adverse outcomes ranging from
cognitive deficits to potentiated peripheral neuropathy are associated not only
with elevated CNS glial reactivity, but also

adult-onset injury-induced

exaggerated peripheral immune cell responses suspected to participate in
ongoing peripheral neuropathies. A recent study using moderate PAE in rats
conducted by Noor et al. (Noor et al., 2017) reported the striking observation of
identical baseline sensory responses in saccharin and PAE offspring, suggesting
the pathological consequences of PAE are not necessarily overt, but rather, can
be unmasked following a secondary insult. These results further suggest PAE
may create risks associated with later-life CNS pathology (i.e. neuropathy)
triggered by challenges typically unnoticed and resolved in non-PAE individuals.
The current work demonstrates that in later-life adult PAE offspring, PAE creates
susceptibility to adult-onset peripheral neuropathy despite a substantial reduction
in sciatic nerve injury not typically observed in the absence of prenatal alcohol
exposure (Fig. 1).
In the current report, analysis of the dorsal horn of the spinal cord
collected from the same rats examined for peripheral neuropathy revealed that
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standard (4-suture) CCI induces exaggerated bilateral microglial activation and
proliferation, as assessed by immunoreactivity (IR) of two microglial markers Iba1
and TMEM119, providing converging lines of evidence (Fig. 3 A-E). Elevated
bilateral spinal astrocyte activation was observed concurrently, as measured by
GFAP IR (Fig 2). These data agree with previous reports that have demonstrated
that both astrocytes and microglia mediate allodynia through their activation and
release of proinflammatory cytokines (Milligan et al., 2003). Interestingly, spinal
cords from PAE offspring with minor CCI (and corresponding allodynia) revealed
no changes from sham conditions in microglial activation, as measured by both
Iba1 and TMEM119, yet bilateral astrocyte activation was observed as significant
increases in GFAP IR compared to Sac control rats (Fig 2A and B) were evident.
Together, these data suggest that spinal astrocytes and not microglia are playing
a key role in mediating a PAE-associated increased risk for developing allodynia
following minor injury. This notion is supported in previous studies showing no
microglial activation in PAE animal within the visual cortex (Wong et al., 2017).
Further characterization of immune cell populations collected from
surgically-naïve saccharin and PAE offspring provided insight into the PAEinduced priming on immune subsystems, such as the adaptive immune system
that requires the action of both B and T cells and the innate immune system that
can initially act without T and B cell involvement (Janeway et al., 2017). Our T
and B cell data revealed normal distribution patterns regardless of whether these
cells were derived from Sac or PAE rats (Fig. 4f-g), which is consistent with prior
reports (Norman et al., 1991; Basham et al., 1998; Moscatello et al., 1999).
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However, other studies that ranged from a moderate PAE (Jerrells and Weinberg,
1998; Zhang et al., 2012) to a chronic life-long PAE (McGill et al., 2009) have
shown cellular activation states and altered adaptive immune responses prior to
subsequent challenge in adult rodents following PAE. The work in the current
report support that further exploration into the possible effects of PAE on
inflammatory versus anti-inflammatory T cell phenotypes underlying chronic
neuropathy is needed, Using recently developed flow cytometry techniques, such
as mass cytometry and imaging flow cytometry, would be beneficial (Korn et al.,
2007; Jäger and Kuchroo, 2010; Barteneva et al., 2012; Carvajal et al., 2017;
McFarlin and Gary, 2017).
Cellular populations critical to the function of the innate immune system
revealed significantly different levels between Sac and PAE treatment groups
(Fig. 4h). NK cells play a role similar to that assigned to T cytotoxic lymphocytes
and provide rapid immune responses to tissue injury such as sciatic nerve
damage, or infection (Janeway et al., 2017). NK cells populate/migrate to lymph
nodes when activated and may influence adaptive immune cell differentiation
(Fehniger et al., 2003; Martín-Fontecha et al., 2004). Thus, observing elevated
NK cell populations in PAE lymph nodes suggests these cells are in a state of
increased activation after trafficking from peripheral regions where they may
reside in less differentiated and activated states.
Myeloid cell proportions were heightened in PAE rats specifically in the
spleen and lymph node compared to Sac controls (Fig 5), further supporting an
increase in an activated phenotype. In general, myeloid cells act as potent
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antigen-presenting cells and upon immune activation, which can occur following
recognition of altered self-antigens (i.e. damaged sciatic nerve axons), they
acquire a “mature” differentiated state and relocate to secondary lymphoid
organs to induce T cell mediated immune responses (Martín-Fontecha et al.,
2009). In light of what is currently understood about myeloid cell function, the
data reported here support the idea that cells from PAE rats are in a state of
chronic mild heightened activation in key immune tissue systems. Given reported
data here show elevated immune surveillance, the functional significance of
these alterations was further explored and revealed that following in vitro
stimulation, PAE-derived leukocytes show significant increases in TNFα and IL1β protein (Fig. 6). Together, these data suggest that PAE alters the distribution
of cells as well as their functional reactivity to immune stimulators that persists
into middle age in PAE rats. A second insult results in heightened immune
responses inducing allodynia.
The results of these data may extend beyond neuropathic pain and may
apply to other peripheral inflammatory and CNS conditions. Additionally, the
long-term clinical implications of these results suggest that some adverse
consequences of in utero alcohol exposure only occur upon a secondary insult
sometime after prenatal alcohol exposure. This possibility is supported by studies
in animal models of PAE where enhanced severity and disease outcomes are
associated with influenza virus (McGill et al., 2009), adjuvant-induced arthritis
(Zhang et al., 2012), or following sciatic nerve damage in young adult PAE
animals that display heightened allodynia and exaggerated glial activation (Noor
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et al., 2017). Clinically, children with FASD display alterations in peripheral
immune responses and show overall increased susceptibility to developing
infections (Johnson et al., 1981). Collectively, these reports provide intriguing
evidence that the effects of PAE on adult-onset disease are not observed until a
secondary insult.
Astrocytes have been well-characterized to act as key mediators of
enduring allodynia following peripheral neuropathy (Zhuang et al., 2005; Milligan
and Watkins, 2009; Ji et al., 2013), and this possibility is further supported by
current data from PAE rats with allodynia. Prior work demonstrated that
moderate PAE downregulates the expression of the astrocyte specific glutamate
transporter, glutamate aspartate transporter or GLAST (Danbolt, 2001; Brolese et
al., 2015) , which may underlie the observed elevation in spinal astrocyte
activation in PAE allodynia rats described in the current report. Indeed, following
CCI in rats, spinal astrocyte-specific glutamate transporters downregulate leading
to the induction of allodynia (Sims and Robinson, 1999), which is thought to
occur as a consequence of reduced glutamate clearance and enhanced
glutamate action on spinal pain projection neurons. In addition, prior reports have
shown that inhibition of astrocyte glutamate transporters results in potentiated
allodynia (Sung et al., 2003). Together these data suggest that PAE-induced
allodynia may be a result of alterations within astrocyte-specific glutamate
transporters.
In PAE rats with minor injury, astrocyte but not microglial activation in the
contralateral dorsal horn of the spinal cord are significantly elevated compared to
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sham conditions, coinciding with slight increases in contralateral hindpaw
sensitivity. Previous publications suggest that contralateral allodynia is a result of
astrocyte activation and subsequent release of proinflammatory cytokines
(Milligan et al., 2003) that spread to the contralateral spinal cord via
communication through astrocyte-specific gap junctions (Spataro et al., 2004).
Thus, it is possible that following minor CCI in PAE rats, elevated contralateral
spinal cord astrocyte activation is sufficiently elevated to induce small increases
in contralateral hindpaw sensitivity. This data supports the notion that a sufficient
threshold of astrocyte activation is needed to induce bilateral allodynia. It should
be noted that microglial activation is also observed following standard CCI.
Previous reports have suggested that elevated microglial activation plays a
greater role in the induction of

contralateral allodynia

(Gallo et al.,

2017).Therefore, a combination of both astrocyte and microglial activation mat be
required to generate robust bilateral allodynia observed following standard
unilateral sciatic nerve injury.

Conclusions
In conclusion, the risks of PAE associated with pathological pain endure long into
middle adulthood and can be unmasked following even minor injuries to the
peripheral nervous system. A contributing factor in the PAE-induced susceptibility
to peripheral neuropathy is heightened spinal astrocyte responses following
minor CCI. Additionally, not only does PAE alter peripheral immune cell
distribution, but also primes peripheral immune cell responses to immune stimuli
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resulting in heightened cytokine production. Heightened immune-cytokine
responses as a consequence of PAE may be the critical underlying factor
rendering one susceptible to chronic adult-onset neuropathies from minor insults.
The results demonstrate that some of the adverse effects of PAE occur via longlasting pathologically-altered neuroimmune responses.
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Figure 1

Figure 1. Prenatal alcohol exposure (PAE) causes enhanced allodynia
following standard sciatic damage and allodynic susceptibility following
minor nerve damage. Hindpaw response thresholds from (a-b) minor (1-suture)
vs (c-d) standard (4-suture) unilateral sciatic nerve injury (CCI) in middle-aged
PAE rats. (a-d), All Sac and PAE rats displayed similar baseline hindpaw
sensitivity responses following application of mechanical stimuli. Following
surgical sciatic nerve manipulation, a main effect of alcohol exposure, surg, and
an interaction between alcohol exposure and surgery was seen. (a-b) Following
minor CCI, PAE rats developed increased sensitivity whereas Sac rats did not. A
main effect of alcohol exposure, surgery, as well as an interaction between
alcohol exposure and surgery was revealed. Asterisks indicate p < 0.05. The
data are presented as the mean ± SEM.
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Figure 2

Figure 2. PAE induces heightened spinal cord astrocyte activation
following both standard and minor CCI. Quantification of immunoreactivity (IR)
following immunohistochemical (IHC) procedures was applied to assess the
degree of astrocyte activation (GFAP) following standard and minor CCI.
Fluorescence intensity is defined as the total sum intensity within the dorsal horn
spinal cord (identified as a region of interest - ROI) divided by the area of the
ROI. (a-b) A main effect of alcohol exposure and surgery is seen in both
ipsilateral and contralateral dorsal spinal cord relative to the side of sciatic nerve
injury. PAE rats with standard 4-suture CCI had significantly elevated ipsilateral
and contralateral GFAP IR compared to Sac control rats with standard 4-suture
CCI. Following minor CCI, PAE rats had elevated ipsilateral and contralateral
GFAP IR compared to PAE Sham, Sac Sham, Sac 1-suture. Minor CCI-PAE rats
revealed comparable IR to Sac 4-suture. Representative images (c) of GFAP IR
used in IHC analysis are shown for Sac Sham, Sac standard CCI, and PAE
standard CCI conditions at 20x. N=5-6 rats per group. Asterisks indicate p < .05.
Number sign indicates significance amongst groups at p < 0.05. The data are
presented as the mean ± SEM.
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Figure 3

Figure 3. Minor CCI does not augment microglial activation in PAE rats.
Applying IHC quantification following either standard CCI or minor CCI, two
markers to identify alterations in microglial activation were examined: the
microglial specific marker TMEM119 and the microglial and macrophage marker
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Iba1. (a-b) TMEM119 IR revealed a main effect of surgery. Comparisons a priori
of TMEM119 IR (a-b) showed that following standard CCI, PAE rats display
elevated bilateral microglial activation compared to the PAE sham condition as
well as PAE rats with minor injury. TMEM119 IR was also significantly elevated in
PAE rats with standard CCI compared to Sac rats with standard CCI within the
ipsilateral dorsal spinal cord. Sac rats with standard CCI displayed elevated
TMEM119 IR within the ipsilateral dorsal spinal cord compared to Sac sham rats.
These rats also revealed bilateral increases in TMEM119 IR compared to Sac
rats with minor injury. No significant differences in TMEM119 IR were seen
between PAE sham and PAE minor CCI conditions. (d-e) Iba1 results reveal a
main effect of surgery. Iba1 comparisons a priori (c-d) revealed significantly
elevated IR in PAE with standard CCI compared to PAE sham rats, PAE rats with
minor injury, as well as Sac rats with standard CCI. Sac rats with standard CCI
had significantly elevated Iba1 IR compared to Sac sham rats in the ipsilateral
dorsal spinal cord and contralateral spinal cord. No significant differences were
seen between PAE sham and PAE minor CCI conditions. (e) Representative
images of TMEM119 IR and (f) Iba1 IR that were included in the IHC analysis are
shown for Sac Sham rats, Sac rats with standard CCI, and PAE rats with
standard CCI at 20x. Inset for TMEM119 is shown at 60x. Asterisks indicate p <
0.05. NS indicates not significant. The data are presented as the mean ± SEM.
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Figure 4

Figure 4. Characterization of major immune cell subsets in peripheral
leukocytes as a consequence of PAE. (a-e) Representative flow cytometry
plots and gating strategy to identify immune cell subsets in surgically-naive Sac
and PAE rats. (a) The intact/healthy cells were identified based on their light
scatter properties. (b) Only live cells (verified by the absence of viability dye)
were included for subsequent analyses. (c) T cells and B cells were identified by
positive expression of CD3 and CD45RA, respectively. The double negative cell
population was identified as P1. (d) Within P1, NK cells were quantified by their
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expression of CD161. The cell population not expressing CD161 was identified
as P2. (e) P2 cells were further analyzed for the expression of CD11b/c (binds
common epitope between CD11b and CD11c) to identify myeloid cells. Bar
graphs represent proportions of (f) T cells, (g) B cells and (h) NK cells in
leukocytes collected from thymus, spleen, lymph nodes, peritoneal cavity (PEC)
and peripheral blood (PBMNs). Data are presented as percentages of their
parent populations. A significant increase of NK cells was observed in the lymph
node, whereas NK cells in the peritoneal cavity were reduced. Data are
representative of two independent experiments. Sac (N=3 rats) and PAE (N=4
rats), in each experiment (total of Sac; N=6 and PAE; N=8). Asterisks indicate p
< 0.05. The data are presented as the mean ± SEM.
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Figure 5

Figure 5. PAE induced myeloid cells in the secondary lymphoid organs.
Leukocytes displaying negative expression of B cell, T cell and NK cell markers
(P2 population in Fig. 4), were further analyzed for myeloid cell marker (CD11b/c)
expression. (a) Bar graphs showing proportions of myeloid cells in the spleen,
medial iliac lymph nodes, peritoneal cavity (PEC) and peripheral blood
mononuclear cells (PBMN). Myeloid cell proportions were significantly increased
in the spleen and in the lymph nodes in PAE rats. (b) Representative flow
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cytometry plots of CD11b/c expression vs side scatter (SSC-A) in the spleen (top
panels) and in the lymph node (bottom panels) from Sac and PAE rats is
provided. Data are representative of two independent experiments. Sac (N=3
rats) and PAE (N=4 rats), in each experiment (total of Sac; N=6 and PAE; N=8).
Asterisks indicate P < 0.05. The data are presented as the mean ± SEM.
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Figure 6

Figure 6. Peripheral immune cells in middle age PAE rats display
augmented pro-inflammatory cytokine production. (a-b) Splenic leukocytes
and (c-d) PEC were stimulated in vitro to examine their functional response
profiles in proinflammatory cytokine production from Sac vs PAE rats. (a)
Representative flow cytometry plots showing TNFα expression with CD11b/c
expression on splenic leukocytes. (b) Bar graph of proportions of leukocytes
displaying intracellular TNFα protein levels following 5 hrs of PMA/Io stimulation.
Proportions of TNFα producing splenic leukocytes were significantly induced in
PAE rats, (c) TNFα levels in the media/ cell-free supernatant after 24 hrs of LPS
stimulation of PECs. Both LPS stimulation and PAE increased TNFα production.
A significant interaction between LPS stimulation and PAE was observed (F1,24 =
10.74, p = 0.0032). LPS stimulated leukocytes from PAE rats induced the
greatest number of TNFα production than LPS stimulated leukocytes from Sac
rats. (d) IL-1β levels in cell lysates of PECs following leukocyte stimulation with
LPS. Both LPS stimulation and PAE increased IL-1β production. Following
stimulation with LPS, IL-1β production was significantly increased in leukocytes
from PAE than leukocytes from Sac rats. N=6 rats in Sac groups and N=8 rats in
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PAE groups. Asterisks indicate p < 0.05. The data are presented as the mean ±
SEM.
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Chapter 3 - Targeting the β2-integrin LFA-1, reduces adverse
neuroimmune actions in neuropathic susceptibility caused
by prenatal alcohol exposure
Abstract
Recently, moderate prenatal alcohol exposure (PAE) was shown to be a risk
factor for peripheral neuropathy following minor nerve injury. This effect coincides
with elevated spinal cord astrocyte activation and ex vivo immune cell reactivity
assessed by proinflammatory cytokine interleukin (IL) -1β protein expression.
Additionally, the β2-integrin adhesion molecule, lymphocyte function-associated
antigen-1 (LFA-1), a factor that influences the expression of the
proinflammatory/anti-inflammatory cytokine network is upregulated. Here, we
examine whether PAE increases the proinflammatory immune environment at
specific anatomical sites critical in the pain pathway of chronic sciatic neuropathy;
the damaged sciatic nerve (SCN), the dorsal root ganglia (DRG), and the spinal
cord. Additionally, we examine whether inhibiting LFA-1 or IL-1β actions in the
spinal cord (intrathecal; i.t., route) could alleviate chronic neuropathic pain and
reduce spinal and DRG glial activation markers, proinflammatory cytokines, and
elevate anti-inflammatory cytokines. Results show that blocking the actions of
spinal LFA-1 using BIRT-377 abolishes allodynia in PAE rats with sciatic
neuropathy (CCI). This effect is observed (utilizing immunohistochemistry; IHC,
with microscopy analysis and protein quantification) in parallel with reduced
spinal glial activation, IL-1β and TNFα expression, and elevated IL-10 in the
spinal cord. DRG from PAE rats with neuropathy reveal significant increases in
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satellite glial activation and IL-1β, with a reduction of IL-10. Further, blocking
spinal IL-1β with i.t. IL-1RA transiently abolishes allodynia in PAE rats,
suggesting that IL-1β is necessary for susceptibility to adult-onset peripheral
neuropathy caused by PAE. mRNA analysis reveal that BIRT-377 increased
CCL2 and CXCL1 at the damaged SCN in rats with CCI. These data
demonstrate that PAE creates life-long dysregulated IL-1β /IL-10 responses to
minor injury in the sciatic-DRG-spinal pain pathway. PAE creates a risk for
developing peripheral neuropathies, and LFA-1 may be a novel therapeutic target
for controlling dysregulated neuroimmune actions as a consequence of PAE.
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Introduction
Fetal alcohol spectrum disorder (FASD), a condition that occurs as a result of
prenatal alcohol exposure (PAE), results in cognitive and behavioral deficits
(Mattson et al., 1998). Unfortunately, many of the central nervous system (CNS)
deficits are not always apparent. By using animal models of FASD, many of the
insidious effects of PAE have been uncovered. Interestingly, a growing body of
evidence shows that PAE alters immune function and reactivity. Specifically, the
viability of microglial cells within the cerebellum is decreased as a consequence
of developmental ethanol exposure (Kane et al., 2011). Additionally, a separate
study demonstrates that hippocampal glial cells are increased in their activation
state, which coincides with heightened expression of the proinflammatory
cytokine interleukin (IL)-1β (Topper et al., 2015). These and other PAE studies
utilize high levels of alcohol exposure to mimic the effects of binge alcohol
consumption, leaving the question of whether low-to-moderate levels of PAE
adversely impacts the function of the central nervous system in adulthood.
Recent reports aim at understanding whether PAE alters spinal cord pain
processing by utilizing an animal model of neuropathic pain. These studies
demonstrate that moderate PAE alters both peripheral and spinal neuroimmune
function, which are immune processes well-characterized to mediate pathological
pain. Additionally, these reports demonstrate that the immune responses
becomes ‘primed’ (i.e. sensitized) such that applying a sciatic nerve (SCN) injury
generates potentiated microglial and astrocyte responses at the spinal cord, as
well as enhanced expression of proinflammamtory cytokines, such as tumor

80

necrosis factor-α (TNFα) and IL-1β, at the damaged SCN (Noor et al., 2017;
Noor and Milligan, 2018). Additionally, blunted expression of the antiinflammatory cytokine IL-10, which suppresses neuropathic pain (Wilkerson et al.,
2012a; Khan et al., 2015), is observed in PAE rats compared to controls at both
the dorsal root ganglia (DRG) and the SCN (Noor et al., 2017). These data
suggest that PAE results in heightened pro-nociceptive and proinflammatory
neuroimmune responses creating enduring susceptibility to developing
pathological pain.
In an effort to address the possible risk of developing neuropathy created
by PAE, the injury to the SCN was substantially reduced in an effort to unmask
the effects of moderate PAE on glial and immune priming (Sanchez et al., 2017).
This reduction uncovered an alteration in spinal astrocytes, as the astrocyte
marker, glial fibrillary acidic protein (GFAP) is significantly elevated in PAE rats
with neuropathy (Noor et al., 2017; Sanchez et al., 2017), while evidence for
microglial activation was not observed. In support of a role for peripheral immune
cells in sensitized responses to minor injury/challenge, heightened expression of
TNFα and IL-1β was observed in leukocytes from PAE rats (Sanchez et al.,
2017). Together, these data suggest that the PAE leads to hyper-reactive
neuroimmune response which may render one vulnerable to developing
neuropathic pain.
Interestingly, the chemokine CCL2 and the β 2-integrin, lymphocyte
function-associated antigen-1 (LFA-1) is altered in PAE rats (Noor et al., 2017).
CCL2 activates the surface receptor, intercellular adhesion molecule-1 (ICAM-1)
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that is expressed on endothelial cells and critically interacts with LFA-1 (Dustin
and Springer, 1988), a process underlying transendothelial leukocyte migration
into CNS sites expressing CCL2. LFA-1 is expressed by peripheral leukocytes
(e.g. macrophages and T-cells) and microglia (Hailer et al., 1997; Evans et al.,
2006). Following peripheral nerve damage, peripheral leukocytes utilize ICAM-1LFA-1 interactions to extravasate into the spinal cord where projections of the
damaged nerve terminate onto spinal pain projection neurons and release CCL2.
Thus, high CCL2 expression occurs in the spinal regions where excitatory
neuronal communication and pain relays occur, further aiding in the induction of
allodynia. Interestingly, LFA-1 expression can potentially influence IL-10
expression (Labuda et al., 1998; Emoto et al., 2003). A separate study looking at
the influence of LFA-1 on cytokine activity demonstrate that pretreating cultured
macrophage cells (RAW267) stimulated with lipopolysaccharide (LPS) using an
LFA-1 antagonist, BIRT-377, results in a dose-dependent increase in IL-10
protein release with a simultaneous decrease in IL-1β and TNFα protein release
(Lam et al., 2014). Therefore, the present study examines whether blocking LFA1 activation can generate an anti-inflammatory phenotype within the DRG and
spinal cord resulting in reversal of chronic allodynia in neuropathic susceptible
PAE rats.
The present report utilizes a rodent model of peripheral neuropathy
referred to as chronic constriction injury (CCI), but modified with significantly
reduced injury by applying a single suture (minor CCI) rather than the established
4-suture paradigm. By applying a minor CCI to a characterized rat model of
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moderate PAE, allodynia is induced only in PAE rats, replicating prior findings
(Sanchez et al., 2017). Following CCI, BIRT-377 is injected intrathecally followed
by behavioral assessment. At maximal efficacy of BIRT-377 on suppression of
allodynia, tissue is collected from the SCN, DRG, and dorsal horn of the spinal
cord to characterize the proinflammatory cytokine and chemokine profile using
IHC, electrochemiluminescence (for protein quantification assays), and mRNA
gene expression. Additionally, IL-1 receptor antagonist (IL-1RA) is administered
via the intrathecal (i.t.) route to determine whether spinal IL-1β is necessary to
induce allodynia following minor injury. The goals of these studies are to
determine the SCN, DRG, and spinal immune factors altered and whether
controlling the spinal cord cytokine/chemokine environment can reverse PAE
induced sensitivity to allodynia.

Materials and Methods
Animals and Study Group Strategy
All procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of New Mexico Health Sciences Center and
closely adhered to guidelines from the International Association for the Study of
Pain for the use of animals in research. Long-Evans rat breeders purchased from
Harlan Industries (Indianapolis, IN) were maintained in a breeding colony on a
12:12-hour reverse light/dark schedule (lights on from 2100 to 0900 hours), and
fed Harlan Teklad rat chow and water, available ad libitum. For all experiments,
5-8-month old male prenatal alcohol or saccharin exposed (described below) rat

83

offspring derived from 56 litters were used. Offspring were transferred to a
standard light/dark cycle (lights on from 0600 hours to 1800 hours) and allowed
to acclimate to these conditions for at least 30 days before commencing
experiments. Additionally, rats were kept in these conditions for the duration of
the study.
Moderate Prenatal Alcohol Exposure Using the Voluntary Drinking
Paradigm. Pregnant female rat dams are given either ethanol or saccharin
throughout pregnancy until birth according to the voluntary drinking paradigm
previously described (Savage et al., 2010). Briefly, 3- to 4-month-old female
Long-Evans rats are acclimated for 4 hours per day, from 1000 to 1400 hours
(during their active phase), to drinking water containing 0.066% (w/v) saccharin
(Sac) that gradually increased in ethanol content from 0% (v/v) on Days 1-2, to
2.5% (v/v) on Days 3-4, to 5% (v/v) on Day 5 and thereafter for two weeks. It
should be noted that regular drinking water is available at all times during
housing. Thus, animals could voluntarily choose to drink either saccharin
sweetened water containing 5% ethanol or regular water during the 4-h drinking
period. At the end of the 2-week pre-pregnancy drinking phase, the mean daily
ethanol consumption is determined for each rat and rats that consumed 1
standard deviation below the group mean are excluded from the study.
Subsequently, female rats are assigned to either a 5% ethanol or Sac control
drinking group such that the mean pre-pregnancy ethanol consumption was
similar between groups. The females are then placed with proven male rat
breeders until pregnant (~2-5 days). No alcohol is consumed during the breeding
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period. Beginning on gestational day 1, rat dams are given either 0% (Sac) or 5%
(PAE) ethanol in Sac water (4 hours/day, during the active phase). Sac rats are
given a volume of 0% ethanol in Sac water that is matched to the mean volume
voluntarily consumed by the 5% ethanol group. Total ethanol consumption is
recorded for each dam, which averaged 2.04 g of ethanol/kg body weight/day.
This level of drinking by rat dams produced a mean peak serum blood alcohol
concentration of 60.8mg/dl (Savage et al., 2010). No significant differences are
observed between prenatal treatment groups in dam weight gain during
pregnancy, pup birth weights, or litter size, replicating previous reports (Savage
et al., 2010; Noor et al., 2017; Sanchez et al., 2017). Offspring are weaned at 24
days of age and male offspring pair-housed with the exception of five singlehoused rats due to incompatibility with a cage mate. For all experiments, 5-8month-old prenatal alcohol or saccharin-exposed animals are used. Behavioral
testing of offspring is performed during the first three hours of the light cycle
(inactive phase) to avoid the influence of elevated hormones under normal
circadian rhythms.
A total of 108 male offspring are used in all experiments. Offspring are
predominantly pair-housed with 5 rats single-housed due to incompatibility with a
cage mate. Rat offspring are split into three groups. It should be noted that none
of the experimental groups contained more than one subject from a given litter to
avoid “litter effects”. The first group and second group consists of 43 (24 with
prenatal saccharin exposure, Sac; and 19 with prenatal alcohol exposure; PAE)
and 51 (23 Sac and 28 PAE) rats, respectively, and are used for behavioral
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examination of hindpaw sensitivity following i.t. treatment of BIRT-377 and its
effects on neuropathy produced by minor peripheral nerve injury. Following
behavioral verification for allodynia, Group 1 rats are used for protein and mRNA
analysis whereas Group 2 rats are used for spinal cord and DRG
immunohistochemical (IHC) analysis. Group 3 consisted of 14 (PAE) rats and are
used to examine the effects of an i.t. administration of IL-1 receptor antagonist
(IL-1RA) on CCI-induced allodynia. In all cases, experimenter is blinded to the
group identities of all experimental conditions.

Chronic constriction injury (CCI)
In adult male Sac or PAE rats, sham or CCI aseptic surgical procedures are
performed as previously described (Bennett and Xie, 1988; Noor et al., 2017;
Sanchez et al., 2017) and modified, as described here. Under isoflurane
anesthesia (3% volume in oxygen), the sciatic nerve is carefully isolated with
sterile glass prongs and snuggly ligated with 1 (minor CCI) segment of sterile 4-0
chromic gut suture (Ethicon, Somerville, NJ) without pinching into the nerve.
Sterile isotonic saline (0.9%) is applied to the nerve during the procedure to
prevent dehydration. Sham surgery involves isolation of the sciatic nerve similar
to CCI but without nerve ligation. The nerve is then gently placed back into
position and the overlying muscle is sutured closed with two 3–0 sterile silk
sutures (Ethicon, Somerville, NJ). Rats fully recover from anesthesia within
approximately 5 minutes and are monitored daily following surgery for any postoperative complications. Two rats (1.8%) were excluded from the study due to

86

the presence of hindpaw autotomy.

Behavioral Assessment of Allodynia
Allodynia was assessed using the von Frey fiber test as previously described
(Dengler et al., 2014; Sanchez et al., 2017). Briefly, habituation to the testing
environment required placing rats atop 2-mm thick parallel bars spaced 8-mm
apart allowing full access to the plantar hindpaw. Habituation occurres for
approximately 45 min/day for 4 sequential days within the first 3 hours of the light
cycle (inactive phase) in a sound- and temperature-controlled dimly lit section of
the home colony room. Baseline (BL) responses are then assessed using the
von Frey behavioral test. A total of 13 calibrated monofilaments are used in these
studies. Additionally, these calibrated monofilaments (3.61–5.18 log stimulus
intensity) are applied to the plantar surface of the left and right hindpaw for a
maximum of 8 seconds per application. Random order between left and right
hindpaw assessment is conducted. A metronome placed in the room provided
guidance at 1 tick/sec. Lifting, licking, or shaking of the paw is considered a
response. In a similar manner to BL evaluation, one group of rats is re-assessed
following CCI or sham surgery through Day 10 prior to drug treatment. A second
group of rats is assessed through Day 28 prior to drug treatment. The
experimental tester was blind to the prenatal and surgical treatment groups. At
either Day 10 or Day 28, rats are given an i.t. injection of drug or vehicle
(described below) and behavioral re-assessment occurs daily for 4 sequential
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days post-injection to examine the effects of i.t. BIRT-377, or at 1, 2, 2.5, 3, and
24hrs post-injection to examine the effects of i.t. IL-1RA.

Drug preparation
BIRT-377 is a small molecule characterized as a non-competitive inhibitor of
leukocyte function-associated antigen-1 (LFA-1) that minimizes the active
conformation of this transmembrane β2-adhesion receptor expressed on
leukocytes (e.g. T cell and myeloid cells). BIRT-377 (Tocris, Bristol, UK) was
initially reconstituted in 100% ethanol as a stock solution at a concentration of
22.156mg/ml, aliquoted into 0.5 ml sterile Eppendorf tubes and stored in a clean
sealed container at 4°C for later use. On the day of i.t. injection, sterile ddH 20 is
warmed in a water bath and BIRT-377 is added to reach a concentration of 500
ng/20μl for i.t. injection and vortexed for 2 min. Vehicle consisted of sterile ddH2O.
Animals are injected within the hour following drug dilution.
IL-1 receptor antagonist (IL-1RA) (R&D systems, Minneapolis, MN) is
reconstituted in sterile ddH20 at a stock concentration of 50 mg/ml, aliquoted into
0.5 ml sterile Eppendorf tubes and stored at -20°C for later use. On day of i.t.
drug injection, IL-1RA is diluted in 0.1% rat serum albumin (RSA) in sterile
phosphate buffered saline (PBS) to a concentration of 1μg/μl containing 0.01%
RSA. Therefore, each rat receives 20μg of IL-1RA in 20μl i.t. Vehicle consists of
0.1% RSA in sterile PBS.

Intrathecal (i.t.) Injection
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BIRT-377, IL-1RA or vehicle is administered using an i.t. catheter on Day 28
(BIRT-377) or Day 10 (BIRT-377 or IL-1RA) post-surgery as described previously
(Milligan et al., 2005). Briefly, under isoflurane anesthesia (3% volume in oxygen),
the beveled needle end of an 18-gauge sterile (Bectin Dickson, Franklin Lakes,
NJ) needle with the plastic hub removed is inserted between lumbar vertebrae
L5-L6. PE-10 tubing (Fisher Scientific, Hampton, NH) is fitted with a 30-gauge
sterile needle (Bectin Dickson, Franklin Lakes, NJ) containing a Hamilton syringe
at one end and labeled with a marking at 7.7 cm at the opposite end. Drug or
equivolume of vehicle (20 μl) is withdrawn from the open side of the PE-10 tubing.
The open end of the tubing is then threaded into the 18-gauge needle until the
7.7 cm marking is reached. This position corresponds to the lower lumbar L4-L5
region of the spinal cord. Correct placement of the PE-10 is determined by
twitching of the hindleg and/or tail during catheter advancement, as well as
cerebrospinal fluid efflux from the externalized portion of the needle. Drug is
administered over a 25 second interval. Immediately following drug or vehicle
administration, tubing is removed followed by removal of the needle and rats are
allowed to recover before being placed in their home cage. Rats fully recover
from anesthesia within 5 minutes and 100% motor recovery is observed following
injection.

Immunohistochemical (IHC) tissue sample preparation
All tissue from rats behaviorally verified for allodynia on Day 4 (Day 32 postsurgery) after i.t. BIRT-377 injection are collected for IHC processing as
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described previously (Noor et al., 2017; Sanchez et al., 2017). Briefly, rats are
overdosed with sodium phenobarbital ( 390 mg/ml Sleepaway, Fort Dodge
Animal Health, Fort Dodge, IA) and transcardially perfused with 0.1 M phosphate
buffered saline (PBS; pH = 7.4), initially at a rate of 28 ml/min, then increased to
32 ml/min (~10 min), followed by 4% paraformaldehyde (PFA; pH = 7.4; 28-34
ml/min, 8 min). Immediately following transcardial perfusion, the spinal vertebral
column from C2-L6 with the spinal cord intact within the vertebral column are
collected and cut at vertebra T7 into a rostral and caudal half of the spinal
vertebral column. All spinal cord sections undergo 48-hour post-fixation in 4%
PFA at 4 °C.
Following post-fixation, the entire spinal cord (T7- L6) is carefully isolated,
and separately, the corresponding L4-L6 dorsal root ganglia (DRG), making sure
to maintain tissue integrity. The isolated spinal cords are then subsequently
paraffin processed. At a later time, DRGs are individually dissected and paraffin
processed. Paraffin-embedded blocks are then subsequently sliced on a
microtome with adjacent 7 μm tissue sections mounted onto vectabond-treated
slides.
To investigate spinal augmented neuroimmune activation, we analyze the
expression of the astrocyte marker, glial fibrillary acidic protein (GFAP), the
microglial activation marker ionized calcium-binding adapter molecule 1 (Iba1),
the proinflammatory cytokine marker IL-1β, and the anti-inflammatory marker IL10 in L4-6 spinal segments, as reported previously (Wilkerson et al., 2012a).
Slides containing tissue from lumbar (L4-L6) spinal cord and (L4-L6) DRG are
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chosen for staining to capture overall reactivity (Wilkerson et al., 2012a).
Paraffin-processed tissues undergo deparaffinization followed by rehydration and
antigen retrieval procedures in a standard rice cooker at 94-96° C allowing for
gentle and equal distribution of temperature warming throughout tissue sections.
For antigen retrieval, polyclonal GFAP required a Tris-based buffer at pH 9.5
(BioCare Medical, Concord, CA), Monoclonal GFAP, Iba1, and IL-1β required a
Tris-based buffer at pH 9.0 (Vector, Burlingame, CA), and IL-10 required a
citrate-based buffer at pH 6.0 (BioCare Medical, Concord, CA). All tissue
sections are incubated with 5% normal donkey serum (NDS), PBS pH 7.4 for 2h,
followed by overnight primary antibody incubation using rabbit anti-rat polyclonal
GFAP (Millipore, 1:1000), rabbit anti-rat monoclonal GFAP (Abcam. 1:400),
rabbit anti-rat polyclonal Iba-1 (Wako, 1:300), or rabbit anti-rat polyclonal IL-1β
(Santa Cruz, 1:100), or goat anti-rat polyclonal IL-10 (Vector Labs, 1:250) in a
humidity chamber at 4° C. Tissues are washed 3x with 0.1M PBS pH 7.4. All
tissues, except those containing IL-10 antibody, are incubated with donkey-anti
rabbit FITC- or TRITC- conjugated secondary antibody incubation for 2 hr in a
humidity chamber at room temperature and rinsed in 0.1 M PBS. IL-10 spinal
cord and DRG sections are incubated with a biotinylated donkey anti-goat
secondary antibody (Vector Labs, 1:1300) for 1 hr followed by a 1h incubation
with Vectastain ABC Elite kit (Vector Labs, Burlingame, CA). Sections are
incubated for 10 min with TSA plus Fluorescein System (PerkinElmer Life
Sciences, Waltham, MA,). All tissues are stained with the nuclear stain 4,6diamidino-2-phenylindole (DAPI) (Vector Labs, Burlingame, CA) separately
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before cover slipping. These slides are left at room temperature overnight and
then placed at 4° C until proceeding with image acquisition and microscopy
analysis (Wilkerson et al., 2012a; Sanchez et al., 2017).

Microscope spectral imaging for immunofluorescent quantification
Image acquisition for spectral analyses is performed using the Nuance spectral
imaging system (http://www.cri-inc.com/products/nuancew.asp; Perkin Elmer,
Waltham, MA) as described previously (Noor et al., 2017; Sanchez et al., 2017).
Briefly, images of dorsal horn spinal cord are obtained using either a 20X or 40X
(IL-10 spinal cord sections) objective with a Zeiss Axioplan2 inverted
fluorescence microscope. A flat-field correction is applied to correct for uneven
illumination during image acquisition. Image cubes are obtained from multilabeled tissue containing DAPI, conjugated secondary antibody, as well as
autofluorescence. A spectral library is then created using single-labeled slides for
each fluorophore (e.g. FITC or TRITC) and a label-free (autofluorescence) slide.
A computed spectrum (420 – 720 nm) is obtained by separating the known
spectrum (autofluorescence) from mixed spectrum (single labeled) to produce a
pure spectrum of each fluorophore. This allowed the separation of spectrum from
multi-labeled slides (e.g. DAPI + TRITC) to obtain composite images containing
only labels of interest. These composite images are then used for further analysis
using Slidebook 6 software (below). For dorsal horn spinal cord sections
ipsilateral to sciatic manipulation, sixteen to thirty-two images per experimental
group (4 sections per animal, 4-8 animals per condition) were acquired and
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analyzed. For L4-L6 DRG sections ipsilateral to the sciatic manipulation, thirty
images per experimental group (6 sections/rat, 5 rats per condition) were
acquired and analyzed. It should be noted that the 6 sections per animal were
made up of the L4, L5, and L6 DRG and contained two images per DRG level.
Representative acquired images from the Nuance spectral imaging system from
the dorsal horn spinal cord of GFAP immunoreactive (IR) and Iba1 IR regions are
shown in Fig. 2c-d, as well as IL-1β and IL-10 shown in Fig. 3c-d; and in DRG of
satellite glial cells (SGCs), IL-1β, and IL-10 in Fig. 5. 20x and 40x objectives are
used to produce representative images.

SlideBook6 software image analysis
Composite images are analyzed using SlideBook6 software (Intelligent Imaging
Innovations, Denver, CO, USA) as described previously (Sanchez et al., 2017).
Briefly, to discriminate signals originating from artifacts, the experimenter
determined an acceptable threshold of very low-level emission fluorescence
intensity per each experimental condition (polyclonal GFAP and Iba1 analysis),
or per individual animal (monoclonal GFAP, IL-1β and IL-10 analysis). This was
done by closely replicating the on-screen composite computer image with that
observed through the microscope eyepiece, as described previously (Noor et al.,
2017; Sanchez et al., 2017). In addition, for spinal cord sections, the dorsal horn
(region of interest (ROI)) is outlined for analysis eliminating the surrounding white
matter and peri-spinal blank space (intrathecal space). For DRG sections, ROI
included all cell bodies found within the composite image. The image is refined to
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include the predetermined threshold within the outlined area. The ‘Sum Intensity’
(the total signal within the outlined area in the dorsal horn) is determined and
divided by the ‘Area’ (total area in micrometers squared (μm 2)) to obtain the
‘Fluorescence Intensity’. The average of the adjacent sections from a single slide
(representing a single animal) is calculated to determine the value for each
animal. Finally, averages for each slide within the same condition are calculated
along with the standard deviation and standard error of the mean. Data are
analyzed as “Sum Intensity of ROI/μm2.

Tissue collection and total RNA isolation
Following behavioral assessment on Day 4 post-injury (Day 14 post-surgery),
rats are deeply anesthetized with isoflurane (induction 3% vol. followed by 5% in
oxygen) for 10 -12 minutes. Rats are then transcardially perfused with ice cold
0.1M PBS pH 7.4 for 3 min at a rate of 24 ml per minute. The perfused body is
placed on a frozen gel refrigerant pack (Glacier Ice, Pelton Shepherd Industries,
Columbus, OH). Laminectomy and tissue dissection is performed to collect both
ipsilateral and contralateral lumber L4-L6 spinal cord, followed by L4-L6 dorsal
root ganglia, and finally ipsilateral sciatic nerve. All samples are placed in
DNase/RNAse-free 1.5 ml centrifuge tubes (VWR International, Radnor, PA),
flash frozen on dry ice, and stored at -80 C for future analysis.
Flash frozen tissues are transferred to ice and 100 μl sterile 1 x PBS was
added. It should be noted that, in contrast to spinal cord and DRG tissue, sciatic
nerve is quickly chopped with scissors for ~2 minutes on ice. All tissues are then
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homogenized using a motorized VWR disposable Pellet Mixer and motor pestle
system (VWR International, Radnor, PA) for about 30 seconds. 60% of the tissue
homogenate is then processed for protein analysis (described below). The
remaining 40% of the homogenate is added to chilled Qiazol Lysis Reagent
(Qiagen, Hilden, Germany) for total RNA isolation (described below). It should be
noted that, due to the small quantity of DRG tissue collected, 100% of tissue
homogenate is used for RNA isolation and not protein analysis.

Tissue lysate preparation and Meso Scale Discovery (MSD) Multi-Spot
Assay System
Flash frozen ipsilateral sciatic nerve and ipsilateral and contralateral lower
lumbar L4-L6 spinal cord sections collected from animals are prepared for MSD
Multi-Spot Assay system as previously described (Noor et al., 2017). Briefly,
tissues are allowed to thaw on ice and homogenized using a Fisherbrand
Disposable Pestle system (Fisher Scientific, Hampton, NH). Samples are then
sonicated in buffer containing protease inhibitors per instructions of manufacturer.
All samples are then centrifuged at 4200 g, at 4 C, for 10 minutes. Lysate is
collected from samples and Bradford protein assay (Biorad, Hercules, Ca) is
used to determine protein concentrations. Using a V-PLEX immunoassay
(MesoScale Discovery, Gauthersburg, MD), 100 μg protein of all samples is used
to determine cytokine expression levels for TNFα, IL-1β, IL-10, and CXCL1 as
previously validated (Maxwell et al., 2015; Noor et al., 2017; Robinson et al.,
2017).
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Total RNA isolation and mRNA analysis by quantitative real-time PCR
Total RNA is extracted from ipsilateral sciatic nerve, ipsilateral and contralateral
spinal cord, and ipsilateral DRG. Tissue is placed in chilled Qiazol Lysis Reagent
(Qiagen, Hilden, Germany) and homogenized for 15 seconds. Total RNA is then
extracted using a miRNeasy Micro Kit (Qiagen, Hilden, Germany) per
manufacturer’s instructions. It should be noted that an additional buffer RPE and
80% EtOH wash steps is added to remove any additional salt contaminants
added from the PBS step. Tissue is centrifuged at 15,000 rpm for 1.5 min at 4 C.
PBS is aspirated and 35 μl of protease inhibitor solution (MesoScale Discovery
System) is added and samples were stored on dry ice and later stored at -80 C
for future analysis (described below).
RNA

concentration

and

quality

is

assessed

using

Nanodrop

(ThermoFisher Scientific, Walham, MA). RNA samples are then diluted to
standardized RNA concentrations of 195 ng/μl for ipsilateral DRG, 137ng/μl for
ipsilateral and contralateral lumbar spinal cord, and 100 ng/μl for ipsilateral
sciatic nerve. Standardized samples are then transcribed to cDNA at 2,145 ng for
ipsilateral DRG, 950 ng for ipsilateral SCN, and 1,438.5 ng for ipsilateral and
contralateral lumbar spinal cord. Reverse transcription is performed for all tissue
types using a Superscript IV VILO cDNA Synthesis Kit (Invitrogen, Carlsbad, CA).
Levels of mRNA expression is measured and analyzed as described
previously (Mellios et al., 2014). For assessment of transcripts, a dilution factor of
1:2.5 is applied to cDNA samples for ipsilateral DRG, 1:2 for ipsilateral SCN, and
96

1:2.2 for ipsilateral and contralateral lumbar spinal cord. cDNA dilution for
assessment of rat 18S rRNA normalizer is 1:200 for all tissue types. Levels of
mRNA and “Normalizer” rat

18s rRNA

(Rn18s, Taqman Assay ID#:

Mm03928990_g1), is assayed in triplicate using quantitative real-time PCR (qRTPCR) with Taqman Gene Expression Assays (ThermoFisher Scientific, Waltham,
MA). Gene expression assays are deemed to be “best coverage” assay by the
manufacturer and is analyzed with the formula C = 2^CTNormalizer/2^CTTarget in
order to exclude detection of genomic DNA (Livak and Schmittgen, 2001;
Schmittgen and Livak, 2008). Chemokines chosen for qRT-PCR include CCL2
(Taqman Assay ID#: Rn00580555_m1), CXCL10 (Taqman Assay ID#:
Rn01413889_g1), CXCL1 (Taqman Assay ID#: Rn00578225_m1), and CX3CL1
(Taqman Assay ID#: Rn00593186_m1). These chemokines have been
previously shown to be upregulated during neuropathic pain conditions (Lindia et
al., 2005; Akimoto et al., 2013; Zhang et al., 2013; Jiang et al., 2016), and
additionally, CCL2 and CX3CL1 have been shown to be altered following PAE
(Roberson et al., 2011; Noor et al., 2017).

Statistical analysis
SPSS (IBM, Chicago, IL, USA) is used for all behavioral analysis. At baseline
(BL), a 3-way (2 x 2 x 2) analysis of variance (ANOVA) is applied to assess
differences between prenatal exposure (Sac versus PAE), surgical treatment
(Sham versus minor CCI) and drug injection (vehicle versus BIRT-377).
Additionally, a 3-way (2 x 3) repeated measures ANOVA is used for analysis of
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the between-subject factors of prenatal exposure, surgery, and injection for days
post-surgery as well as days post-injection. Furthermore, 3-way (2 x 2 x 2)
ANOVA is used for analysis of all IHC immunoreactivity (IR) data. Data acquired
from V-Plex immunoassay and qRT-PCR are analyzed using GraphPad Prism
version 7 software (GraphPad Software Inc., San Diego, CA, USA). Post-hoc
examination of IHC IR is analyzed using Fisher’s LSD test. The threshold for
statistical significance was set a priori at α = 0.05 for all sets of multiple
comparisons. In order to minimize unnecessary duplication, we use the minimum
number of animals possible to make statistically significant conclusions, which is
based on our previous publications (Wilkerson et al., 2012a; Dengler et al., 2014;
Noor et al., 2017; Sanchez et al., 2017; Whitehead et al., 2017). Outliers were
removed following Grubbs’ Z-test (Grubbs, 1950). In all cases, the data are
presented as the mean ± SEM. All figures are created in GraphPad Prism
version 7 software (GraphPad Software Inc., San Diego, CA, USA).

Results
i.t. injection of BIRT-377 reverses enduring allodynia resulting from minor
CCI in PAE rats.
Previous studies show that PAE-induced sensitivity to allodynia is enduring for at
least 28 days after CCI (Noor et al., 2017). Thus, we want to determine whether
blocking the activated LFA-1 altered enduring PAE induced sensitivity to
allodynia. To accomplish this, i.t. BIRT-377 is administered at Day 28 postsurgery. Interestingly, all rats reveal similar hindpaw sensitivity at BL, indicating
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that PAE alone does not induce allodynia, but rather, it is not until a second insult
is applied that the effects of PAE are unmasked, which replicates prior findings
(Zhang et al., 2012; Noor et al., 2017; Sanchez et al., 2017) (Fig. 1). Normal
sensitivity is maintained throughout the 28-day time-course following sham or
minor (1-suture) CCI surgery in healthy Sac control rats (Fig. 1a). In contrast,
compared to PAE rats with sham surgery that maintain normal sensitivity through
day 28 post-surgery, minor CCI results in robust and enduring unilateral allodynia
(Fig. 1b). At Day 28, all rats received BIRT-377 or vehicle injection. Chronic
allodynia is reversed in PAE rats with hindpaw responses similar to BL levels
following BIRT-377, with maximal reversal seen by day 4 post-injection (Fig. 1b).
No changes in hindpaw sensitivity are observed in sham groups or Sac-minor
CCI. Additionally, no significant differences are seen in contralateral hindpaw
responses (Fig. 1c-d). These data suggest that the blockade of activated LFA-1
may alter the pronociceptive glial and immune cytokine/chemokine spinal milieu
such that a full reversal from chronic allodynia in PAE rats occurs.

Spinal BIRT-377 treatment blunts spinal glial activation.
To further explore how BIRT-377 works to reverse enduring (Day 28 post-CCI
surgery) allodynia in PAE rats, spinal cords are collected and processed for IHC
and image analysis from all rat groups (rats from data shown in Fig. 1) for
evaluation of glial activation (Fig. 2), cytokine expression (Fig. 3) and LFA-1
expression (Fig. 4) immediately following behavioral characterization of the
effects of i.t. BIRT-377 (BIRT) on allodynia. Analysis of GFAP IR reveal elevated
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spinal astrocyte responses in Sac and PAE rats with minor CCI given vehicle
(Veh) injection compared to their corresponding sham groups (Fig. 2a).
Additionally, minor CCI result in significant differences in astrocyte activation in
PAE and Sac rats given vehicle (Fig. 2a). However, spinal cord astrocyte
responses are decreased in BIRT-377 treated rats (Fig. 2a). Interestingly, spinal
microglial responses were increased in both PAE and Sac rats with minor CCI
given vehicle compared to their corresponding sham groups (Fig. 2b) despite
ongoing allodynia only in PAE rats. BIRT-377 injection results in significant
decreases in microglial activation (Fig. 2b), suggesting that processes underlying
allodynia do not have to be present for BIRT-377 to exert Iba-1 expression on
activated microglia. Representative images (Fig. 2c-d) for GFAP and Iba1 are
from Sac/Sham/Veh, Sac/1-Sut/Veh, Sac/1- Sut/ BIRT, PAE/Sham/Veh, PAE/1Sut/Veh, and PAE/1-Sut/BIRT. These data suggest that PAE-induced allodynia
requires mechanisms in addition to microglial activation because elevated
microglial activation is observed in non-allodynia Sac/1-Sut/Veh rats. From these
data, it is plausible that astrocyte actions play a greater role in PAE susceptibility
to allodynia from minor injury.

PAE blunts normal IL-10 responses following minor CCI
Both IL-1β and IL-10 IR in the dorsal horn of the spinal cord are assessed for
changes following i.t. BIRT-377 injection (Fig. 3a-b). Compared to sham groups,
PAE rats with minor CCI given vehicle reveal elevated levels of IL-1β (Fig. 3a).
Interestingly, this elevation is also seen in Sac rats with minor CCI given vehicle
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injection despite the absence of allodynia (Fig. 1a and 3a). Furthermore, BIRT377 is sufficient to significantly decrease spinal IL-1β IR (Fig. 3a). In healthy Sac
control rats, elevated levels of IL-10 IR are measured following minor CCI given
vehicle compared to Sac-sham rats given vehicle (Fig. 3b). Interestingly, PAE
CCI rats with ongoing allodynia (e.g. given vehicle) do not show a significant
increase in IL-10 IR expression, an observation that is present in Sac CCI rats
without allodynia. The elevated IL-10 IR in healthy rats (Sac) with CCI suggests
the increase is in response to minor damage to maintain homeostasis and
consequent non-neuropathy. In contrast, it is possible that in PAE rats, IL-10 fails
to upregulate, thereby allowing for the development of allodynia following minor
CCI (Fig. 3b). IL-10 IR is significantly greater in Sac-minor CCI rats given vehicle
compared to PAE-minor CCI rats given vehicle (Fig. 3b). Intrathecal BIRT-377
results in slight non-significant increases in IL-10 IR. Images of IL-1β (Fig. 3c)
and IL-10 (Fig. 3b) represent Sac/Sham/Veh, Sac/1-Sut/Veh, Sac/1-Sut/BIRT,
PAE/ Sham/Veh, PAE/1-Sut/ Veh, and PAE/1-Sut/BIRT is shown. These results
demonstrate that PAE alters healthy IL-10 responses demonstrated by Sac
control rats following minor sciatic nerve injury. Additionally, the data
demonstrate that BIRT-377 may reverse chronic allodynia by reducing glial
activation (Fig. 2a-b) and decreasing IL-1β (Fig. 3a).

LFA-1 expression is dysregulated in PAE rats
Immunoreactivity for Cd11a (LFA-1) is analyzed in the dorsal horn of the spinal
cord in rats behaviorally verified for allodynia. Data show a significant increase in
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LFA-1 IR occurs in PAE-sham rats given vehicle compared to Sac-sham rats
given vehicle (Fig. 4). Importantly, PAE-sham rats have not undergone a second
insult, suggesting that the effects of PAE alone alter the LFA-1 levels. No
significant differences are observed between PAE-sham rats given vehicle and
PAE-minor CCI given vehicle (Fig. 4). The data suggest that PAE dysregulates
the basal expression of LFA-1, which may be an underlying neuroimmune factor
in the “primed” spinal cord of PAE rats leading to susceptibility upon a second
challenge. While BIRT-377 significantly decreases LFA-1 in PAE rats, these
levels are similar to those under basal conditions (Fig. 4), suggesting that
“resetting” LFA-1 to basal levels is sufficient to ultimately control PAE-induced
sensitivity to allodynia.

Alteration of normal SGC and cytokine responses is seen in DRGs of PAE
rats following minor CCI
The critical action of IL-1β underlying chronic neuropathy to minor damage may
occur in more than a single anatomical region of the pain pathway. That is, it is
possible that L4-L6 DRGs of damaged sciatic nerve axons may respond to
damage signals in an exaggerated manner acting to exacerbate events occurring
in the spinal cord. GFAP IR for satellite glial cells (SGCs), IL-1β, and IL-10 in the
L4-L6 DRGs is analyzed. Thus, the goal of this experiment is to identify
neuroimmune factors influenced by PAE that may underlie susceptibility.
Therefore, rats treated with BIRT-377 were intentionally omitted from this
analysis. Large and significant increases in the expression of GFAP in PAE rats
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with minor CCI compared to controls are observed (Fig. 5a), suggesting that
SCGs are more reactive/activated than in non-neuropathic controls inclusive of
PAE/Sham rats. Additionally, data show significant increases in IL-1β only in PAE
rats following minor CCI (Fig. 5b). Interestingly, compared to Sac-sham rats
displaying basal levels of IL-10 IR, PAE-sham rats display dramatically reduced
basal levels of IL-10 IR (Fig. 5c) with no compensatory IL-10 elevation under
neuropathy (Fig. 5c). These data provide further support that PAE leads to
dysregulated IL-10 responses to injury (Fig. 3b and 5c). Representative images
(Fig. 5d-f) of SGCs, IL-1β, and IL-10 are shown for Sac/Sham/Veh, Sac/1Sut/Veh, PAE/Sham/Veh, and PAE/1-Sut/Veh. These data suggest that PAE
induced sensitivity to allodynia may be a result of significant increases in IL-1β in
combination with a diminished capacity of IL-10 expression and action in the
DRG.

Spinal IL-1β is necessary for induction of allodynia in PAE rats
Following minor CCI, Sac and PAE rats display elevated IL-1β despite the
absence of allodynia in Sac-minor CCI rats (Fig. 3a). A number of prior reports
that indicate the action of spinal IL-1β is necessary for the early and chronic
phase of allodynia, the goal of the current experiment is to assess whether spinal
IL-1β is necessary for allodynia susceptibility in PAE rats induced by minor
peripheral nerve injury. All rats are assessed prior to surgery to determine BL
responses and demonstrated no significant differences between groups (Fig. 6ab). Following minor CCI, all PAE rats develop allodynia when comparing hindpaw
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response to their BL values (Fig. 6), replicating prior findings (Fig. 1 and 7).
However, on Day 10 immediately following hindpaw threshold values, that action
of IL-1β in the spinal cord is blocked by an i.t. injection of IL-1 receptor antagonist
(IL-1RA). Compared to vehicle, allodynia is reversed with hindpaw sensitivity
initially changing within 1 hr after the injection. This reversal is sustained
reversal for at least 3 hours post-injection (Fig. 6). Allodynia returns by 24 hours
post-injection replicating prior reports of the duration of action of IL-1RA. No
significant differences are seen in sensitivity within the contralateral hindpaw
throughout the behavioral time-course (Fig. 6b). These data demonstrate that IL1β is a critical factor underlying the susceptibility for developing allodynia in PAE
rats.

I.t. BIRT-377 reverses PAE induced allodynia at Day 10 post-surgery
Prior reports and the initial studies detailed in the present report demonstrate
robust unilateral allodynia through Day 28 after minor CCI in PAE rats (Sanchez
et al., 2017). To further explore the spinal mechanisms underlying earlyestablished allodynia following minor injury, adult PAE and Sac rats are
subjected to either sham or minor CCI surgery, and upon established allodynia
observed on Day 10, the effect of i.t. BIRT-377 on allodynia was assessed. As
before (Fig. 1), BL light touch sensory thresholds are similar across all groups
(Fig. 7). While normal sensitivity is maintained near BL values in Sac groups with
sham or minor CCI throughout the time-course, a pronounced level of unilateral
allodynia is observed ipsilateral to sciatic CCI was observed in PAE rats while no
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change in contralateral hindpaw sensitivity (Fig. 7a-b). Following BIRT-377 or
vehicle injection in Sac rats, hindpaw thresholds remained stable throughout the
remainder of the 4-day time-course, hovering close to pretreatment BL values.
However, BIRT-377 induces complete reversal of ipsilateral allodynia for the
remainder of the time-course while contralateral hindpaw thresholds continued to
remain stable and non-allodynic (Fig. 7a-b). These data demonstrate that LFA-1
blockade during early established allodynia may alter factors similar to those
driving enduring (Day 28 or longer) allodynia. Candidate factors that lead to PAE
allodynia susceptibility are carefully examined, as detailed below, from these
behaviorally verified rats.

PAE may induce allodynia by altering proinflammatory factors at the sciatic
nerve
To further assess how BIRT-377 may change spinal immune environment
resulting in the reversal of allodynia in PAE rats, ipsilateral sciatic nerve (SCN) as
well as ipsilateral and contralateral (as a potential within animal biochemical
control) lumbar spinal cord is collected at Day 4 post-injection at maximal i.t.
BIRT-377 efficacy for protein analysis using the V-plex immunoassay.
Expression levels of IL-10, IL-1β, and TNFα are measured in the SCN and
lumbar spinal cord as well as CXCL1 in the SCN. Results for the SCN
demonstrate that following vehicle injection, minor CCI induces a modest but
significant increase in IL-10 expression in PAE rats compared to Sac rats.
Additionally, allodynic PAE rats with vehicle or BIRT-377 reveal significant
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elevations of IL-1β, CXCL1, and TNFα expression compared to Sac/CCI and
PAE/sham groups (Fig. 8a). Ipsilateral lumbar spinal cord IL-10 data reveal no
significant differences between groups. Similar IL-1β expression is seen in both
PAE and Sac rats with minor CCI and vehicle injection despite ongoing allodynia
only observed in PAE rats, which may reflect other factors downstream of IL-1β
expression are important for controlling allodynia in the Sac rats. While a modest
reduction of IL-1β in allodynic PAE rats treated with BIRT-377 is measured, the
reduction was not significant. Spinal TNFα is significantly increased in PAE
allodynic rats compared to Sac non-allodynic rats with minor CCI. Following
BIRT-377 treatment, a strong trend towards reduced levels of TNFα is observed
in pain-reversed PAE rats (Fig. 8b). Contralateral lumbar spinal cord did not
show any significant differences between rat groups (data not shown) which
coincides with the normal sensitivity observed. These data demonstrate that
pronounced immune reactivity by peripheral leukocytes around the injured nerve
as well as augmented levels of spinal TNFα likely play significant roles in driving
allodynia in PAE rats following a minor CCI. Furthermore, BIRT-377 may reverse
PAE allodynia through multiple cytokine actions; through the reduction of both IL1β and TNFα which are known to act synergistically to mediate pathological pain
(McGee et al., 1995).

Minor CCI alters CCL2 and CXCL1 in the ipsilateral SCN and DRG
Previous reports demonstrate that following sciatic nerve injury, the chemokines
CCL2, CXCL1, CX3CL1, and CXCL10 become upregulated (Lindia et al., 2005;
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Akimoto et al., 2013; Zhang et al., 2013; Jiang et al., 2016). Furthermore,
separate studies find that astrocytes may mediate allodynia through the release
of CXCL1 (Chen et al., 2014), CX3CL1, and CXCL10 (Liu et al., 2013).
Interestingly, minor CCI results in the activation of spinal astrocytes but not
microglia (Sanchez et al., 2017). In addition, PAE alters the release of CCL2
(Noor et al., 2017). Together, these reports suggest that susceptibility to
allodynia in PAE rats may result from alterations in chemokine production and
release. Thus, in order to characterize the chemokine profile following minor CCI,
qRT-PCR is used to assess the expression of CCL2, CXCL1, CX3CL1, and
CXCL10 gene expression in the ipsilateral SCN, DRG, and ipsilateral and
contralateral lumbar spinal cord. SCN data show that only following CCI are
significant increases seen in expression of CCL2, CXCL1, and CXCL10 in both
Sac and PAE rats (Fig. 9a). Interestingly, significant differences in CXCL1
expression are seen between SCN of PAE and Sac rats with CCI that received
BIRT-377 (Fig. 9a). Assessment of the DRG demonstrated that CCL2 is
upregulated following CCI in both Sac and PAE rats (Fig. 9b). Only PAE rats with
BIRT-377 display significant increases in CXCL1 and CX3CL1 (Fig. 9b). Overall,
data suggest that minor CCI upregulates pain relevant chemokines within the
periphery that is not solely the result of PAE. Our mRNA analysis reveals that
immune signals known to drive leukocyte trafficking at the SCN and DRG during
chronic neuropathy are similar between rats exposed to Sac or PAE.
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I.t. BIRT-377 alters chemokine expression only in PAE rats with minor CCI
within the spinal cord
Assessment of mRNA within the ipsilateral and contralateral spinal cord reveals
that minor CCI increases CCL2 gene expression in Sac rats compared to sham
conditions (Fig. 9c) irrespective of BIRT-377. Interestingly, CCL2 gene
expression is blunted in PAE rats with CCI in that no significant differences seen
when compared to Sham rats (Fig. 9c). Significant differences in CCL2 and
CXCL10 gene expression are only observed in PAE rats with minor CCI that
received BIRT-377 (Fig. 9c). It should be noted that these increases are not
significantly different when compared to Sac rats with minor CCI and BIRT-377
injection (Fig. 9c). Contralateral data demonstrated no significant differences in
CCL2, CXCL1, and CXCL10 gene expression are seen between groups which
correspond with normal sensitivity seen in the contralateral hindpaw (Fig. 1c-d
and 7b). Interestingly, PAE alone was sufficient to induce increases in CXCL1
gene expression (Fig. 9d).
The lack of changes in chemokines assessed in this report at the lumbar spinal
cord may suggest that BIRT-377 may not work primarily by transcriptional
regulation of these chemokines.

Discussion
A growing body of evidence has demonstrates that PAE leads to heightened
immune reactivity peripherally, as well as in the brain and spinal cord (Topper et
al., 2015; Noor et al., 2017; Sanchez et al., 2017). Interestingly, the effects of

108

PAE are not unmasked until a secondary insult is applied (Noor et al., 2017;
Sanchez et al., 2017)

-adhesion molecule LFA-1,

which is classically known to facilitate immune cell trafficking in response to
CCL2-CCR2 signaling on immune cells followed by migration to regions where
tissue damage has occurred. In the present report, we identify a possible novel
additional role of LFA-1 activation in that the local milieu is biased toward the
proinflammatory cytokine network leading to susceptibility to pathological pain
(Noor et al., 2017). These reports demonstrate that a minor injury results in
enduring unilateral allodynia up to 28 days post-surgery only in PAE rats.
Furthermore, previous work demonstrates that PAE alone alters LFA-1, while
separate reports show the negative consequences of LFA-1 on proinflammatory
actions are influenced by IL-10 expression. In light of these existing data, we
explore whether antagonism of LFA-1 could influence allodynia. i.t. injection of
the LFA-1 antagonist BIRT-377, abolishes allodynia with maximum reversal
occurring at Day 4 post-injection (Fig. 1). It is important to note this is a small
molecule antagonist with high specificity to LFA-1, and is not an antibody that
could have unintended off-target effects. The present report additionally
demonstrates that spinal and DRG glial activation as well as proinflammatory
cytokine expression is reduced (Fig. 2, 3 and 5). Together, these data are the
first demonstration that LFA-1 is a potential therapeutic target for a primed
neuroimmune response that leads to neuropathic pain susceptibility.
Curiously, prenatal Sac-treated controls demonstrate upregulation of
microglial activation and IL-1β expression following a 1-suture nerve injury that is
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considered minor and does not produce allodynia (Fig 1 and 2b). Despite this
upregulation in both Sac and PAE rats, blocking the actions of IL-1β binding to its
receptor demonstrates a transient but robust reversal of allodynia in PAE rats
with minor CCI injury , an efficacy time-course observed in prior reports (Fig.
6)(Milligan et al., 2003). This suggests that spinal IL-1β action is necessary to
induce allodynia following minor injury, but is not the only final common
denominator to generate allodynia in this minor nerve injury model in PAE,
because allodynia is not observed in Sac controls with minor injury with elevated
spinal IL-1β. However, the actions of IL-10 may indeed be the critical factor in
controlling allodynia because IL-10 levels are blunted within the spinal cord and
DRG only in PAE rats (Fig. 3 and 5). Thus, the data suggest that PAE induced
sensitivity to allodynia may be a result of heightened proinflammatory immune
factors in combination with blunted anti-inflammatory cytokine expression.
Our data show that although microglia become upregulated following
minor injury, astrocytes show greater activation in PAE rats when compared to
controls (Fig. 2). Previous studies show that LFA-1 is upregulated on spinal
microglia (and possibly macrophages) as a result of PAE alone (Noor et al.,
2017), and interestingly, previous reports show that LFA-1 is expressed on
microglia whereas its ligand ICAM-1 is expressed on astrocytes (Rozemuller et
al., 1989; Akiyama et al., 1993; Lee et al., 2000). In light of these prior reports, it
is possible that during pathological conditions, microglia may communicate to
astrocytes expressing ICAM-1 resulting in an ICAM-1 to LFA-1 interaction
consequently inducing proinflammatory cytokine and chemokines during the
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induction of allodynia. Furthermore, in addition to our own data (Fig. 2a), prior
reports show that PAE is able to alter astrocytes within the spinal cord following
peripheral nerve injury (Noor et al., 2017; Sanchez et al., 2017). Together these
data suggest that although spinal microglia are activated similarly between Sac
controls and PAE, dysfunctional astrocytes in PAE rats may be sensitized and
require only modest stimulation to undergo augmented activation. This alteration
would underlie the induction of allodynia following minor injury.
The current study additionally demonstrates that TNFα is upregulated both
at the SCN and the spinal cord compared to Sac controls (Fig. 8). Previous
studies show that TNFα is upregulated following CCI (George et al., 1999).
Additionally, reports demonstrate that TNFα is able to induce allodynia when
injected at the sciatic nerve (Wagner and Myers, 1996). Together, these data
suggest a critical role for TNFα during the induction of allodynia. Furthermore,
previous reports show that TNFα is able to induce the expression of LFA-1
(Hideshima et al., 2001). As noted above , LFA-1 expression impacts the
expression of IL-10 (Labuda et al., 1998; Emoto et al., 2003). Thus, TNFα may
play a role in the susceptibility to allodynia created by PAE following minor injury
by increasing spinal LFA-1 and consequent immune and glial sensitization.
Under states of immune and glial sensitization, the expression of IL-10 is
diminished, further contributing to enhanced immune reactivity upon a second
challenge. Considering that PAE rats reveal altered IL-10 expression (Fig. 3b
and 5b), any further dysregulation as a result of TNFα expression may result in
susceptibility to developing allodynia.
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Interestingly, we show that SGCs within the DRG are upregulated as a
result of minor injury only in our PAE rats (Fig. 5a). These cells are supportive by
providing sensory neuron cell bodies with essential amino acids as well as
clearing toxic substances from the extracellular space (Hanani, 2005; Milligan
and Watkins, 2009; Takeda et al., 2009; Wong et al., 2017). During pathological
conditions, pain signals from the periphery travel into the DRG and on to the
dorsal horn spinal cord (Milligan and Watkins, 2009). In the DRG, SGCs can
communicate with neurons through the release of IL-1 and IL-10 (Takeda et al.,
2009). Our data demonstrate that following minor injury, IL-1 is significantly
upregulated whereas IL-10 expression is blunted within the DRG as a result of
PAE alone (Fig. 5), suggesting that pro- and anti-inflammatory SGC responses to
minor challenges are dysregulated as a result of PAE. The data demonstrate that
one source of heightened IL-1 expression and dysregulated IL-10 expression
occurs in the DRG. Ultimately, unchecked IL-1 actions in the DRG due to the
lack of IL-10 can contribute to amplified pain signals projecting into the spinal
cord during minor CCI.
Curiously, microglial states of activation are not always altered by PAE ,
particularly under models of moderate PAE (Wong et al., 2017). In support of
these prior reports, data from the current study also show that in spinal cords of
PAE rats with minor injury, a significant upregulation of the astrocyte activation
marker , GFAP is present but no differences in microglial activation was
observed in PAE neuropathic and non-neuropathic Sac rats. In fact, levels of
Iba1 IR (a potential indicator of heightened microglial activation) was similar
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between Sac rats with 1-suture sciatic manipulation (no allodynia) and PAE rats
with 1-suture sciatic manipulation (with allodynia) (Fig. 2). These data suggest
that PAE induced sensitivity to allodynia may be mediated through astrocyte
mechanisms. Interestingly, prior reports show that PAE downregulates the
expression of the astrocyte specific glutamate transporter GLAST that coincided
with a decrease in glutamate uptake (Brolese et al., 2015). In addition, a
separate report demonstrated that only after GLAST function is inhibited in
addition to the other glutamate transporters, GLT-1 (on glia and neurons) and
EAAC1 (solely on neurons), potentiated allodynia is observed (Sung et al., 2003).
Curiously, it is demonstrated that following a standard 4-suture sciatic CCI,
potentiated allodynia is observed in PAE rats (Noor et al., 2017). Together, these
data suggest that PAE may lead to susceptibility to developing allodynia by
altering astrocytes, and in doing so, also alter the functional response of the
astrocyte-specific glutamate transporter GLAST upon minor challenge.
In conclusion, data from the current report support the possibility that PAE
may lead to susceptibility to developing pathological pain through the alteration of
LFA-1 function and expression. By antagonizing the spinal activation of LFA-1, a
switch in the local environment within the spinal cord from proinflammatory to an
anti-inflammatory phenotype occurred, abolishing allodynia. Normal protective
responses of astrocyte glia are altered as a consequence of PAE, which is
unmasked only following a second minor challenge in adulthood; the challenge
being minor peripheral nerve injury. Additionally, these data demonstrate that
PAE suppresses healthy IL-10 expression, which may aid in the induction of a
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proinflammatory phenotype following injury and over-reactive astrocytes. Overall,
these data shed light on potential mechanisms underlying PAE’s glial and
neuroimmune actions that renders one vulnerable to chronic CNS diseases such
as neuropathic pain.

114

Figure 1

Figure 1. Enduring allodynia from minor injury in PAE rats is controlled by
i.t. BIRT-377. Ipsilateral and contralateral hindpaw response thresholds from
minor sciatic nerve injury (CCI) in adult PAE and Sac control rats. (a-b) At
baseline (BL), rats displayed no differences in hindpaw sensitivity (ipsilateral,
F1,43 = 1.568, p = 0.217). Following CCI, a main effect of alcohol exposure
(ipsilateral, F1,43 = 152.120, p < 0.0001), surgery (ipsilateral, F1,43 = 404.296, p <
0.0001) and an interaction between alcohol exposure and surgery (ipsilateral,
F1,43 = 170.740, p < 0.0001) is observed. (a-b) Following minor CCI, Sac control
rats do not develop increased sensitivity whereas PAE rats develop enduring
unilateral allodynia up to Day 28 post-surgery (ipsilateral, F1,43 = 165.47, p <
0.0001). (c-d) No changes in contralateral hindpaw sensitivity is observed
following sham or CCI in Sac or PAE rats (contralateral, F1,43 = 0.953, p = 0.334).
(a-b) At Day 28, all animals received either vehicle or BIRT-377 where a
significant interaction is seen in the ipsilateral hindpaw between alcohol
exposure, surgery, and injection (ipsilateral, F1,43 = 26.280, p < 0.0001;). (a-b)
Following injection of BIRT-377, Sac rats maintain normal sensitivity. In contrast,
allodynic rats with PAE return to normal sensitivity compared to vehicle injected
rats. Sensitivity in the contralateral paw remained normal in all rat groups
(contralateral, F1,343 = 0.181, p = 0.672). N = 5-8 rats per group. Arrow indicates
time of i.t. injection.
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Figure 2

Figure 2. Glial activation is significantly decreased following i.t. BIRT-377
injection in rats with enduring allodynia. (a-d) At Day 4 post-injection spinal
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cord tissues is harvested for quantification of immunohistochemical (IHC)
immunoreactivity (IR) for (a) astrocyte activation (GFAP) and (b) microglial
activation (Iba1) within the ipsilateral dorsal horn of the spinal cord. Fluorescence
intensity is defined as the total IR within the dorsal spinal cord [identified as a
region of interest (ROI)] divided by the area of the ROI. (a-b) A significant
interaction is seen between surgery and injection (GFAP, F1,32 = 9.237, p = .005;
Iba1, F1,27 = 6.775, p = 0.015). Following minor CCI, both PAE and Sac rats
display significant increases in GFAP and Iba1 IR compared to their
corresponding sham groups, with spinal cords from PAE/1-sut rats revealing the
most robust GFAP increases. BIRT-377 resulted in significant decreases in both
GFAP and Iba1 IR in rats with minor CCI. Minor CCI PAE rats reveal elevated
GFAP IR compared to Sac rats with minor CCI. Representative images of (c)
GFAP and (d) Iba1 IR used in IHC analysis are shown for Sac/Sham/Veh, Sac/1Sut/Veh, Sac/1-Sut/BIRT, PAE/ Sham/Veh, PAE/1-Sut/Veh, and PAE/1-Sut/BIRT
at 20x. The white dashed line represents a portion of the superficial dorsal horn
as is the ROI under examination. N = 4-8 rats per group. “1-sut CCI” is the same
as “minor CCI”. N = 4-5 rats per group. Asterisks indicate p < 0.05. Pound sign
indicates significance amongst groups at p < 0.05.
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Figure 3

Figure 3. i.t. BIRT-377 injection significantly decreases IL-1β expression. (ab) Separate analysis of IL-1β and IL-10 IR within the dorsal horn spinal cord at
Day 4 post-injection reveal an interaction between surgery and injection (IL-1β,
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F1,27 = 9.559, p < 0.001; IL-10, F1,32 = 7.066, p = 0.012), while no significant
differences are observed between Sac and PAE rats with minor CCI and vehicle
injection. Following BIRT-377 injection, IL-1β is significantly decreased compared
to vehicle injected rats with minor CCI regardless of prenatal exposure. (b)
Significant differences in IL-10 expression are observed in between Sac-sham
rats and Sac-minor CCI rats given vehicle, whereas no differences are observed
between all experimental conditions in PAE rats. Sac rats with minor CCI given
vehicle reveal elevated IL-10 IR compared to allodynic PAE rats given vehicle.
PAE rats lack the compensatory IL-10 elevation to minor injury. Representative
images of (c) IL-1β and (d) IL-10 IR used in IHC analysis are shown for
Sac/Sham/Veh, Sac/1-Sut/Veh, Sac/1-Sut/BIRT, PAE/Sham/Veh, PAE/1Sut/Veh, and PAE/1-Sut/BIRT at either 20x for IL-1β and 40x for IL-10. The white
dashed line represents a portion of the superficial dorsal horn as is the ROI
under examination. “1-sut CCI” is the same as “minor CCI”. N = 4-5 rats per
group. Asterisks indicate p < 0.05.
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Figure 4

Figure 4. Increased basal levels of LFA-1 expression is present in PAE rats.
Quantification of LFA-1 (Cd11a) IR expression reveal elevated expression of
Cd11a observed in PAE- sham rats given vehicle compared to Sac-sham given
vehicle (p = 0.0188). Additionally, a main effect of BIRT-377 (F1,42 = 5.529, p =
0.027) is seen. That is, BIRT-377 injection resulted in significant decreases of
Cd11a in PAE minor CCI rats. Additionally, no significant differences are
observed between PAE rats given vehicle with sham or minor CCI. “1-sut CCI” is
the same as “minor CCI”. N = 5-8 rats per group. Asterisks indicate p < 0.05.
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Figure 5

Figure 5. PAE results in elevated SGC activation and cytokine
immunoreactivity in the dorsal root ganglia (DRG). IR of (a) SGCs (as
measured by GFAP IR), (b) IL-1β, and (c) IL-10 are determined for the ipsilateral
L4-L6 DRG of PAE and Sac minor CCI vehicle injected rats at Day 4 postinjection. A main effect of PAE (SGCs, F1,20 = 17.74, p = 0.0004; IL-1β, F1,16 =
17.16, p < 0.0008; IL-10, F1,16 = 12.58, p = 0.0027), surgery (SGCs, F1,20 = 77.53,
p < 0.0001; IL-1β, F1,16 = 24.87, p < 0.0001; IL-10, F1,16 = 25.7, p = 0.0001), and
an interaction of PAE and surgery is seen (SGCs, F1,20 = 27.81, p < 0.0001; IL1β, F1,16 = 30.67, p < 0.001; IL-10, F1,16 = 26.81, p < 0.001). (a) SGCs activation
is significantly upregulated following minor CCI in both Sac and PAE rats.
121

Additionally, compared to Sac rats, PAE rats have heightened SGCs activation.
(b) Significant increases are observed following minor CCI in vehicle injected
PAE rats compared to Sac rats with sham or minor CCI. (c) Sac-sham rats with
vehicle display significantly greater IL-10 IR compared to PAE-sham rats with
vehicle rats. N = 5 rats per group. Asterisks indicate p < 0.05. Representative
images of SGCs, IL-1β, and IL-10 IR used in IHC analysis are shown for Sac/
Sham/Veh, Sac/1-Sut/Veh, PAE/Sham/Veh, PAE/1-Sut/Veh, at 20x. “1-sut CCI”
is the same as “minor CCI”. N = 5=7 rats per group. Asterisks indicate p < 0.05.
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Figure 6

Figure 6. Spinal IL-1β is necessary for PAE induced allodynia following
minor CCI. (a) PAE rats with minor CCI receive either i.t. IL-1 receptor
antagonist (IL-1RA) or vehicle and ipsilateral and contralateral hindpaw
responses are assessed. Prior to surgery, no hindpaw response threshold
differences ae observed between vehicle and IL-1RA groups (Ipsilateral, F1,12 =
4.523, p = 0.055; Contralateral, F1,12 = 0.014, p = 0.907). Following minor CCI
and prior to injection, similar levels of robust allodynia is observed in both groups
(Ipsilateral, F1,12 = 0.743, p = 0.406; Contralateral, F1,12 = 2.213, p = 0.163). PAE
rats receiving IL-1RA reveal reversal from allodynia by 1 hr that persisted
throughout the 3h time-course compared to vehicle injected rats (Ipsilateral, F1,12
= 139.459, p < 0.001; Contralateral, F1,12 = 1.089, p = 0.317). By 24 hours postinjection, all rats demonstrate full allodynia, with no significant differences
observed between groups (Ipsilateral, F1,12 = 0.887, p = 0.365; Contralateral,
F1,12 = 0.743, p = 0.406). “1-sut CCI” is the same as “minor CCI”. N = 7 rats per
group. Asterisks indicate p < 0.05.

123

Figure 7

Figure 7. BIRT-377 reverses PAE induced allodynia following i.t. injection.
(a-b) At baseline (BL), rats displayed no differences in hindpaw sensitivity
(ipsilateral, F1,35 = 0.687, p = 0.413; contralateral, F1,35 = 0.041, p = 0.840).
Additionally, sham groups maintain normal sensitivity throughout the time-course
demonstrating that repeated von Frey behavioral testing has no significant
effects on touch stimuli. Following CCI, a main effect of alcohol exposure
(ipsilateral, F1,35 = 52.497, p < 0.0001; contralateral, F1,35 = 1.929, p = 0.174),
surgery (ipsilateral, F1,35 = 148.009, p < 0.0001; contralateral, F1,35 = 3.118, p =
0.086 ) and an interaction between alcohol exposure and surgery (ipsilateral,
F1,35 = 87.448, p < 0.0001; contralateral, F1,35 = 0.387, p = 0.538) is seen only in
the ipsilateral hindpaw. Additionally, PAE, but not Sac rats, develop robust
unilateral allodynia as measured on Day 28 and Day 10 (ipsilateral, F 1,35 =
89.118, p < 0.0001; contralateral, F1,35 = 0.710, p = 0.405). Following injection of
BIRT-377, PAE rats return to normal sensitivity through Day 4 post-injection
(ipsilateral, F1,35 = 9.808, p = 0.003; contralateral, F1,35 = 0.032, p = 0.858) at
which time, the experiment was terminated for tissue collection. “1-sut CCI” is the
same as “minor CCI”. Arrow indicates when i.t. injection was given. N = 4-6 rats
per group. Asterisks indicate p < 0.05.
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Figure 8

Figure 8. PAE alters cytokine expression in the ipsilateral sciatic nerve and
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spinal cord. Ipsilateral sciatic nerve and spinal cord are collected at Day 4 postinjection and examined by multiplex protein analysis for levels of IL-10, IL-1β,
TNFα, and CXCL1 (sciatic nerve only). Levels of protein are expressed as
picograms of target protein per 100μg of total protein. Data for ipsilateral (a)
sciatic nerve and (b) lumbar spinal cord are represented. (a) IL-10 significantly
increased in PAE rats with minor CCI given vehicle injection compared to Sac
CCI vehicle injected rats (F7,35 = 1.672, p = 0.0271). Additionally, compared to
Sac/minor CCI vehicle injected rats and PAE sham vehicle rats, PAE minor CCI
rats with vehicle injection displayed elevated levels of IL-1β (F7,35 = 5.224, Sac
minor CCI: p = 0.0060; PAE Sham Veh: p = 0.0008), TNFα (F 7,35 = 5.224, Sac
minor CCI: p = 0.0239; PAE Sham Veh: p = 0.0005) and CXCL1 (F 7,35 = 5.224,
Sac minor CCI: p = 0.0158; PAE Sham Veh: p = 0.0004). No significant
differences were seen between PAE minor CCI vehicle groups and PAE minor
CCI BIRT groups (F7,35 = 5.224, IL-10: p = 0.4716; IL-1β: p = 0.9904, TNFα: p =
0.5436, CXCL1: p = 0.2309). (b) IL-10 expression did not change significantly
throughout any groups in the ipsilateral lumbar spinal cord. PAE minor CCI
vehicle injected rats had significant increases in IL-1β expression compared to
PAE sham vehicle rats (F7,32 = 5.224, Sac minor CCI: p = 0.0097). Additionally,
no significant differences are seen in IL-1β between Sac minor CCI vehicle rats
and PAE minor CCI vehicle rats (F7,32 = 5.224, Sac minor CCI: p = 0.9070).
Significant differences are seen between Sac minor CCI vehicle rats and PAE
minor CCI rats (F7,32 = 5.224, Sac minor CCI: p = 0.0432). “1-sut CCI” is the
same as “minor CCI”. N = 4-6 rats per group. Asterisks indicate p < 0.05.
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Figure 9

Figure 9. i.t. BIRT-377 alters mRNA expression of specific chemokines only
in PAE neuropathic rats. Ipsilateral SCN and DRG as well as ipsilateral and
contralateral spinal cord are collected from rats at Day 4 post-injection for qRTPCR analysis. Messenger RNA expression from ipsilateral (a) SCN and (b) DRG,
as well as (c) ipsilateral and (d) contralateral lumbar spinal cord are shown. (a)
CCL2, CXCL1, and CXCL10 expression is significantly increased following minor
CCI in both Sac and PAE rats (Sac: CCL2 F7,34 = 5.32, p = 0.0242, CXCL1 F7,34
= 5.32, p = 0.0033, CXCL10 F7,34 = 5.32, p = 0.0117; PAE: CCL2 F7,34 = 5.32, p =
0.0027, CXCL1 F7,34 = 5.32, p = 0.0038, CXCL10 F7,34 = 5.32, p = 0.0133).
Interestingly, CXCL1 is significantly increased following minor CCI in PAE rats
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compared to Sac rats receiving BIRT-377 (F7,34 = 5.32, p = 0.0007). (b) Minor
CCI significantly increases CCL2 in the DRG in both Sac and PAE rats (Sac:
F7,35 = 5.26, p = 0.0014; PAE: F7,35 = 5.26, p = 0.0168). BIRT-377 significantly
increases CXCL1 and CX3CL1 only in PAE rats with Minor CCI (CXCL1: F 7,34 =
2.377, p = 0.0057; CX3CL1: F7,35 = 1.593, p = 0.0079). (c) The expression of
CCL2 is increased following minor CCI in Sac rats (Sac: F7,35 = 3.879, p =
0.0139). Additionally, BIRT-377 increased CCL2 and CXCL10 only in PAE minor
CCI rats that reversed from allodynia (CCL2: F7,35 = 3.879, p = 0.0321; CXCL10:
F7,35 = 3.879, p = 0.0373). (d) Contralateral dorsal spinal cord revealed significant
CXCL1 increases from PAE when compared to Sac rats (F7,35 = 1.289, p =
0.0182). “1-sut CCI” is the same as “minor CCI”. N = 4-6 rats per group. Asterisks
indicate p < 0.05.
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Chapter 4 – PAE alters glutamate transporter expression leading
to enhanced susceptibility to developing neuropathic pain
Abstract
Background
Prenatal alcohol exposure (PAE) alters immune function rendering children
susceptible to infection and other disorders. Animal models with moderate PAE
demonstrate susceptibility to developing increased sensitivity to light touch
clinically termed allodynia. These studies demonstrate that PAE alters spinal
astrocytes, which is apparent only following sciatic nerve injury. Additionally, the
astrocyte specific glutamate transporter, glutamate aspartate transporter (GLAST)
is dysregulated by PAE. Considering GLAST clears glutamate from the synaptic
cleft following sciatic nerve injury, it would stand to reason that PAE may
increase susceptibility to developing allodynia through its alteration. Thus, the
goals of this study are to determine whether PAE dysregulates GLAST resulting
in allodynia following minor sciatic nerve injury.
Methods
Minor chronic constriction injury (CCI) or sham surgery was applied to adult male
Long Evans rats that underwent prenatal saccharin (Sac) or alcohol exposure. At
Day 10 post-surgery, a GLAST inhibitor (UCPH101) was given intrathecally (i.t.)
and behavior was assessed. Spinal cords from a separate group of non-injected
behaviorally verified rats were collected to determine gene and protein
expression of glutamate transporters using qrt-PCR and immunohistochemistry
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(IHC). Additionally, western blot is used to determine the expression of phosphorGluN2B and total GluN2B following CCI.
Results
Data show that following GLAST inhibition, only PAE rats with sham surgery
develop allodynia. When minor CCI is applied and GLAST is inhibited, Sac rats
develop allodynia whereas PAE rats display potentiated allodynic responses.
Gene and protein expression data show no significant differences in glutamate
transporters or in phosphorylated GluN2B. Interestingly, IHC data demonstrate
that PAE alone upregulates both GLAST and Glutamate Transporter 1 (GLT-1)
expression followed by downregulation when minor CCI is applied.
Conclusion
These studies demonstrate that PAE alters glutamate transporter expression
within the dorsal horn spinal cord which may contribute to susceptibility to
developing allodynia.
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Introduction
Significant modulation of pain signaling occurs within the spinal cord dorsal horn.
Following peripheral nerve damage, the release of glutamate and other pain
neurotransmitters not only activate their respective receptors on the postsynaptic membrane of pain projection neurons, such as N-methyl-d-aspartate
(NMDA) receptor in the spinal dorsal horn, but also peri-synaptic glial cells
(astrocytes and microglia). In turn, glia release cytokines IL-1β and TNF-α
(Hashizume et al., 2000; Milligan and Watkins, 2009), which bind to and further
activate receptors on pain projection neurons as well as on nearby glial cells.
This creates positive feedforward excitation of pain signaling. Ultimately, overexcited pain projection neurons relay these amplified signals to the brain (Milligan
and Watkins, 2009).
Following peripheral nerve injury, the excitatory pain neurotransmitter
glutamate is released in the synaptic terminal within the dorsal horn of the spinal
cord (Milligan and Watkins, 2009). Over time persistent release of glutamate
amongst other excitatory neurotransmitters results in depolarization of pain
projection neurons leading to phosphorylation of the NMDA receptor subunit
NR2B at serine 1303 (Ser 1303) (Castany et al., 2018). This phosphorylation
results in plasticity changes to the NMDA receptor allowing its depolarization
leading to amplifications of the pain signal that is relayed to the brain (Milligan
and Watkins, 2009).
Synaptic glutamate concentration is influenced not only by the degree of
presynaptic release, but also by glutamate clearance through glutamate
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transporters (Danbolt, 2001). Among the glutamate transporters that have been
identified, GLAST is found exclusively on astrocytes, GLT-1 is found on neurons
and glia, and EAAC1 is found solely on neurons. Normally, these glutamate
transporters clear glutamate from the synaptic and perisynaptic cleft (Danbolt,
2001). However, during peripheral nerve injury, an initial excessive release of
glutamate causes compensatory responses of the glutamate transporters,
GLAST, GLT-1, and EAAC1 to upregulate (Sung et al., 2003). Within a few days,
this up-regulation is followed by their downregulation resulting in increased
glutamate accumulation thought to generate exaggerated pain signaling (Sung et
al., 2003).
Interestingly, prior reports demonstrate potentiated allodynia in PAE rats
with standard sciatic nerve damage. This corresponded with elevations in
microglial and astrocyte activation (Noor et al., 2017). Additionally, significantly
reducing the damage to the sciatic nerve reveals that PAE rats have an
increased susceptibility to developing allodynia. These rats in parallel, show
spinal astrocyte activation but not microglial activation (Sanchez et al., 2017).
This suggests that the increased susceptibility to developing allodynia may be
astrocyte mediated. Interestingly, previous reports show that PAE downregulates the expression of the astrocyte specific glutamate transporter, GLAST
within the hippocampus (Brolese et al., 2015). Furthermore, only after inhibiting
GLAST expression within the spinal cord do rats develop potentiated allodynia
similar to what is seen in PAE rats with a standard CCI (Sung et al., 2003; Noor
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et al., 2017). These data support a larger role for astrocyte dysregulation via the
astrocyte-specific glutamate transporter GLAST.
The current study explores the mechanisms that PAE alters to increase
susceptibility to developing neuropathic pain. Determining the expression pattern
of phosphorylated NMDAR may shed light on whether PAE increases neuronal
sensitivity to glutamate. Additionally, it is possible that PAE alters spinal
glutamate transporter expression results in accumulation of glutamate in the
synapse leading to allodynia following minor injury. Thus, the goals of the study
are to determine whether PAE increases susceptibility to developing allodynia by
changing glutamate mediated functions.

Materials and Methods
Animals and Study Group Strategy
All procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of New Mexico Health Sciences Center and
closely adhered to guidelines from the International Association for the Study of
Pain for the use of animals in research. Long-Evans rat breeders purchased from
Harlan Industries (Indianapolis, IN) were maintained in a breeding colony on a
12:12-hour reverse light/dark schedule (lights on from 2100 to 0900 hours), and
fed Harlan Teklad rat chow and water, available ad libitum. For all experiments,
5-8-month male prenatal alcohol or saccharin exposed (described below) rat
offspring derived from 56 litters are used. Offspring are transferred to a standard
light/dark cycle (lights on from 0600 hours to 1800 hours) and allowed to
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acclimate to these conditions for at least 30 days before commencing
experiments. Additionally, rats are kept in these conditions for the duration of the
study. A total of 102 male offspring are used in all experiments. Offspring are
predominantly pair-housed with 5 rats single-housed due to incompatibility with a
cage mate. Rat offspring are split into three groups. The first group consists of 54
(29 with prenatal saccharin exposure, Sac; and 25 with prenatal alcohol
exposure; PAE) rats and are used for examination of behavioral hindpaw
sensitivity following intrathecal (i.t.) treatment of UCPH101 and its effects on
neuropathy produced by minor peripheral nerve injury. The second and third
groups consists of 27 (12 Sac and 15 PAE) and 21 (12 Sac and 9 PAE)
behaviorally verified rats and are used for spinal cord immunohistochemical (IHC)
analysis (Group 2) or for protein and mRNA analysis (Group 3).

Moderate Prenatal Alcohol Exposure Using the Voluntary Drinking
Paradigm
Pregnant female rat dams are given either ethanol or saccharin throughout
pregnancy until birth according to the voluntary drinking paradigm previously
described (Savage et al., 2010). Briefly, 3 to 4-month pre-pregnant female LongEvans rat breeders are acclimated for 4 hours per day, from 1000 to 1400 hours
(during their active phase), to drinking water containing 0.066% (w/v) saccharin
(Sac) that gradually increased in ethanol content from 0% (v/v) on Days 1-2, to
2.5% (v/v) on Days 3-4, to 5% (v/v) on Day 5 and thereafter for two weeks.
Regular drinking water is available at all times during housing. Thus, rats
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voluntarily choose to drink either saccharin sweetened water containing 5%
ethanol or regular water during the 4-h drinking period. At the end of the 2-week
pre-pregnancy drinking phase, the mean daily ethanol consumption is
determined for each rat and rats that consumed 1 standard deviation above or
below the group mean are excluded from the study. Subsequently, female rats
are assigned to either a 5% ethanol or Sac control drinking group such that the
mean pre-pregnancy ethanol consumption is similar between groups. The
females are then placed with proven male rat breeders until pregnant (~2 days).
No alcohol is consumed during the breeding period. Beginning on gestational day
1, rat dams were given either 0% (Sac) or 5% (PAE) ethanol in Sac water (4
hours/day, during the active phase). Sac rats are given a volume of 0% ethanol
in Sac water that is matched to the mean volume voluntarily consumed by the 5%
ethanol group. Total ethanol consumption is recorded for each dam, which
averaged 2.04 g of ethanol/kg body weight/day. This level of drinking by rat dams
produced a mean peak serum blood alcohol concentration of 0.06 g/dl. No
significant differences are observed between prenatal treatment groups in dam
weight gain during pregnancy, pup birth weights, or litter size, replicating
previous reports (Savage et al., 2010; Noor et al., 2017; Sanchez et al., 2017).
Offspring are weaned at 24 days of age and male offspring pair-housed with the
exception of five single-housed rats due to incompatibility with a cage mate. For
all experiments, 5-8-month prenatal alcohol or saccharin exposed animals are
used. A total of 102 male offspring are used in these experiments. Behavioral
testing of offspring is performed during the first three hours of the light cycle
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(inactive phase) to avoid the influence of elevated hormones under normal
circadian rhythms.

Chronic constriction injury (CCI)
In adult male Sac or PAE rats, sham or CCI aseptic surgical procedures are
performed as previously described (Bennett and Xie, 1988; Noor et al., 2017;
Sanchez et al., 2017) and modified, as described here. Under isoflurane
anesthesia (3% volume in oxygen), the sciatic nerve is carefully isolated with
sterile glass prongs and snuggly ligated with 1 (minor injury) segment of sterile 40 chromic gut suture (Ethicon, Somerville, NJ) without pinching into the nerve.
Sterile isotonic saline (0.9%) is applied to the nerve during the procedure to
prevent dehydration. Sham surgery involved isolation of the sciatic nerve similar
to CCI but without nerve ligation. The nerve is then gently placed back into
position and the overlying muscle was sutured closed with two 3–0 sterile silk
sutures (Ethicon, Somerville, NJ). Rats fully recovered from anesthesia within
approximately 5 minutes and are monitored daily following surgery for any postoperative complications. The number of rats that are excluded from the study due
to the presence of hindpaw autotomy was 2 (1.8%).

Behavioral Assessment of Allodynia
Allodynia is assessed using the von Frey fiber test as previously described
(Dengler et al., 2014; Sanchez et al., 2017). Briefly, rats are habituated to the
testing environment for approximately 45 min/day for 4 sequential days within the
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first 3 hours of the light cycle (inactive phase) in a sound- and temperaturecontrolled dimly lit section of the colony room. Baseline (BL) responses are then
assessed using the von Frey behavioral test. A total of 13 calibrated
monofilaments were are in these studies. Additionally, these calibrated
monofilaments (3.61–5.18 log stimulus intensity) are applied to the plantar
surface of the left and right hindpaw for a maximum of 8 seconds per application.
Random order between left and right hindpaw assessment is conducted. A
metronome placed in the room provided guidance at 1 tick/sec. Lifting, licking, or
shaking of the paw is considered a response. In a similar manner to BL
evaluation, rats are re-assessed following CCI or sham surgery through Day 10
prior to drug treatment. A second group of rats is assessed through Day 32. The
last group of rats is assessed through Day 14. The experimental tester was blind
to the prenatal and surgical treatment groups. At Day 10, Group 1 rats are given
an intrathecal (i.t.) injection of UCPH101 or vehicle (described below) and
behavioral re-assessment occurrs at 1hr, 2hr, 3hr, and 24hrs post injection.

Drug preparation
UCPH101 is a selective non-competitive inhibitor that prevents glutamate uptake
of EAAT1 (GLAST) which is expressed solely on astrocytes (Kugler and Schleyer,
2004; Abrahamsen et al., 2013). UCPH101 (Abcam, Cambridge, UK) is initially
reconstituted in 100% DMSO as a stock solution at a concentration of
10.56mg/ml, aliquoted into 0.5 ml sterile Eppendorf tubes and stored in a clean
sealed container at -20°C for later use. On the day of intrathecal (i.t.) injection,
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sterile ddH20 is warmed in a water bath and UCPH101 is added to reach a
concentration of either 100nM or 10μM for i.t. injection and vortexed for 2 min.
Vehicle consisted of sterile ddH2O. Animals are injected within the hour following
drug dilution.

Intrathecal (i.t.) Injection
Drug (UCPH101 or vehicle) is administered using an i.t. catheter on Day 10 postsurgery and is conducted as described previously (Milligan et al., 2005). Briefly,
under isoflurane anesthesia (3% volume in oxygen), the beveled needle end of
an 18-guage sterile (Bectin Dickson, Franklin Lakes, NJ) needle with the plastic
hub removed is inserted between lumbar vertebrae L5-L6. PE-10 tubing (Fisher
Scientific, Hampton, NH) is fitted with a 30-guage sterile needle (Bectin Dickson,
Franklin Lakes, NJ) containing a Hamilton syringe at one end and labeled with a
marking at 7.7 cm at the opposite end. Drug or equivolume vehicle (20μl) is
withdrawn from the open side of the PE-10 tubing. The open end of the tubing is
then threading into the 18-guage needle until the 7.7 cm marking was reached.
This position corresponds to the lower lumbar L4-L5 region of the spinal cord.
Correct placement of the PE-10 is determined by twitching of the hindleg and/or
tail during catheter advancement, as well as cerebrospinal fluid efflux from the
externalized portion of the 18-g needle. Drug is administered over a 25 second
interval. Immediately following drug or vehicle administration, tubing is removed
followed by removal of the 18-guage needle and rats are allowed to recover
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before being placed in home cage. Rats fully recover from anesthesia within 5
minutes and 100% motor recovery is observed following i.t. injection.

Immunohistochemical (IHC) tissue sample preparation
All tissue from behaviorally verified Group 2 rats on Day 32 post-surgery are
collected for IHC processing. Tissues were processed as described previously
(Noor et al., 2017; Sanchez et al., 2017). Briefly, rats are overdosed with sodium
phenobarbital ( 390 mg/ml Sleepaway, Fort Dodge Animal Health, Fort Dodge, IA)
and transcardially perfused with 0.1M phosphate buffered saline (PBS; pH = 7.4),
initially at a rate of 28 ml/min, then increased to 32 ml/min (~10 min), followed by
4% paraformaldehyde (PFA; pH = 7.4; 28-34 ml/min, 8 min). Immediately
following transcardial perfusion, the spinal vertebral column from C2-L6 with the
spinal cord intact within the vertebral column are collected and cut at vertebra T7
into a rostral and caudal half of the spinal vertebral column. All spinal cord
sections underwent 48-hour post-fixation in 4% PFA at 4 °C.
Following post-fixation entire spinal cord (T7- L6) are carefully isolated making
sure to maintain tissue integrity. The isolated spinal cords subsequently paraffin
processed. Paraffin-embedded blocks are subsequently sliced on a microtome
with adjacent 7 μm tissue sections mounted onto vectabond-treated slides.
To investigate spinal glutamate transporters, we analyzed the expression of
glutamate transporter 1 (GLT-1), Glutamate Aspartate Transporter (GLAST), and
Excitatory Amino-acid Carrier 1 (EAAC1). Paraffin-processed tissues undergo
deparaffinization followed by rehydration and antigen retrieval procedures in a
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rice cooker at 94-96° C allowing for gentle and equal distribution of temperature
warming throughout tissue sections. For antigen retrieval, polyclonal GLAST
antibody requires a Tris-based buffer at pH 9.5 (BioCare Medical, Concord, CA)
and polyclonal GLT-1 and EAAC1 antibody requires a Tris-based buffer at pH 9.0
(Vector, Burlingame, CA). All tissue sections are incubated with 5% normal
donkey serum (NDS), PBS pH 7.4 for 2h, followed by overnight primary antibody
incubation using rabbit anti-rat polyclonal EAAT1 (GLAST) (1:300; Abcam,
Cambridge, UK), EAAT2 (GLT-1) (1:1000; Abcam, Cambridge, UK), or EAAT3
(EAAC1) (1:500; Abcam, Cambridge, UK). All tissues are incubated with donkeyanti rabbit TRITC- conjugated secondary antibody incubation for 2h in a humidity
chamber at room temperature and rinsed in 0.1 M PBS. All tissues are then
stained with the nuclear stain 4,6-diamidino-2-phenylindole (DAPI) (Vector Labs,
Burlingame, CA) separately before cover slipping. These slides are left at room
temperature overnight and then placed at 4° C until proceeding with image
acquisition and microscopy analysis (Wilkerson et al., 2012a; Sanchez et al.,
2017).

Microscope spectral imaging for immunofluorescent quantification
Image acquisition for spectral analysis was preformed using the Nuance spectral
imaging system (http://www.cri-inc.com/products/nuancew.asp; Perkin Elmer,
Waltham, MA) as described previously (Noor et al., 2017; Sanchez et al., 2017).
Briefly, images of dorsal horn spinal cord are obtained using either a 20X or 40x
objective with a Zeiss Axioplan2 inverted fluorescence microscope. Flat-field
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corrections is applied to correct for uneven illumination (modest vignetting) image
acquisition. Image cubes are obtained from multi-labeled tissue containing DAPI,
conjugated secondary antibody, as well as autofluorescence. A spectral library is
then created using single-labeled slides for each fluorophore (e.g. TRITC) and a
label-free (autofluorescence) slide. A computed spectrum (420 nm – 720 nm)
was obtained by separating the known spectrum (autofluorescence) from mixed
spectrum (single labeled) to produce pure spectrum of each fluorophore. This
allowed the separation of spectrum from multi-labeled slides (e.g. DAPI + TRITC)
to obtain composite images containing only labels of interest. These composite
images are then used for further analysis using Slidebook 6 software (below). For
dorsal horn spinal cord sections ipsilateral to sciatic manipulation, sixteen to
twenty-eight images per experimental group (4 sections per animal, 4-7 animals
per condition) were acquired and analyzed.

SlideBook6 software image analysis
Composite images are analyzed using SlideBook6 software (Intelligent Imaging
Innovations, Denver, CO, USA) as described previously (Noor et al., 2017;
Sanchez et al., 2017). Briefly, to discriminate signals originating from artifacts,
the experimenter determined an acceptable threshold of very low-level emission
fluorescent intensity per individual animal (monoclonal GFAP, IL-1β and IL-10
analysis). This was done by closely replicating the on-screen composite
computer image with that observed through the microscope eyepiece, as
described previously (Noor et al., 2017; Sanchez et al., 2017). In addition, for

141

spinal cord sections, the dorsal horn (region of interest (ROI)) is outlined for
analysis eliminating the surrounding white matter and peri-spinal blank space
(intrathecal space). The image is then refined to include the predetermined
threshold within the outlined area. The ‘Sum Intensity’ (the total signal within the
outlined area in the dorsal horn) is determined and divided by the ‘Area’ (total
area in micrometers squared (μm2)) to obtain the ‘Fluorescence Intensity’. The
average of the adjacent sections from a single slide (representing a single animal)
is calculated to determine the value for each animal. Finally, averages for each
slide within the same condition are calculated along with the standard deviation
and standard error of the mean. Data are analyzed as “Sum Intensity of ROI/μm 2.

Tissue collection and total RNA isolation
Following behavioral assessment on Day 14 post-surgery (Group 3) rats are
deeply anesthetized (induction 3% vol. followed by 5% in oxygen) for 10
minutes. Rats are then transcardially perfused with ice cold 0.1M PBS pH 7.4 for
3 min at a rate of 24 ml per minute. Perfused body is then placed on a frozen gel
refrigerant pack (Glacier Ice, Pelton Shepherd Industries, Columbus, OH).
Laminectomy and tissue dissection is performed to collect both ipsilateral and
contralateral

lumber

(L4-L6)

spinal

cord.

All

samples

are

placed

in

DNase/RNAse-free 1.5 ml centrifuge tubes (VWR International, Radnor, PA),
flash frozen on dry ice, and stored at -80 C for future analysis.
Flash frozen tissues are transferred to ice and 100μl sterile 1x PBS was added.
All tissues are then homogenized using a motorized VWR disposable Pellet
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Mixer and motor pestle system (VWR International, Radnor, PA) for about 30
seconds. 60% of the tissue homogenate is then processed for protein analysis
(described below). The remaining 40% of the homogenate is added to chilled
Qiazol Lysis Reagent (Qiagen, Hilden, Germany) for total RNA isolation
(described below).

Tissue lysate preparation and Western Blot Analysis
Flash frozen ipsilateral and contralateral lower lumbar (L4-L6) spinal cord
sections are collected from animals as previously described (Jantzie et al., 2013;
Jantzie et al., 2014). Briefly, tissues are homogenized using a Fisherbrand
Disposable Pestle system (Fisher Scientific, Hampton, NH). Samples are then
sonicated in buffer containing protease inhibitors. All samples are then
centrifuged at 4200g, at 4 C, for 10 minutes. Lysate is then collected from
samples and Braford protein assay (Biorad, Hercules, Ca) is used to determine
protein concentrations.
Western blot is used to detect NMDA receptor subunits GluN2B (NR2B) and
phosphorylated GluN2B (p-NR2B) (Huang et al., 2018). This was done on
ipsilateral spinal cord whole cell fractions from Group 3 rats. Each sample is
normalized to 30μg and loaded onto Criterion Precast 4-20% Tris-HCl Precast
gels (Bio-Rad, Hercules, CA). For electrophoresis, gels are run at 125V for 1.5
hours. Protein is then transferred to polyvinylidine difluoride (PVDF) membranes,
blocked, and are incubated with NMDA receptor subunit antibodies. For antiNR2B (1:1500, Abcam, Cambridge, MA), 5% milk in Tris Buffered Saline with
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Tween 20 (TBS-T) is used to block membrane and dilute antibody. For antiNR2B (p-Ser1303; 1:3000, Abcam, Cambridge, MA), 1% Bovine Serum Albumin
(BSA) (Sigma-Aldrich, St. Louis, MO) in TBS-T is used to block and dilute
antibody. Primary antibody incubations are done at 4̊C overnight. The next day, a
goat anti-rabbit HRP secondary antibody (1:5000; Thermofisher, Waltham, MA)
is applied and the membranes are incubated at room temperature for 1 hour. For
band detection, ImageQuant LAS 4000 (GE Healthcare Life Sciences, Chicago,
IL) is used. GAPDH (1:40,000; Sigma-Aldrich, St. Louis, MO) is used as a
loading control.

Total RNA isolation and mRNA analysis by quantitative real-time PCR
Total RNA is extracted from ipsilateral and contralateral spinal cord. Tissue is
placed in chilled Qiazol Lysis Reagent (Qiagen, Hilden, Germany) and
homogenized for 15 seconds. Total RNA is then extracted using an miRNeasy
Micro Kit (qiagen, Hilden, Germany) per manufacturer’s instructions. It should be
noted that an additional RPE and 80% EtOH wash steps are added to remove
any additional salt contaminants added from PBS step. Tissue is centrifuged at
15,000rpm for 1.5 min at 4 C. PBS is aspirated and 35μl of protease inhibitor
solution is added and samples are stored in dry ice and later stored at -80 C for
future analysis (described below).
RNA concentration and quality is assessed using Nanodrop (Thermofisher
Scientific, Walham, MA). RNA samples are then diluted to standardized RNA
concentrations of 137ng/μl for ipsilateral and contralateral lumbar spinal cord.
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Standardized samples are then transcribed to cDNA at 1438.5ng for ipsilateral
and contralateral lumbar spinal cord. Reverse transcription is performed for all
tissue types using a Superscript IV VILO cDNA Synthesis Kit (Invitrogen,
Carlsbad, CA).
Levels of mRNA expression are measured and analyzed as described previously
(Mellios et al., 2014). For assessment of transcripts a dilution factor of 1:2.2 for
ipsilateral and contralateral lumbar spinal cord is done. cDNA dilution for
assessment of rat 18S rRNA normalizer is 1:200 for all tissue types. Levels of
mRNA and “Normalizer” rat

18s rRNA

(Rn18s, Taqman Assay ID#:

Mm03928990_g1), are assayed in triplicate using quantitative real-time PCR
(qRT-PCR) with Taqman Gene Expression Assays (ThermoFisher Scientific,
Waltham, MA). Gene expression assays are deemed to be “best coverage”
assay by the manufacturer and are analyzed with the formula C =
2^CTNormalizer/2^CTTarget in order to exclude detection of genomic DNA. Glutamate
transporters

target

include

SLC1A3

(EAAT1)

(Taqman

Assay

ID#:

Rn00665089_m1), SLC1A1 (EAAT3) (Taqman Assay ID#: Rn00564705_m1),
and SLC1A2 (EAAT2) (Taqman Assay ID#: Rn00691548_m1).

Statistical analysis
SPSS (IBM, Chicago, IL, USA) is used for all behavioral analysis. At BL, a 3-way
(2 x 2 x 2) analysis of variance (ANOVA) is applied to assess differences
between prenatal exposure (Sac versus PAE), surgical treatment (Sham versus
minor CCI), and drug injection (vehicle versus UCPH101). Additionally, a 3-way
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(2 x 3) repeated measures ANOVA is used for analysis of the between-subject
factors of prenatal exposure, surgery, and injection for days post-surgery as well
as days post-injection. Data acquired from IHC, western blot, and qRT-PCR are
analyzed using GraphPad Prism version 7 software (Graphpad Software Inc.,
San Diego, CA, USA). Post-hoc examination of IHC IR, western blot, and qRTPCR is determined prior to experiments and is analyzed using Fisher’s LSD test.
The threshold for statistical significance is set a priori at α = 0.05 for all sets of
multiple comparisons. In order to minimize unnecessary duplication, the
minimum number of animals possible to make statistically significant conclusions
is used, which is based on our previous publications (Wilkerson et al., 2012a;
Dengler et al., 2014; Noor et al., 2017; Sanchez et al., 2017; Whitehead et al.,
2017). Outliers were removed following Grubbs’ Z-test (Grubbs, 1950). In all
cases, the data are presented as the mean ± SEM. All figures are created in
GraphPad Prism version 7 software (Graphpad Software Inc., San Diego, CA,
USA).

Results
Inhibiting GLAST function leads to induction of allodynia only in PAE rats
Prior to either sham (Fig. 1) or minor CCI (Fig. 2) surgery, all rats display basal
levels of light touch sensory thresholds in that both ipsilateral and contralateral
hindpaw responses occurred at about 10 grams of stimulus intensity (Fig. 1a-d
and Fig. 2a-b). These responses remain consistent following sham surgery at
Day 3 and 10 post-surgery (Fig. 1a-d). At Day 10 post-surgery all rat groups are
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given i.t. 10M or 100nM UCPH101 or equivolume vehicle and tested at 1hr, 2hr,
3hr, and 24hrs post-injection. Vehicle injected Sac and PAE rats maintained
hindpaw responses comparable to pre-injection values (Fig. 1a-d). Additionally,
Sac rats receiving only 10M UCPH101 maintained normal sensitivity through
the behavioral time-course (Fig. 1a,c). Interestingly, PAE rats receiving 100nM
UCPH101 demonstrate increased sensitivity to light touch. Furthermore, when
the dose of UCPH101 is increased to 10M, sensitivity is increased in both
ipsilateral and contralateral hindpaw (Fig. 1b,d). Sensitivity returns to BL levels
by 24 hours post-injection. These data indicate that increasing glutamate at the
synaptic cleft of the lower lumbar spinal cord is able to induce allodynia only
following PAE. Additionally, these data suggest that PAE leads to enhanced
reactivity to glutamate either on glia or at the post-synaptic terminal.

Alteration of GLAST function enhances susceptibility to developing
allodynia
Following BL assessment, Sac and PAE rats receive minor (1 Sut.) CCI surgery
(Fig. 2a-b). Data show that in comparison to Sac rats which maintain sensitivity
comparable to baseline at Days 3 and 10, PAE rats develop robust unilateral
allodynia (Fig. 2a-b) which has previously been demonstrated (Sanchez et al.,
2017). At Day 10 post-surgery rats receive either i.t. 10M or 100nM UCPH101.
Strikingly, Sac rats with minor CCI develop allodynia similar to PAE rats with
injury (Fig. 2a). PAE rats with minor CCI do not develop increases in sensitivity
following 100nM injection but there are increases in sensitivity following 10M
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injection at 2 hours and 3 hours post-injection (Fig. 2a). Normal sensitivity in Sac
rats returns whereas allodynia comparable to pre-injection values in PAE rats
returns by 24 hours post-injection (Fig. 2a). Interestingly, assessment of
contralateral hindpaw sensitivity demonstrates normal sensitivity at BL and up to
Day 10 post-surgery (Fig. 2b). Following i.t. injection of either 10M or 100nM
UCPH101 at Day-10 post-surgery, Sac and PAE rats develop slight increases in
sensitivity (Fig. 2b). Furthermore, no changes in sensitivity are seen as a result of
increasing UCPH101 concentration. Considering allodynia is induced in Sac rats
with minor CCI only following GLAST inhibition, this would suggest that PAE may
increase susceptibility to developing allodynia through alteration of GLAST
function.

PAE does not alter gene expression of spinal glutamate transporters
In behaviorally assessed Sac and PAE rats receiving either sham or minor CCI,
dorsal horn spinal cord is collected to determine gene expression of GLAST,
GLT-1, and EAAC1 (Fig. 3). Interestingly, minor CCI or PAE does not
significantly alter the expression of GLAST or EAAC1. Furthermore, although not
significant, slight increases in GLT-1 are seen following minor CCI in both Sac
and PAE rats. Our data indicate that PAE does not alter gene expression of
glutamate transporters. In addition, considering our behavioral data (Fig. 1-2)
suggests a role for GLAST function it is possible that alterations may be seen at
the protein level which is demonstrated by previous reports (Brolese et al., 2015).
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Glutamate transporter expression is altered following PAE within the spinal
cord
Sac and PAE rats that are behaviorally assessed following sham and minor CCI,
IHC is used to determine immunoreactivity (IR) of glutamate transporters within
the dorsal horn spinal cord (Fig. 4). Interestingly, compared to Sac rats with
sham surgery, PAE rats demonstrate upregulation of both GLAST and GLT-1
(Fig. 3a-b). Furthermore, when minor CCI is applied, Sac rats demonstrate an
upregulation of only GLAST expression whereas PAE rats demonstrate a
downregulation in both GLAST and GLT-1 (Fig. 3a-b). IR for EAAC1 show no
significant changes in expression as a result of prenatal exposure or surgery (Fig.
3c). These data indicate the PAE alone is able to significantly alter the
expression of GLAST and GLT-1 resulting in a downregulation following minor
CCI. Additionally, no changes are seen in the expression of the neuronal specific
glutamate transporter EAAC1. Together our data demonstrate that PAE may
alter glutamate transporters which may lead to increased susceptibility to
developing allodynia.

PAE or minor CCI do not alter p-NR2B in the dorsal horn spinal cord
Spinal cords from Sac and PAE rats with minor CCI are assessed through
western blot to determine the protein expression of phosphorylated GluN2B (pNR2B) and total GluN2B (NR2B) (Fig. 5). Data are presented as a ratio of pNR2B divided by total NR2B. No significant differences are seen in the
phosphorylated NR2B as a result of PAE or minor CCI. Previous reports
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demonstrate that p-NR2B/NR2B is increased following a standard CCI but this is
not observed following a minor CCI.

Discussion
An emerging body of literature supports the idea that moderate PAE alters
neuroimmune function (Drew and Kane, 2014; Topper et al., 2015) which may
lead to heightened susceptibility to developing neuropathic pain as previously
shown (Noor et al., 2017; Sanchez et al., 2017). Interestingly, the effects of PAE
are not unmasked until a secondary insult such as CCI is applied. Recent reports
demonstrate that susceptibility is mediated through alteration of glial cells within
the spinal cord, specifically astrocytes (Noor et al., 2017; Sanchez et al., 2017).
This suggests that induction of allodynia following minor CCI may be mediated
through an astrocyte specific mechanism. In support this notion, reports
demonstrate that moderate PAE alters the astrocyte specific glutamate
transporter GLAST (Brolese et al., 2015). Thus, the current work sought to
determine what effect PAE has on glutamate transporters and whether alteration
of GLAST function can induce a PAE behavioral phenotype in healthy Sac
controls. Additionally, we sought to determine whether PAE alters the
phosphorylation of the NMDA receptor subunit NR2B within the spinal cord.
In the current report, only PAE rats with sham surgery receiving i.t.
UCPH101 demonstrate induction of allodynia in a dose dependent manner (Fig.
1b,d). Interestingly, it was not until minor CCI is applied with GLAST inhibition
that Sac control rats demonstrate robust unilateral allodynia (Fig. 2a-b). This
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induction of allodynia in Sac rats mimicked allodynia seen in PAE rats with minor
CCI suggesting that PAE alters GLAST function. Gene expression analysis for
glutamate transporters within the dorsal horn spinal cord reveal no significant
differences between Sac and PAE groups receiving either sham or minor CCI
(Fig. 3). Interestingly, IHC analysis demonstrates that PAE alone alters GLAST
and GLT-1 but not EAAC1 expression within the dorsal horn spinal cord (Fig. 4).
Our gene and protein expression data suggests that PAE may alter posttranslational modification of glutamate transporters. Furthermore, when minor
CCI is applied, Sac rats demonstrate compensatory upregulation of GLAST and
GLT-1 whereas PAE rats show a downregulation of these transporters (Fig. 4).
This downregulation potentially allows glutamate to accumulate within the
synaptic cleft of the dorsal horn spinal cord leads to induction of allodynia
following minor CCI. This idea is supported considering allodynia was induced in
Sac with minor CCI and GLAST inhibition. Furthermore, our data suggest that
PAE does not alter neuronal reactivity in that no significant differences are
observed in the neuronal specific transporter EAAC1 (Fig. 4c) or changes in pNR2B (Fig. 5). Together, our data suggest that PAE alters glutamate transporter
function making them more susceptible to downregulation which ultimately leads
to allodynia following even a minor CCI.

Susceptibility to allodynia is glial mediated rather than neuronal
It has been well characterized that the induction of allodynia is mediated by glial
activation and release of proinflammatory cytokines (Milligan and Watkins, 2009).

151

Following sciatic nerve damage, the release of glutamate triggers glial activation,
resulting in release of proinflammatory cytokines which ultimately result in NMDA
receptor depolarization (Milligan and Watkins, 2009). Studies that explore the
effects of PAE on glia show that PAE primes glial cells within the brain and spinal
cord making them more reactive following a secondary insult (Topper et al., 2015;
Noor et al., 2017; Sanchez et al., 2017). In addition to this, proinflammatory
cytokine release is heightened in PAE immune cells compared to controls
(Topper et al., 2015; Noor et al., 2017; Sanchez et al., 2017). Together the data
support the idea that heightened susceptibility to developing allodynia following
PAE is glial mediated.
Although this is true, neuronal mediated mechanisms in neuropathic pain
cannot be discounted. Considering pain signals from the periphery travel into the
spinal cord through primary afferent terminals where they synapse onto pain
projection neurons, it is possible that PAE could result in neuronal alterations.
Previous reports have demonstrated that PAE alters NMDA receptor subunits
within the brain (Brady et al., 2013). This would lead to the idea that neurons may
be more sensitive to the release of glutamate within the post-synaptic terminal.
Thus, during minor CCI, allodynia may be induced due to the heightened
reactivity of NMDA receptors to glutamate. Interestingly, our data argue for a
more glial mediated mechanism. Our behavioral data utilizing 100nM and 10μM
show a dose dependent response following sham surgery, which is not present
following minor CCI. PAE rats with minor CCI do not show concentration
dependent increases in allodynia (Fig. 2a). Similarly, contralateral hindpaw
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responses are identical regardless of concentration of UCPH101 used (Fig. 2b).
These data show increasing glutamate at the synapse by increasing the dose of
UCPH101 does not result in an increase in sensitivity. There is a threshold that is
reached preventing allodynia from becoming potentiated. In addition to this data,
our gene expression (Fig. 3) and protein (Fig. 4) expression data show no
significant alterations as a result of PAE for the neuronal specific glutamate
transporter EAAC1. In addition, no significant differences are seen in the
phosphorylation of NR2B as a result of PAE (Fig. 5). Taken together, it would
suggest that PAE induced susceptibility to developing allodynia is mediated
primarily through glial activation.

Regulation of glutamate transporter expression
Previous reports characterizing the expression of glutamate transporters within
the spinal cord demosntrate that following nerve injury there is an initial
upregulation of transporters by Day 1 and 4 post-surgery followed by a
downregulation at Days 7 and 14 (Sung et al., 2003). Interestingly, our data show
that PAE results in an upregulation of GLAST and GLT-1 without nerve injury and
leads to downregulation following a minor injury (Fig. 4a-b). In contrast, healthy
controls demonstrate compensatory upregulation which may be preventing the
development of allodynia (Fig. 4a-b). Thus, this begs the question of what
mechanisms may regulate the expression of glutamate transporters and how
PAE may alter these mechanisms.
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As mentioned previously, following nerve injury, glial cells release
proinflammatory cytokines including IL-1β. Recent reports demonstrate that this
release of IL-1β will work through the calcium/Protein kinase C (PKC) pathway to
enhance endocytosis of both GLT-1 and GLAST (Yan et al., 2014). A separate
report demonstrates that the proinflammatory cytokine TNFα may also regulate
both GLAST and GLT-1 (Dumont et al., 2014). Interestingly, previous reports
show that although PAE leads to heightened expression of both TNFα and IL-1β
following insult, basal levels remain normal. Furthermore, other studies find that
PAE downregulates basal expression of the anti-inflammatory IL-10 (Noor et al.,
2017). Although speculative, it is possible that this alteration of IL-10 may lead to
a more proinflammatory environment within the spinal cord leading to heightened
expression of both GLAST and GLT-1. Thus, when insult is applied and
additional IL-1β and TNFα are released, it quickly results in downregulation of
both glutamate transporters. Further studies are needed to characterize the
immune mechanisms that regulate glutamate transporters within the spinal cord.

Effects of PAE on GLAST and GLT-1 function may be region specific
Interestingly, our data show that PAE upregulates the expression of both GLAST
and GLT-1 within the spinal cord dorsal horn (Fig. 4a-b). In contrast separate
reports within the hippocampus show that PAE leads to downregulation of
GLAST and upregulation of GLT-1 (Brolese et al., 2015). Thus, although GLT-1
data are similar to what we are demonstrating, conflicting data are seen in
GLAST expression. One possible reason for this difference may be that
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alterations in glutamate transporter expression following PAE are a result of
differences in exposure paradigms. In this study, alcohol exposure occurred
throughout gestation which is the human equivalent to the first and second
trimesters. In contrast, Brolese and colleagues utilized a paradigm that exposed
rat pups to alcohol throughout gestation and following birth until weaning
(Brolese et al., 2015). Considering that a lot of critical hippocampal development
occurs during the third trimester in rodents (Mohajerani and Cherubini, 2006;
Lohmann and Kessels, 2014), it is possible that further alterations in glutamate
transporter expression may occur following third trimester exposure. Thus, it is
important to note that the method of PAE may play a role in how glutamate
transporters are altered and warrants further exploration.

Alteration of glutamate transporters may lead to susceptibility to
developing glutamate mediated disorders
Glutamate transporters as well as glutamate excitotoxicity has been shown to be
involved in the development of various neurodegenerative disorders such as
amyloid lateral sclerosis (ALS) and Alzheimer’s disease (AD) (Masliah et al.,
1996; Dumont et al., 2014; Takahashi et al., 2015). Additionally, altered glial
function and increase in proinflammatory cytokines have been suggested to be
involved in both ALS and AD (Kim et al., 2018). Considering our data as well as
other reports (Brolese et al., 2015) demonstrate that PAE may alter glutamate
transporter function as well as glial function, it is possible that this may render
individuals susceptible to neurodegenerative disorders. Unfortunately, since
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FASD has only recently been recognized (Jones and Smith, 1973), it is possible
that life-long effects such as neurodegenerative disorders in clinical studies may
only begin to become apparent in the near future. Thus, further examination in
individuals with FASD and in animal models of FASD would need to be done to
explore this notion.

Conclusions
Taken together, our data demonstrate the PAE leads alterations of glutamate
transporters within the spinal cord. In addition, this alteration may result in
increased glutamate at the synaptic cleft which may in turn lead to activation of
primed glial cells. Overall, this could ultimately lead to heightened susceptibility to
developing neuropathic pain following minor CCI.
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Figure 1

Figure 1 – Inhibition of GLAST function induces allodynia only in PAE rats.
Response thresholds from (a-b) ipsilateral and (c-d) contralateral hindpaw from
Sac control and PAE rats with sham surgery. a-d Similar hindpaw sensitivity is
observed in all Sac and PAE rats prior to surgery (Baseline; BL) [ipsilateral, F 1,30
=0.143, p = 0.708; contralateral, F1,30 = 3.918, p = 0.056]. After sham surgery,
normal sensitivity was maintained as no significant differences are observed as a
result of exposure in the ipsilateral or contralateral hindpaw [ipsilateral, F1,30
=1.137, p = 0.295; contralateral, F1,30 = 0.081, p = 0.922]. At Day 10 postsurgery all rats received an i.t. injection of vehicle, 10μM (Sac and PAE rats), or
100nm (only PAE rats) of UCPH101. Interestingly, a main effect of exposure
[ipsilateral, F1,30 =21.192, p < 0.0001; contralateral, F1,30 = 18.519, p < 0.0001],
injection [ipsilateral, F1,30 =22.208, p < 0.0001; contralateral, F1,30 = 23.829, p <
0.0001], and an interaction between exposure and injection [ipsilateral, F 1,30
=9.362, p = 0.001; contralateral, F1,30 = 12.026, p < 0.0001] is observed. All rats
return to normal sensitivity by 24 hours post-injection in that no significant
differences are seen between groups [ipsilateral, F1,30 =1.271, p = 0.295;
contralateral, F1,30 = 0.758, p = 0.477]. Asterisks indicate p < 0.05. The data are
presented as the mean ± SEM. Arrows indicate when i.t. injection was done.
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Figure 2

Figure 2 – Sac rats develop allodynia following minor CCI following GLAST
inhibition. (a) Ipsilateral and (b) contralateral response thresholds are shown for
Sac and PAE rats with minor CCI. At BL similar hindpaw sensitivity is observed
between all groups [ipsilateral, F1,16 =3.779, p = 0.070; contralateral, F1,16 =
1.164, p = 0.222]. Following minor 1-suture CCI PAE rats develop robust
allodynia within the ipsilateral paw compared to Sac control rats where a
significant effect of exposure is seen [ipsilateral, F1,16 =34.332, p < 0.0001;
contralateral, F1,16 = 0.189, p = 0.670]. Following i.t. injection of either 10μM (Sac
and PAE rats) or 100nm (only PAE rats) UCPH101, a main effect of exposure
[ipsilateral, F1,15 =18.650, p = 0.001; contralateral, F1,15 = 4.041, p = 0.063] and
injection is demonstrated in the ipsilateral hindpaw [ipsilateral, F1,15 =5.085, p =
0.040; contralateral, F1,15 = 0.166, p = 0.690]. By 24 hours post-injection the
effects of UCPH101 are no longer present as no main effect of injection is seen
[ipsilateral, F1,16 =0.866, p = 0.367; contralateral, F1,16 = 0.520, p = 0.482].
Asterisks indicate p < 0.05. The data are presented as the mean ± SEM. Arrows
indicate when i.t. injection was done.
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Figure 3

Figure 3. PAE does not alter glutamate transporter gene expression
Gene expression of (a) EAAT1, (b) EAAT2, and (c) EAAT3 within the ipsilateral
dorsal horn spinal cord was determined using qRT-PCR. No significant
differences are seen between groups in that no main effects of treatment
[EAAT1, F3,17 =1.104, p = 0.3746; EAAT2, F3,17 = 1.241, p = 0.3258; EAAT3, F3,17
= 0.5529, p = 0.6531] are observed. No significant increases were observed as a
result of PAE. Additionally, no significant differences are seen as a result of
minor CCI. The data are presented as the mean ± SEM.
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Figure 4

Figure 4. GLAST and GLT-1 are upregulated as a result of PAE alone.
Protein expression of glutamate transporters within the ipsilateral dorsal horn
spinal cord was determined through quantification of immunoreactivity (IR)
following IHC procedures. IR of (a) EAAT1, (b) EAAT2, and (c) EAAT3 is
represented by fluorescence intensity which is defined as the total sum intensity
within the dorsal horn spinal cord (identified as a region of interest (ROI)) divided
by the area of the ROI. An interaction between surgery and exposure is seen for
both EAAT1 and EAAT2 but not EAAT3 [EAAT1, F1,21 =8.788, p = 0.0074;
EAAT2, F1,18 = 5.058, p = 0.0373; EAAT3, F1,19 = 0.3217, p = 0.5772]. Sac control
rats demonstrate an increase in EAAT1 but not EAAT2 expression following
minor CCI. Interestingly, PAE alone upregulates both EAAT1 and EAAT2
expression compared to Sac rats. Applying minor CCI to PAE rats downregulates
expression of EAAT1 and EAAT2. No significant differences are seen in EAAT3
expression. Asterisks indicate p < 0.05. The data are presented as the mean ±
SEM.
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Figure 5

Figure 5. PAE does not alter the phosphorylation of NR2B.The ratio of
protein expression of phosphorylated NR2B by total NR2B within the ipsilateral
dorsal horn spinal cord was determined using western blot. No significant
differences are seen between groups in that no main effects of treatment
[EAAT1, F1,16 =0.1602, p = 0.6944] are observed. No significant increases were
observed as a result of PAE. Additionally, no significant differences are seen as a
result of minor CCI. The data are presented as the mean ± SEM.
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Chapter 5 – Discussion

Specific Aim 1: Determine whether PAE generates life-long
spinal glial and peripheral immune dysregulation resulting in
susceptibility to allodynia

Prior reports demonstrate that PAE results in altered neuroimmune
function (Kane et al., 2011; Topper et al., 2015; Noor et al., 2017). More
specifcally, glial function is altered within the brain which coincides with
increased expression of IL-1 (Topper et al., 2015). Furthermore, peripheral
immune responses show heightened reactivity (Noor et al., 2017). Similarly, PAE
increased severity and duration of infection as well as increased vulnerability to
developing autoimmune disorders (Chiapelli and Taylor, 1995; McGill et al.,
2009).
Conditions that are exacerbated by PAE suggests that other chronic CNS
diseases with an underlying neuroinflammatory mechanism could also be
worsened. Therefore, we used a model of CCI in middle aged rats that have
moderate PAE. Applying a standard 4-suture CCI demonstrated potentiated
allodynia compared to healthy Sac controls, which coincided with heigthened
spinal glial responses. Additionally, peripheral immune responses were amplified,
suggesting that PAE primes the immune system resulting in increased reactivity
following secondary insult. This led me to hypothesize that PAE may increase
susceptibility to allodynia by priming spinal and peripheral immune responses
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such that significantly reduced damage to the sciatic nerve, a minor 1-suture CCI,
would unmask the deleterious effects of PAE on pain processing. Thus, Aim 1
tested the hypothesis that applying a minor sciatic nerve injury results in
allodynia and glial activation only in PAE rats.
The major findings of this aim include: 1) the effects of PAE are life-long; 2)
significantly reducing the damage to the sciatic nerve from a standard 4-suture
CCI to a minor 1-suture CCI induces allodynia; 3) minor CCI induces only spinal
astrocyte activation but not microglial activation; 4) surgically naïve peripheral
immune NK cells of PAE rats are altered within the lymph node and peritoneal
exodate; 4) PAE alters myeloid cells within the spleen and lymph node; and 6)
stimulation by PMA/io or LPS reveals heigthened expression of both TNF and IL1 in peripheral leukocytes of PAE rats compared to Sac rats. Collectively, these
data demonstrate that PAE heigthens the susceptibility to developing
pathological pain. The data suggest that increased suscpetibility is a result of
hieghtened immune reactivity within spinal astrocytes as well as peripheral
immune cells. Furhtermore, the effects of PAE were life-long in that a standard
CCI resulted in potentiated allodynia which coincided with heightened glial
immune respones. This data supports findings from

a prior report

where

moderate PAE generated increased allodynia (Noor et al., 2017). Overall, the
data show that PAE alters both peripheral and spinal immune responses that
lead to life-long susceptibility to developing pathological neuropathic pain.
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Specific Aim 2: Determine whether susceptibility to allodynia
from PAE is mediated by spinal and peripheral immune cytokine
dysregulation

Findings from Aim 1 demonstrate that reducing the damage to the sciatic
nerve unmasked the effects of PAE, where astrocyte activation is altered and
stimulation of immune cells revealed heightened reactivity as measured by
proinflammatory cytokine production, IL-1 and TNF-. Consequently, I
investigated whether utilizing a minor 1-suture CCI (referred to as a minor sciatic
nerve damage) would reveal specific PAE immune cell responses not only in the
damaged sciatic nerve, but also in the sensory ganglia (DRG) and the dorsal
horn of the spinal cord.
Recent studies have demonstrate that PAE alone is able to increase the
expression of both the chemokine CCL2 as well as the -2 integrin LFA-1.
Interestingly, CCL2 alters the surface receptor ICAM-1 which is the ligand for
LFA-1 expressed on peripheral immune cells (Dustin and Springer, 1988). This
ultimately aids in the migration of peripheral leukocytes into the spinal cord which
aid in the induction of allodynia (Sweitzer et al., 2002). Interestingly, LFA-1 alters
the expression of IL-10 (Labuda et al., 1998; Emoto et al., 2003). In support of
this, a separate study used a macrophage cell line (RAW 267 cells) and
demonstrated that incubating these cells with an LFA-1 antagonist prior to LPS
stimulation

resulted

in

heightened

IL-10

responses

and

decreased

proinflammatory cytokine expression (Lam et al., 2014). Curiously, rebound IL-10
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expression was blunted both at the sciatic nerve and the DRG only in PAE rats
following CCI (Noor et al., 2017). Taken together the data suggest that PAE may
heighten susceptibility to allodynia by altering the spinal immune profile
potentially through the actions of LFA-1 expression. Thus, Aim 2 tested the
hypothesis that PAE alters proinflammatory immune reactivity leading to
increased susceptibility to developing pathological pain.
The major findings of this aim include: 1) induced allodynia in PAE rats
with minor CCI is enduring at least until Day 28; 2) the LFA-1 antagonist, BIRT377, reverses allodynia where peak drug efficacy is seen at Day 4 post i.t.
injection; 3) glial activation and IL-1 expression is decreased as a result of LFA1 antagonism; 4) within the DRG, minor CCI heightens SGCs and IL-1
expression, although PAE alone blunts normal IL-10 responses; 5) PAE alone
alters LFA-1 expression; 6) IL-1 is necessary in the induction of allodynia
following minor CCI; 7) LFA-1 antagonism may work through TNFα expression in
vivo; 8) CXCL1 mRNA is significantly upregulated in PAE rats with minor CCI
compared to Sac rats within the ipsilateral sciatic nerve and DRG; 9) and LFA-1
antagonism alters CCL2 expression. Together these data support the idea that
PAE increases LFA-1 and antagonizing its activation results in reversal of PAE
induced sensitivity to allodynia. Furthermore, the data demonstrate the induction
of allodynia following minor CCI in PAE rats could be a result of heightened
expression of IL-1 in addition to a blunted IL-10 response. This report also
establishes specific chemokines that may be altered as a result of PAE.
Specifically, CXCL1 and CCL2 are significantly altered. This could point toward a
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role for peripheral leukocytes in the induction of allodynia. Interestingly, this work
sheds light on the contribution that the DRG may have in the induction of PAE
susceptibility to allodynia. More specifically, the mechanisms may be via the
actions of proinflammatory cytokines. For example, IL-1 expression was
significantly upregulated whereas normal IL-10 responses were blunted in PAE
rats. In addition, SGCs in PAE rats showed significant activation compared to
healthy Sac rats following minor CCI. Overall, the data demonstrate that PAE
may induce susceptibility to allodynia by altering specific immune factors such as
glial cells, SGCs, LFA-1, IL-1β or IL-10both peripherally and in the spinal cord.

Specific Aim 3: Determine whether PAE-induced susceptibility to
allodynia is due to altered astrocyte glutamate transporter
function

The data from Aim 1 as well as Aim 2 demonstrate a significant alteration in the
activation of astrocytes. This may explain how PAE induces allodynia following
minor challenges such as CCI. As mentioned previously, three glutamate
transporters are responsible for clearing glutamate that is released during CCI,
and are responsible for minimizing neuronal hyperexcitabilty (inclusive of pain
projection neurons). These transporters include GLT-1, EAAC1, and the
astrocyte specific transporter GLAST (Furuta et al., 1997). Prior studies show
that following CCI, an initial upregulation followed by a downregulation in
glutamate transporter expression below basal levels, occurs by Day 7 post166

surgery (Sung et al., 2003). This study also inhibited the function of these
transporters. Interestingly, by inhibiting the function of GLT-1 and EAAC1, only a
slight increase in allodynia compared to controls is observed. Strikingly, not until
GLAST is also inhibited that potentiated allodynia is seen (Sung et al., 2003).
This potentiation is similar to what is seen in PAE rats with a standard CCI (Ch. 1
Fig. 1 and 3), suggesting that susceptibility to allodynia may be a result of
altered astrocyte responses to increased extracellular glutamate, as GLAST is
exclusively expressed on astrocytes. In support of GLAST dysfunction in this
model of neuropathy, prior reports have shown that PAE alone is able to
downregulate the expression of GLAST resulting in decreased uptake of
glutamate within the hippocampal slices (Brolese et al., 2015). Thus, Aim 3
tested the hypothesis that PAE alters glutamate transporters resulting in
heightened susceptibility to developing neuropathic pain.
The major findings of this aim are: 1) inhibition of GLAST function in PAE
rats with sham surgery (i.e. rats lacking neuropathy) results in allodynia; 2) no
allodynia is induced in Sac rats with sham surgery; 3) applying a minor injury to
PAE rats and inhibiting GLAST results in potentiated allodynia similar to that
observed in PAE rats with greater CCI; 4) Sac rats with minor injury and GLAST
inhibition results in the induction of allodynia; 5) PAE does not alter mRNA
expression of glutamate transporters; 6) non-neuronal GLT-1 and GLAST but not
the neuronal specific transporter EAAC1 are upregulated as a result of PAE
alone; 7) PAE does not alter phosphorylation of the NR2B (not expressed on glia)
within the spinal cord. This data sheds light on the potential effects that PAE may

167

exert on the clearance of glutamate from the synapse. More specifically, the data
demonstrate increased susceptibility to allodynia is due to a combination of
several discrete factors. For example, if glial and not neuronal glutamate
transporter function is altered due to PAE, it may result in large accumulations of
glutamate within and around the synapse in the spinal cord region responsible for
relaying pain signals. Glutamate accumulation may lead to exaggerated
responses of primed glial cells that is disproportionately greater than the initiating
stimulation (e.g. minor injury). Activation of primed glial cells results in
heightened release of the classic pro-nociceptive cytokine, IL-1β as well as other
proinflammatory factors such as TNFα. Considering PAE alone alters LFA-1
shown to influence IL-10 responses, these animals may not be able to mount a
healthy anti-inflammatory response. As a result, induction of allodynia following
minor injury may be due to a global dysregulation of IL-10 responses. Thus,
future studies need to focus on neuronal vs. glial glutamate release and
consequent changes in LFA-1 expression alongside astrocyte activation to
identify novel targets of adverse neuroinflammatory processes in FASD adults
and children.
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Discussion
How does PAE lead to enhanced susceptibility to allodynia?
Figure 1.

Figure 1. Dorsal horn spinal cord under healthy non-pathological
conditions. Under basal conditions both microglia and astrocytes are not
reactive. Proinflammatory cytokines such as IL-1β and TNFα remain as inactive
precursors within glial cells. In addition to this, any glutamate that is released into
the synapse is cleared using the glutamate transporters GLT-1, EAAC1, and
GLAST. Glutamate receptors AMPA, Kainate, and NMDA remain silent.
Furthermore, magnesium remains bound to NMDA receptors preventing
depolarization. This homeostasis is maintained until a peripheral nerve injury
occurs.

During healthy non-pathological conditions where peripheral nerve
damage is not present, microglia and astrocytes are non-reactive. Both of these
glia continue to survey the environment and proinflammatory cytokines such as
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IL-1β and TNFα and the anti-inflammatory IL-10 remain in their inactive forms. If
glutamate is released from the pre-synaptic afferent terminal, glutamate
transporters such as GLT-1, EAAC1, and GLAST will clear glutamate from the
synapse. This prevents glia from becoming activated and depolarization of AMPA
and Kainate receptors does not occur (Ch. 5 Fig. 1). Ultimately, glutamate is not
continuously present and the immune response does not occur thus, painful
stimuli are not felt.
Data show (Ch. 2 Fig. 1, Ch. 3 Fig. 1, and Ch3. Fig. 7) that normal
sensitivity is maintained in healthy Sac rats with minor 1-suture CCI. When
incoming noxious stimuli comes from the periphery, glutamate is released in the
synapse. This results in activation of microglia and astrocytes which then release
IL-1β and TNFα within the spinal cord (Ch. 2 Fig. 2, Ch. 3 Fig. 2, and Ch. 3 Fig.
3). Furthermore, glutamate binds AMPA receptors resulting in activation and
depolarization of the post-synaptic membrane of pain projection neurons via
sodium ions entering the cell. Compensatory upregulation of IL-10 as well as
GLT-1 and GLAST occurs (Ch. 4 Fig. 3). This inhibits the actions of IL-1β and
TNFα and it results in clearance of glutamate from the synapse stopping AMPA
receptor depolarization. These mechanisms prevent NMDA receptors from
becoming phosphorylated and magnesium is maintained keeping these receptors
silent. This ultimately maintains normal sensitivity in Sac control rats (Ch. 5 Fig.
2).
In contrast, when minor 1-suture CCI is applied to PAE rats robust allodynia is
induced (Ch. 2 Fig. 1, Ch. 3 Fig. 1, and Ch. 3 Fig. 7). Additionally, data show
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Figure 2

Figure 2. Compensatory mechanisms prevent the induction of allodynia
following minor CCI in Sac controls rats. Applying a minor injury to healthy
Sac control rats results in release of glutamate from the pre-synaptic afferent
terminal. Glutamate binds AMPA and Kainate receptors on the post-synaptic pain
projection neuron. Additionally, glutamate activates microglia and astrocytes
resulting in the release of IL-1β and TNFα. These cytokines will bind their
receptors on pain projection neurons and other nearby glia. To compensate for
this response, glia will release the anti-inflammatory IL-10. Additionally,
glutamate transporter expression is upregulated. IL-10 inhibits the
proinflammatory response and glutamate is cleared from the synapse by
glutamate transporters. These compensatory mechanisms prevent the
magnesium block on NMDA receptors from coming off, which ultimately prevents
the induction of allodynia.

that PAE primes astrocytes (Ch. 2 Fig. 2 and Ch. 3 Fig. 2), suppresses healthy
IL-10 responses (Ch. 3 Fig. 3), upregulates LFA-1 expression (Ch. 3 Fig. 4), as
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well as glutamate transporters (Ch. 4 Fig. 3) within the spinal cord. Thus, it is
possible that when minor CCI is applied, glutamate binds AMPA and Kainate
receptors. AMPA receptor expression is increased with the activation and
depolarization of the cell membrane on pain projection neurons (Henley and
Wilkinson, 2013). Activation of both microglia and primed astrocytes occurs
resulting in the release of IL-1β and TNFα. In addition to this, upregulated LFA-1
expression amplifies the release of proinflammatory cytokines potentially through
the Src family of kinases. The compensatory IL-10 response is severely blunted
in PAE rats which allows for the proinflammatory environment to persist long
after the injury occurs. These cytokines will then activate other nearby glia and
bind their receptors on post-synaptic pain projection neurons. In addition to this,
dysregulated glutamate transporters are quickly downregulated as a result of
proinflammatory cytokine release leading to accumulation of glutamate in the
synapse. IL-1β binding its receptor on pain projection neurons leads to
phosphorylation of NMDA receptor subunits through the Src family kinases
leading to a decreased affinity for magnesium (Zhou et al., 2011). Finally, influx
of sodium through AMPA receptors leads to strong depolarization of the pain
projection neuron cell membrane leading to the release of magnesium (Zhou et
al., 2011). Ultimately strong depolarization of glutamate receptors in addition to
AMPA receptors occur leading to the induction of allodynia in PAE rats with
minor CCI (Ch. 5 Fig. 3).
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Figure 3.

Figure 4. PAE results in alteration of glial mechanisms leading to
susceptibility to developing allodynia. PAE results in priming of astrocytes
and upregulation of glutamate transporters and LFA-1 expression. Thus, when a
minor injury is applied, glutamate is released into the synapse where it binds
AMPA and Kainate receptors and activates glial cells. Microglia and astrocytes
will release IL-1β and TNFα. LFA-1 upregulation leads to a heightened
proinflammatory environment by further increasing the release of IL-1β and
TNFα. In addition to this, the normal compensatory upregulation of IL-10 is
suppressed potentially through LFA-1 mediated mechanisms. These events
result in glutamate transporters to downregulate their expression leading to
accumulation of glutamate into the synapse. This leads to further activation of
glia cells as well as phosphorylation of NMDA receptor subunits. Additionally,
AMPA receptor expression is increased leading to strong depolarization of the
pain projection neuron cell membrane. These events lead to magnesium to be
released from NMDA receptors. Ultimately, strong depolarization from through
AMPA and NMDA receptors occurs resulting in the induction of allodynia.
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PAE blunts normal IL-10 responses
My data demonstrate that PAE results in blunting normal IL-10 responses
in both the spinal cord (Ch. 3 Fig. 3d and 5c). It is possible that a combination of
increased proinflammatory cytokines with blunted IL-10 may be responsible for
induction of allodynia in PAE rats (Ch. 3 Fig. 1 and Fig. 7). This raises questions
as to what alterations does PAE have leading to blunted IL-10. Previous reports
demonstrate mechanisms by which IL-10 is upregulated. Although speculative it
is possible that PAE could alter one or all of these mechanisms. For example, IL10 has been shown to be produced through stimulation of toll like receptor (TLR)
2 as well as the pattern recognition receptor (PRR), dectin (Saraiva and O'garra,
2010). Although no data have demonstrated the effects of PAE on these specific
receptors, previous reports do show significant alteration of the TLR4 leading to
upregulation of proinflammatory factors (Pascual et al., 2017). This would
suggest that PAE could potentially alter both TLR2 and dectin.
In addition to this, upregulation of LFA in PAE rats (Ch. 3 Fig. 4) could
also potentially influence IL-10 responses. Previous reports show that LFA-1
knockout animals demonstrate changes in their expression of IL-10 (Emoto et al.,
2003). Furthermore, a separate study shows that stimulation of the ICAM1, the
ligand for LFA-1, suppressed the IL-10 responses (Labuda et al., 1998). In
support, of these studies our lab utilized an in vitro study to demonstrate the
antagonizing LFA-1 results in decreased proinflammatory factors in combination
with increases in IL-10 expression following LPS stimulation (data not shown).
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These data provide evidence for LFA-1 mediated mechanisms involved in IL-10
expression.
Previous reports suggest that PAE alters the transcription factors (Ogony
et al., 2013). Thus, PAE could potentially change IL-10 expression levels through
alteration of various transcription factors. More specifically, specific protein 1
(SP1) (Brightbill et al., 2000), CCAAT/enhancer binding protein – β(Brenner et al.,
2003), IFN- regulatory factor 1 (IRF1) and STAT3 (Ziegler-Heitbrock et al., 2003)
all control IL-10 production. Thus, PAE may blunt normal IL-10 responses by
affecting the function of any of these transcription factors.
Interestingly, PAE can disturb micro RNA (miR) function (Wang et al.,
2008). Previous reports demonstrate that IL-10 expression is influenced by miR466I (Ma et al., 2010) which works through the TLR pathway. Thus, it is possible
that PAE could alter miR in order to influence IL-10 expression. Overall, the data
present intriguing evidence as to potential mechanisms that PAE alters in order
to influence IL-10 which leads to susceptibility to developing allodynia.

PAE rats do not display increased sensitivity at BL or following
sham surgery
Interestingly, prior reports discuss sensitivity to light touch in children with
FASD (O'Malley, 2007). In support of this, a separate study demonstrates that
alcohol alone is able to alter sensitivity to light touch in primate models of FASD
(Schneider et al., 2008). Curiously, in our PAE rats, no significant differences are
demonstrated at BL or after sham surgery. Based on the literature, we would
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hypothesize that rats may demonstrate initial sensitivity as a result of PAE. It is
not until a second insult is applied that the effects of PAE are unmasked. This
leads to the question of why neuroimmune differences as a result of PAE alone
are not observed.
Clinically, children with PAE demonstrate altered immune function
(Johnson et al., 1981). More specifically, lymphocyte formation is altered in
children with FASD. Studies using animal models of FASD without a secondary
insult also show immune alteration (Noor et al., 2017). My data demonstrate that
in PAE rats with sham surgery display blunted expression of IL-10 within the
DRG. As mentioned previously, during the induction of allodynia, glial cells
become activated and the expression of IL-1 is increased. This increase in
proinflammatory factors is not observed following sham surgery. Thus, although
PAE does alter certain factors of the immune system, the critical factors such as
astrocytes, microglia, and IL-1β involved in the disruption of sensory processing
are not affected. This potentially explains the reason why no sensitivity is seen in
our rats that are moderately exposed to alcohol.
In addition to this, many clinical studies of FASD primarily focus on
children that have fetal alcohol syndrome (FAS). These children are commonly
exposed to high levels of alcohol where women are drinking daily and/or binge
drinking multiple times during pregnancy (Jones and Smith, 1973). This would
lead one to believe that the amount of alcohol exposure may also result in
increased sensitivity to touch in children with severe FAS. Additionally, it is
possible that the high levels of alcohol could serve as a secondary insult to an
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FAS child which elicits the effects of PAE. In support of this, previous studies
utilizing binge alcohol exposure during the third trimester demonstrate glial and
proinflammatory cytokine responses only during withdrawal periods (Topper et al.,
2015). Thus, it is possible that even though no sensitivity is seen following a
moderate PAE, sensitivity would be demonstrated in a binge ethanol exposure
during withdrawal periods. This model may more accurately depict what is seen
in the clinic using children with FAS.

Does PAE lead to long-lasting allodynia following minor CCI
Results show that PAE causes an increased severity and duration of
influenza infection (McGill et al., 2009). This may be a result of the heightened
reactivity seen within glial cells as well as peripheral immune cells in PAE, as
supported by animal studies (Noor et al., 2017; Sanchez et al., 2017). These
studies demonstrate that PAE leads to potentiated allodynia when a standard
CCI is applied (Ch. 1 Fig. 1), but do not characterize the entire allodynic
timecourse. These studies only assessed behavior until Day 28 (Ch. 1 Fig. 3).
Taken together, this may suggest that PAE could potentially result in long-lasting
allodynia in comparison to healthy controls.
Previous studies from our lab characterizing the time-course following
standard CCI in healthy rats demonstrate that allodynia can persist up to about
90 days (data not shown) which may coincide with the absorption rate of chromic
gut sutures used in CCI (ethicon.com). In addition to this, astrocytes mediate the
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maintenance of allodynia (Gao et al., 2010a). Considering my data demonstrates
that PAE may work primarily through alteration of astrocytes (Ch. 1 Fig. 2 and
Ch. 2 Fig. 1), PAE may lead to long-lasting allodynia following both a standard
and minor CCI. Future studies should fully characterize the duration of allodynia
following both a standard and minor CCI.

Potential sex differences in PAE and neuropathic pain
Interestingly, previous reports demonstrate sex differences in both neuropathic
pain processing and in PAE. Clinically, observations demonstrate that women
tend to be more at risk for chronic pain (Rosen et al., 2017). Additionally, women
tend to experience pain differently than men in that they rate their pain higher
and also have lower pain tolerance (Mogil et al., 1993). These reports suggest
that mechanisms underlying sex differences may involve neuroimmune
processes during chronic neuropathic pain conditions.
Previous reports that investigate the role of peripheral immune cells in the
induction of allodynia found that a combination of glia in the spinal cord as well
as T-cells facilitate the induction of allodynia (Sweitzer et al., 2002; Milligan and
Watkins, 2009). Additionally, when T-cell deficient mice were used, allodynia was
reduced (Cao and DeLeo, 2008; Costigan et al., 2009b). Despite these
observations, female mice do not require microglia for allodynia to develop
(Sorge et al., 2015). Furthermore, neuropathic females reveal peripheral
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leukocytes such as T-lymphocytes (T-cells) tend to play a greater role in
neuroimmune interactions during the induction of allodynia (Sorge et al., 2015).
Thus, sex differences likely exist in neuropathic pain processing, and importantly,
results found in males may not apply to females. This is an important
consideration because drugs developed to target chronic neuropathic pain have
almost exclusively been studied in preclinical male models.
In addition to these findings, sex differences are demonstrated in PAE.
Generally, sex differences are observed in social recognition memory (Kelly et al.,
2009). Additionally, differences are observed in long-term potentiation in the
hippocampus of males and females (Sickmann et al., 2014). Furthermore,
differences are seen in reversal learning in FASD males compared to females
(O'Leary-Moore et al., 2006). With regard to immune modulation, some studies
show sex differences following PAE. More specifically, females show increased
neuroinflammation in that they demonstrate heightened expression of CCL2, and
in macrophage inflammatory protein-1α (MIP-1α) (Pascual et al., 2017). Taken
together, these data suggest that PAE does result in global sex differences that
include immune function. In addition, it is possible that sex differences may be
observed in my work which combines both PAE and neuropathic pain processing.
As mentioned previously, PAE males have T-cell mediated deficits.
Considering that a lack of T-cells has been shown to reduce allodynia, one would
hypothesize that PAE males might demonstrate reduced allodynia following CCI.
Interestingly, my data do not support this hypothesis (Ch. 1 Fig. 1). It is possible
that the heightened glial response within both the sciatic nerve and within the
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spinal cord is sufficient to prevent this reduction in allodynia. In contrast, one
might predict heightened allodynia in PAE females. Considering PAE females
show heightened expression of the chemotactic cytokine CCL2, one might
predict that there is heightened infiltration of peripheral leukocytes into the spinal
cord. Interestingly, no change in allodynia is observed following a standard CCI
(Ch. 5 Fig. 1). Furthermore, when a minor injury is applied to PAE and Sac
females and behavioral responses are assessed up to Day-28 post-surgery, no
significant increases are observed in female PAE rats compared to males (Ch. 1
Fig. 3 and Ch. 5 Fig. 1). I hypothesize that allodynia is not elevated in females
with CCI because neuroimmune mechanisms in females are primarily due to the
actions of peripheral leukocytes and not on spinal glial activation. Thus, a
heightened peripheral leukocyte response may be sufficient to induce normal
allodynic responses.
Considering Aim 2 focused solely on male PAE rats to examine the effects
of an i.t. LFA-1 antagonist on allodynic responses and proinflammatory and antiinflammatory cytokine network, it may be possible that differences in the effects
of the LFA-1 antagonist, BIRT377, might be observed in PAE female rats with
CCI. In order to investigate this, I did an i.t. injection of BIRT-377 in female PAE
and Sac rats at Day 28 post minor CCI surgery (Ch. 5 Fig. 1a-b). Strikingly, PAE
females did not return to normal sensitivity like the PAE male rats (Ch. 3 Fig. 1).
This data suggests that inducing an anti-inflammatory environment in the spinal
cord by inhibiting LFA-1 activation on microglia is not sufficient to attenuate
allodynia in females. Furthermore, peripheral leukocyte infiltration into the spinal
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Figure 4

Figure 4. Allodynic female rats return to normal sensitivity only following
i.v. injection of BIRT-377. Behavioral responses for both ipsilateral and
contralateral hindpaw for i.t. injection (a-b) and i.v. injection (c-d) of BIRT-377.
(a)At baseline (BL), behavioral responses were similar amongst all Sac and PAE
groups (ipsilateral, F1,18 = 0.001, P = 0.975, contralateral, F1,18 = 0.032, P =
0.860). Following CCI surgery, Sac rats with standard CCI develop robust
bilateral allodynia where a main effect of surgery (ipsilateral, F1,6 = 100.131, P <
0.0001, contralateral, F1,6 = 50.070, P < 0.0001) is seen. PAE rats with minor CCI
develop sensitivity only in the ipsilateral hindpaw comparable to Sac standard
CCI rats in that no significant differences are seen between groups (ipsilateral,
F1,10 = 0.143, P = 0.713, contralateral, F1,9 = 69.905, P < 0.0001). Following i.t.
injection, allodynic PAE rats do not return to normal sensitivity in that no
significant differences are seen between vehicle and BIRT-377 injected groups
(ipsilateral, F1,6 = 5.826, P = 0.052, contralateral, F1,6 = 0.062, P = 0.812).
Similarly Sac rats with standard CCI do not return to normal sensitivity as no
significant differences were observed when compared to PAE rats with BIRT-377
in the ipsilateral hindpaw (ipsilateral, F1,6 = 5.124, P = 0.064, contralateral, F1,36 =
49.759, P < 0.0001).(b) A separate group of PAE and Sac rats were assessed
prior to surgery and show no significant differences at baseline (ipsilateral, F 1,36 =
0.018, P = 0.895, contralateral, F1,36 = 0.562, P = 0.458). Following surgery, a
main effect of exposure in the ipsilateral hindpaw was observed (ipsilateral, F 1,36
= 308.383, P < 0.0001, contralateral, F1,36 = 0.153, P = 0.698), a bilateral effect of
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surgery (ipsilateral, F1,36 = 651.198, P < 0.0001, contralateral, F1,36 = 464.695, P
< 0.0001), and a bilateral interaction between exposure and surgery (ipsilateral,
F1,36 = 98.005, P < 0.0001, contralateral, F1,36 = 6.345, P = 0.016) is seen. PAE
minor CCI rats develop unilateral allodynia whereas Sac standard CCI rats
develop bilateral allodynia up to day 28 post-surgery (ipsilateral, F1,36 = 103.967,
P <0.0001, contralateral, F1,36 = 5.942, P = 0.020). Following i.v. injection, PAE
minor CCI and Sac Standard CCI rats return to normal sensitivity up to day 4
post-injection (ipsilateral, F1,36 = 58.633, P < 0.0001, contralateral, F1,36 = 54.229,
P < 0.0001).

cord might not be altered as a result of LFA-1 antagonism within the spinal cord.
One can consider that the leukocytes primarily involved in inducing allodynia in
females, which despite inhibiting LFA-1 in the spinal cord, are producing
sufficient expression of proinflammatory factors; leukocytes that have already
migrated to the spinal cord and are responsible for generating allodynia. This is
supported through prior studies showing that compared to males, females have a
two-fold higher T-cell population (Scotland et al., 2011; Sorge et al., 2015). Thus,
rather than altering glial cell activation, it may be possible to reverse allodynia by
inhibiting infiltration of peripheral leukocytes.
This hypothesis was explored in a separate group of female rats. At Day
28 after minor CCI surgery, females received an intravenous (i.v.) injection of
BIRT-377 and behavior was assessed up to Day 4 post injection based on
previous male studies (Ch. 3 Fig. 1 and Ch. 5 Fig. 1). Interestingly, following i.v.
injection, female PAE rats reveal reversal of allodynia similar to male rats where
max reversal was seen at Day 4 post-injection (Ch. 5 Fig. 1c-d).
Two potential explanations for the reversal of allodynia exist. As is
observed with the males, it is possible that injecting an LFA-1 antagonist results
in peripheral leukocytes to take on a greater anti-inflammatory phenotype (anti182

inflammatory bias) where these cells expressed more IL-10 than IL-1β amongst
other factors. Additionally, it is possible that the migration of peripheral
leukocytes is significantly decreased as a result of inhibiting the activation of
LFA-1. Considering LFA-1 is not the only adhesion molecule involved in
peripheral leukocyte migration, the former hypothesis might be more feasible.
Overall, these data as well as previous reports support the idea of sex
differences in both PAE and neuropathic pain and warrant further explanation.

A

role

for

adverse

in

utero

conditions

and

increased

suscpetibility to neuropathic pain
Studies have focused on the effects of prenatal events and their relation to
increasing risk for problems later in life (Gluckman et al., 2008). For example,
premature birth has been shown to increase risk for developing diabetes
(Hofman et al., 2004) where premature birth can occur as a result of adverse in
utero conditions such as infection in the mother during pregnancy, stress, or
even smoking (Gravett et al., 2010). Additionally, animals subjected to hypoxia
are more susceptible to infarction during ischemia (Li et al., 2003). Interestingly,
immune system deficits are demonstrated following adverse in utero conditions.
Recent studies demonstrate that immune system reactivity is altered
following

insult

during

gestation.

Reports

using

an

animal

model of

chorioamnionitis, which is inflammation of the fetal membrane, show heightened
reactivty of both astrocytes and microglia (Jantzie et al., 2014). This would
suggest that adverse in utero conditions such as chorioamnionitis might render
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one susceptible to immune mediated pathological issues later in life. In support of
this notion, my data demonstrates that PAE rats have an increased susceptibility
to developing neuropathic pain (Ch. 2 Fig. 1). In addition, my data demonstrate
that the effects are not only present in young adult PAE rats (Fig. 1) but also in
middle aged rats (Ch. 2 Fig. 1), suggesting that the effects of PAE are life-long.
Additionally, glial activation is significantly increased compared to controls in both
young adult and middle aged rats following a standard CCI. Together, these data
suggest that adverse in utero conditions can render one more susceptible to
developing pathological disorders later in life.

Utilizing transgenic animals to explore the effects of PAE on
neuroimmune processing
Many studies presented in this dissertation focus solely on the effects of
PAE on adult rats but not mice, limiting my ability to use transgenics to explore
the effects of PAE on neuroimmune function. The current focus of the lab has
shifted towards replicating allodynia following a minor injury in PAE mice. If this
effort proves suscessful, knockout (KO) mice could be used to explore how
knocking out certain immune factors could result in PAE induced sensitivity to
light touch. For example, my data demonstrates the PAE results in blunted IL-10
expression within the DRG and the spinal cord (Ch3. Fig 3 and 5). Thus, the
question of whether loss of normal IL-10 expression could be explored utilizing
IL-10 KO mice with a minor injury. Comparison of PAE IL-10 KO, healthy IL-10
KO, as well as wild type (WT) controls would shed light on whether IL-10 is a
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major player in allodynia folling minor CCI. Additionally, IL-1β KO mice could
further support whether IL-1β is necessary to induce allodynia in PAE animals.
Furthermore, the question of whether LFA-1 could be used as a potential
therapeutic can be explored throgh LFA-1 KO mice. These studies would limit the
question of whether off target effects of using drugs to inhibit factors such as IL1β or LFA-1 activation could be causing an effect on the results that I have
demonstrated. Thus, the use of transgenic animals could prove to be a powerful
tool to fully explore how PAE renders one susceptible to developing neuropathic
pain as well as other disorders.

Does PAE induce susceptibility to neuropathic pain through
alteration neuronal mediated mechanisms
During neuropathic pain conditions, glutamate is released from the
presynaptic terminal. This gluamate can bind the ionotropic receptors α-amino-3hydroxy-5-methyl-isoxazole propionic acid (AMPA), Kainate, and N-methyl-Daspartate (NMDA) receptors. As mentioned previously, NMDA receptors do not
depolarize because they are kept inactive to cation influx by a magnesium plug
(Latremoliere and Woolf, 2009). It is not until central senzitization occurs that
magnesium comes off and the induction of allodynia occurs (Milligan and
Watkins, 2009). Studies on NMDA receptors demonstrate a role for the subunit
NR2B induction of allodynia (Huang et al., 2018). They showed that
phosphorylation of NR2B is increased folllowing CCI (Huang et al., 2018).
Additionally, Huang and colleagues demonstrate that antagonizing NR2B
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attentuated neuropathic pain. These studies demonstrate a critical role for the
activation of NMDA receptor subunits in the induction of neuropathic pain.
In addition, glutamate can also bind metabotropic glutamate receptors
(mGluRs) which are G-protein-coupled receptors (Masu et al., 1991). These
receptors regulate cell excitability and synaptic transmission (Montana and
Gereau, 2011). Three groups of mGluRs have been implicated in pain
processing (Montana and Gereau, 2011). These receptors are expressed within
the dorsal horn spinal cord where they communicate with sensory neurons
projecting from the periphery (Montana and Gereau, 2011). Furthermore, these
receptors are expressed on DRG cell bodies in rats (Carlton and Hargett, 2007).
The ERK signaling pathway, which is necessary for allodynia, is activated by
Group 1 mGluRs (Carrasquillo and Gereau, 2007). Additionally, upregulation of
Group 2 mGluRs induces sensitivity (Chiechio et al., 2002). Although Group 3
mGluRs play a role in pain, their exact function is still unclear (Montana and
Gereau, 2011). Thus, it is possible that increased susceptibility to developing
pathological pain could be a result of PAE altering the expression or function of
either ionotropic or metabotropic glutamate receptors. It is important to point out
that these are expressed on neurons and are ciritical for pain sensitization.
Studies that have explored the effects of PAE on NMDA receptors find
significant decreases in the expression of NR2B within the dentate gyrus (Brady
et al., 2013). A separate report demonstrates that the altered expression of
NR2B in PAE rats seems to be region specific within the brain (Bird et al., 2015).
Interestingly, this study found that excitatory post synaptic currents (EPSCs) are
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reduced in PAE rats compared to controls (Bird et al., 2015). Furthermore, this
study demonstrated no significant differences in expression of mGluR5
expression (Bird et al., 2015). In contrast, a separate study demonstrates that
PAE reduced the expression and function of mGluR5 within the dentate gyrus
(Galindo et al., 2004). Thus, it is possible that the effects of PAE on mGluR may
be region specific. Unfortunately, the effects of PAE on mGluR and NR2B
expression within the spinal cord have not been charactered. This makes it
difficult to predict whether PAE alters expression of these two factors, which may
aid in the induction of allodynia. While speculative, a decrease in NR2B as a
result of PAE may lead to decreased allodynia following CCI. The fact that less
NR2Bs are present could mean that less NMDA receptors become depolarized
leading to decreased pain signals that are relayed to spinal pain projection
neurons. Interestingly, changes in NR2B is not observed in my data (Ch. 1 Fig. 1,
Ch. 2 Fig. 1, and Ch.3 Fig. 1), arguing that NR2B is not affected in the spinal
cord of PAE rats. Similarly, a decrease in mGluR expression would argue for
decreases in allodynia in PAE rats. This effect is not seen within our behavioral
data. Although this is true, it is possible that both NR2B and mGluRs could be
either located on or aiding in communication with glial cells resulting in their
activation.
Previous studies link neuronal NR2B subunits on NMDA receptors to
astrocyte activation (Kato et al., 2006). This study demonstrates that when
calcium influx into NMDA receptors was inhibited by NR2B subunit containing
NMDA receptor antagonist that the expression of the astrocyte activation marker
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GFAP was decreased (Kato et al., 2006). This led the researchers to conclude
that a potential neuron-to-astrocyte signaling pathway exists that is mediated by
NMDA receptors containing the NR2B subunit . Furthermore, a separate study
found that only following insult do the NMDA receptor subunits NR2B and
NR1colocalize with GFAP expression (Krebs et al., 2003). Interestingly, both
these subunits are involved in the induction of neuropathic pain (Ultenius et al.,
2006; Huang et al., 2018). Thus, in combination with our astrocyte data (Ch. 1
Fig. 2a), it is possible that following minor CCI, significant increases in signaling
occurs between astrocytes and NMDA receptors which may potentially explain
PAE induced sensitivity to light touch.
In addition to this, mGluRs are expressed by astrocytes and microglia
(Drouin‐Ouellet et al., 2011). The results of this study demonstrate that utilizing
an NMDA receptor agonist resulted in heightened activation of astrocytes and
microglia, but in addition, they measured increases in mGluR5 expression
(Drouin‐Ouellet et al., 2011). This is further supported in a separate study that
demonstrates disease states result in upregulation of mGluRs as well as
increased glial proliferation and heightened astrocyte activation (Anneser et al.,
2004), suggesting that PAE could potentially alter mGluR expression specifically
on astrocytes. If true, altered mGluR expression may mediate the heightened
reactivity observed following a minor CCI (Ch. 2 Fig. 1 and Ch. 3 Fig. 1). Further
exploration of the effects of PAE in the dorsal horn spinal cord for mGluRs and
NMDA receptor subunits would need to be persued to determine the exact
involvement of these factors during the induction of allodynia.
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Does PAE alter dopamine receptors leading to allodynia
following minor CCI
Dopamine is primarily involved in cognition and reward (Potvin et al.,
2009). Interestingly, reports suggest that dopamine is also involved in pain
processing. More specifically, in patients with Parkinson’s disease (PD), when
dopaminaergic neurons in the substantia nigra are depleted, patients display a
range of pain symptoms (Giuffrida et al., 2005; Tinazzi et al., 2008). Furthermore,
Schizophrenia patients, which display dopaminergic hyperactivity, display
hypoalgesic responses to mechanical stimuli (Blumensohn et al., 2002; Singh et
al., 2006; Potvin et al., 2009). These findings suggest that dopamine and their
receptors may play a considerable role in the induction of neuropathic pain. In
support, clinical studies have utilized dopamine agonists and found that these
drugs reduce hyperalgesia (Altier and Stewart, 1999). A study utilizing dopamine
D5 receptor knockout animals found a reduction in hyperalegic responses (Megat
et al., 2018). It should be noted that much of these studies focus on hyperalgesia
and not allodynia, and therefore, the role of dopamine may not be similar
between the two pathological states. Overall, these data do present evidence to
consider the actions of dopamine underlying spinal neuropathic pain.
Interestingly, recent studies find that astrocytes express D1 dopamine
receptors (Nagatomo et al., 2017). Additionally, this study find that this
expression may be region specific in that stronger co-localization of GFAP and
D1 dopamine receptors is present within the brain (Nagatomo et al., 2017).
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Considering, dopamine receptors, specifically D1 and D2, are expressed within
the dorsal horn spinal cord (Millan, 2002), it is possible that dopamine receptor
expression may only be upregulated following insult, such as after CCI and
augmented following PAE.
Studies that explore the effects of PAE on dopamine receptor expression
are limited. A recent study using a binge prenatal alcohol exposure found that D2
receptor expression is decreased within the pituitary (Gangisetty et al., 2015). A
separate study utilized a moderate PAE and looked at the effects of D1
dopamine receptor expression. This study found the D1 dopamine receptor
binding was increased as a result of PAE whereas this observation is not seen in
females (Converse et al., 2014). Unforunately, few studies explore the effects of
other dopamine receptor subtypes in the spinal cord following prenatal alcohol
exposure.
While limited, data exploring the effects dopamine on PAE and
neuropathic pain are enticing. Clinical observations provide support for a role of
dopamine receptors in neuropathic pain processing. Additionally, studies suggest
that dopamine receptors may be expressed by astrocytes within the spinal cord.
Considering the literature is not conclusive regarding the effects of PAE on
dopamine receptors in the brain, and much less so in the spinal cord, further
exploration is warrented. While speculative, considering I show an alteration of
astrocyte activation following PAE, and literature shows alterations in DA
receptor expression, I hypothesize PAE influences the expression of dopamine
receptors on astrocytic cells. PAE could have direct effects on receptor
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expression and/or function. Overall, this change could potentially make astrocytic
cells more suscpetible to activation following insult such as CCI, whether that be
through dopamine binding or through heightened activation of astrocytes.
Interestingly, studies show that PAE could potentially increase dopamine
binding to its receptor (Converse et al., 2014). Under peripheral neuropathic
conditions, it is possible dopamine receptors on spinal astocytes activate more
readily facilitating heightened astrocyte activation. This would support my data
that shows PAE altering astrocyte activation which is displayed only following
injury. Overall, this provides a compelling rationale to further explore the effects
of spinal dopamine in neuropathic pain processing in animal models of PAE.

PAE as a risk factor for development of neurodegenerative
diseases
Reports demonstrate a role for the immune system during the development of
neurodegenerative diseases. For example, much evidence has been published
showing the involvement of T-cells during the induction of Multiple Sclerosis (MS).
Using

an

animal

model

of

MS

called

experimental

autoimmune

encephalomyeltisis (EAE), researchers are able to determine how the
inflammatory process occurs through the development of MS. More specifically,
T-helper cell 17 (Th17) as a result of IL-23 expression has a significant role in
MS induction (Langrish et al., 2005). Additionally, both T-helper cell 1 as well as
IL-17 aids in the induction of MS (Gocke et al., 2007; Abromson-Leeman et al.,
2009).
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PAE significantly alters peripheral leukocyte reactivity as well as
chemokines involved in their migration (Noor et al., 2017; Sanchez et al., 2017).
Additionally, PAE increases the expression of IL-17 (Pascual et al., 2017).
Together, the data suggest that PAE may be a risk factor for developing MS due
to the increase in expression and reactivity of T cells involved in MS.
In addition to MS, the immune system plays a major role in Alzheimer’s
Disease (AD). AD is thought to be a result of accumulation of both amyloid beta
(Aβ) and neurofibrillary tau tangles (tau) (Hardy and Selkoe, 2002; Schöll et al.,
2016). An increase in these factors correlates with cognitive decline (Brier et al.,
2016; Schöll et al., 2016). Thus, much research in AD has focused on increasing
clearance of Aβ and tau, but unfortunately, many of these attempts have failed.
Recent literature has focused on the role of the immune system in the
development of AD. Interestingly, studies show that the complement immune
pathway, which is a pathway initially involved in mediating an innate immune
response, is upregulated in AD (Rogers et al., 1992). Many of the factors
released from the complement pathway come from astrocytes and neurons (LeviStrauss and Mallat, 1987). Additionally, the complement pathway factor C1q aids
in neuronal atrophy through the actions of microglia (Hong et al., 2016). In
addition to the complement pathway, release of IL-1β and TNFα by both
astrocytes and microglia play a role in AD (Fakhoury, 2018). As discussed
previously and shown in my own data, PAE primes glia resulting in heightened
activation as well as increased expression of IL-1β and TNF-α. Thus, it would
stand to reason that in individuals with PAE, the accumulation of Aβ and Tau
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could trigger heigthened glial responses, rendering one more susceptibilty to
developing AD and a more rapid and potentially more severe the progression of
the disease.

Conclusions
The aim of this dissertation was to determine the effects of PAE on neuropathic
pain processing. I first investigated whether the effects of PAE were lifelong. In
addition, I investigated whether I could unmask the effects of PAE by significantly
reducing the damage to the sciatic nerve. Interestingly, my hypothesis was
supported in that only PAE rats developed allodynia following a minor CCI which
coincided with astrocyte but not microglial activation. In addition to this,
peripheral leukocytes from PAE rats demonstrated heigthened reactivity and
expressed increased levels of IL-1β and TNFα. Together, this data demonstrated
that the effects of PAE were lifelong and that immune alterations are a global
effect. Consequently, I conclude that PAE increases suscpetibility to developing
allodynia potentially through alterations in astrocyte mediated mechanisms.
I next evaluated whether PAE alters the proinflammatory/anti-inflammatory
immune profile in order to induce suscpetibility to allodynia. Considering previous
data had demonstrated that PAE alone alters LFA-1 expression, which has been
shown to alter cytokine expression, I administered an LFA-1 atagonist to explore
the effects on PAE induced sensitivity to light touch. Interestingly, I found that
following minor CCI, increases in microglial activation, IL-1β, and CCL2 are
observed in the dorsal horn spinal cord. Furthermore, TNFα was significantly
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increased in PAE rats with minor CCI compared to Sac rats with minor CCI. This
would suggest a potentially larger role for TNFα and should be explored further.
Interestingly, when the LFA-1 antagonist, BIRT377, was adminstered i.t.
allodynia was abolished and proinflammatory factors were all significantly
downregulated. Curiously, clear effects between PAE and Sac rats with minor
CCI were observed within the L4-L6 DRGs. Significant increases were seen in
SGC activation, IL-1β expression, and blunted IL-10 expression. Interestingly,
dysregulated IL-10 expression was also observed within the spinal cord. Overall,
these data suggest that PAE may heighten susceptibility to developing allodynia
through alteration of normal IL-10 responses in addition to enhancing
proinflammatory cytokine expression within the spinal cord and DRG.
Lastly, I explored the effects of PAE on glutamate transporter function.
Considering my data demonstrates astrocyte dysfunction in addition to previous
data showing downregulation of GLAST expression, I examined how PAE may
lead to allodynia by preventing the normal function of this transporter to occur.
Strikingly, the PAE allodynic phenotype was replicated when a GLAST inhibitor
was administered within the spinal cord of Sac rats with minor CCI. Additionally,
PAE rats with minor CCI receiving a GLAST inhibitor demonstrated potentiated
allodynia. While no significant differences were mesured in gene expression of
glutamate transporters, increased protein levels of GLT-1 and GLAST expression
in spinal cords from PAE without nerve damage was onserved. In support of
GLAST dysregulation, in PAE rats with minor injury, a robust decreases in
GLAST and GLT-1 protein was measured, supporting the hypothesis that
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astrocytes are not capable of maintianing the demands of consistent glutamate
uptake upon increased glutmate accumulation from minor peripheral nerve
damage. Additionally, no significant differences as a result of PAE were seen in
the neuronal specific glutamate transporter EAAC1 nor in the phosphorylation of
the NMDA receptor subunit NR2B.
Overall, this data supports that in addition to the altering proinflammatory
and anti-inflammatory cytokine expression, glutamate transporter function may
also be altered further enhancing susceptibility to developing allodynia.

Clinical Significance
Clinical studies demonstrate that FASD children have significant immune
alterations as well as increased risk for infection and susceptibility to develop
autoimmune disorders (Church and Gerkin, 1988; Chiapelli and Taylor, 1995;
McGill et al., 2009; Gauthier and Brown, 2017). Furthermore, FASD children
(NOFAS.org) and animal models of FASD (Schneider et al., 2005) display
increased sensitivity to light touch. In neuropathic pain patients, increased
sensitivity to light touch, termed allodynia, is mediated through neuroimmune
processing. Together, these data suggest that underlying mechanisms in FASD
children may be mediated through immune alterations as a function of PAE.
Therefore, investigation into the specific immune processes that occur as a
consequence of PAE are important to determine . Through these studies, we
have demonstrate that PAE results in life-long alterations to the immune system
that are not apparent until a second insult takes place. Furthermore, we
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demonstrate that specific immune factors, such as LFA-1, are altered which may
result in changes in the proinflammatory/anti-inflammatory cytokine network
leading to increased risk for developing neuropathological conditions. More
generally, the findings from this investigation demonstrate the adverse in utero
conditions may render one more suscueptible to developing neuropathic pain.
Overall, these findings represent a novel step toward devleoping potential
therapeutics for children and adults with FASD.

Future Directions
Although this investigation umasked specific effects that PAE exerts on
neuroimmune functioning, and also demonstrate reversal of allodynia following
LFA-1 inhibition, several questions remain regarding PAE. The specific role of
the DRG in the induction of allodynia following minor CCI in PAE needs to be
investigated. Whereas spinal cord data demonstrate elevated IL-1β and TNF,
the DRG presented striking differences in SGC activation, and IL-1β and IL-10
expression. Thus, it is possible that heigthened reactivity at the level of the spinal
cord is mediated through amplfication of signals arriving from the DRG. I would
speculate that although this may be true, astrocytes and microglia remain
sensitized as a result of PAE and are key in the neuroimmune amplification of
pain. Considering that SGCs are similar to astrocytes, it is possible that PAE
alters both cells similarly. Furthermore, it has been demonstrated in other studies
that PAE does in fact alter glial cell reactivity within the brain. Thus, it would
stand to reason the glial cells within the spinal cord should demonstrate
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heigthened reactivity as a result of PAE as our data demonstrate. Further
exploration of this possiblity would need to done to make further conclusions.
In addition to this, IL-10 levels in response to injury are blunted both at the
DRG and the spinal cord, suggesting that PAE may work primarily through
decreased anti-inflammatory responses. It is also possible that a combination of
increased proinflammatory responses and blunted anti-inflammatory responses
could be resulting in allodynia following minor CCI. Furthermore, i.t. IL-1RA
resulted in full reversal from allodynia in PAE rats, supporting the hypothesis that
IL-1β is necessary for allodynia in PAE rats with CCI. Interestingly, the biggest
difference was seen in the IL-10 response between Sac and PAE. It would be
worth exploring whether applying a minor CCI in an IL-10 KO animals would
induce allodynia similar to PAE rats, as discussed earlier. The mechanisms
involved in PAE alteration of IL-10 responses needs to be further explored.
The third component of this work demonstrated a potential role for
glutamate transporter in PAE induced sensitivity to light touch. Astrocyte
alterations were seen in PAE rats with minor CCI, which may be a result of
dysregulated GLAST expression previously demonstrated in PAE (Brolese et al.,
2015). This alteration also results in increased glutamate at and around the
synapse as a aconsequence of PAE, which Brolese and colleagues
demonstrated (Brolese et al., 2015). Thus, it is possible that induction of
allodynia following minor CCI could be a result of increased sensitivity to
glutamate or exaggerated release of glutamate at the synaptic terminal. As
discussed previously, the role of glutamate receptors need further investigation to
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determine the potential impact that PAE exerts on glutamate release and their
respective receptors following a second injury or challenge (i.e. minor CCI
conditions).
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Appendix A – Abbrevations and Acronyms
Aβ – amyloid beta
AMPA – α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
ANOVA – analysis of variance
BAC – blood alcohol concentration
CCI – chronic constriction injury
CXCL – (C-X-C motif) chemokine ligand 1
CX3CL – (C-X3-C motif) chemokine ligand 1
CCL2 – (C-C motif) chemokine ligand
CCR – chemokine receptor type
CNS - central nervous system
DRG – dorsal root ganglia
EAAC1 – excitatory amino-acid carrier 1
EAAT – excitatory amino acid transporter
FAS – fetal alcohol syndrome
FASD – Fetal alcohol spectrum disorder
GFAP – glial fibrillary acific protein
GLAST – glutamate aspartate transporter
GLT-1 – glutamate transporter
Iba1 – ionized calcium-binding adaptor molecule 1
IHC – immunohistochemistry
i.v. – intravenous
i.t. – intrathecal
IL – interleukin
KO – knockout
LFA-1 – lymphocyte function associated protein 1
LPS – lipopolysaccharide
mGluR – metabotropic glutamate receptors
NMDA – N-methyl-D-aspartate receptor
NR2B – N-methyl D-aspartate receptor substype 2B
PAE – prenatal alcohol exposure
pFAS – partial fetal alcohol syndrome
SCN – sciatic nerve
SGCs - sattelite glial cells
T-cells – T-lymphocytes
TH – Thelper
TNFα – tumor necrosis factor α
WT – wild type
Qrt-PCR – reverse transcription polymerase chain reaction
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